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SUMMARY 
The phospholipid polar headgroup composition of 
membranes of C6 cells was modified in vivo by growth for 24h 
in media supplemented with the polar headgroup precursors, 
N, N'-dimethylethanolamine, N-monomethylethanolamine or 
ethanolamine. These modifications were achieved without 
alteration of the cholesterol and phospholipid content of the 
membranes, and without changes in the fatty acyl or protein 
composition of these membranes. No changes were found in the 
physical properties of membranes isolated from these cells . 
. 
Enriching the cell membranes with PDME, PNME or PE 
elevated the basal intracellular cAMP content, but decreased 
the degree of stimulation of intracellular cAMP content in 
response to 8-adrenergic stimulation. This reduction of the 
a-adrenergic response appeared to be due to enhanced phospho-
diesterase activity. 
8-adrenergic stimulation did not affect bulk 
physical properties of the membrane. Exposure to isoproterenol 
increased the amount of [3H] methyl label recovered from TLC 
plates but the different distribution of label indicated that 
such analysis is insufficient to demonstrate specific phospholipid 
methylation. 
This system is a useful means of studying the 
relationship between phospholipid composition, phospholipid 
metabolism and the a-adrenergic response in the C6 cell line. 
J 
CONTENTS 
Title 1 
Dedication 2 
Abbreviations used in this thesis 3 
Abstract 4 
Contents 5 
1.0 
1.1 
1.2 
1. /. . 1 
1. 2.2 
1. 2.3 
1. 2.4 
1. 2 .5 
1. 2.6 
1. 2.7 
1. 2.8 
1.2.9 
1.3 
1.3.0 
1. 3.1 
1. 3.2 
1. 3.3 
1. 3.4 
1. 3.5 
1.4 
1.4.0 
1.4.1 
1. 4.2 
1.4.3 
1.4.4 
INTRODUCTION 
The C6 glioma cell line 
Phospholipid biosynth~sis 
Introduction 
The COP-choline pathway 
Regulation of PC biosynthesis 
Base exchange 
Acylation of lysophosphatidylcholine 
The N-methylation pathway of 
phosphatidylcho1ine biosynthesis 
The relationship between the N-methylation 
and COP-choline pathways of PC biosynthesis 
Other functions of N-methylation of PE 
Non-polar lipid methylation 
The B-adrenergic system 
Components of the system 
The 8-adrenergic receptor 
The guanine nucleotide-binding regulatory 
protein 
Adenylate cyclase 
Mechanism of B-adrenergic activation of 
adenylate cyclase 
Role of phospholipids in membranes 
Lipid-protein interactions 
Effect of lipid physical properties on 
membrane protein function 
Boundary lipid 
Modification of lipid composition in vivo 
as a means of studying specific lipid-
protein interactions 
'" o 
13 
14 
15 
15 
16 
19 
20 
21 
22 
25 
26 
27 
30 
30 
30 
33 
37 
39 
42 
44 
46 
47 
48 
1.5 
1. 5.0 
1. 5.1 
1. 5.2 
1. 5.3 
1. 5.4 
1. 5.5 
1. 5.6 
1. 5.7 
1. 5.8 
1. 5.9 
1.6 
1.6.0 
1. 6.1 
1.6.2 
1.7 
1.7.0 
1. 7.1 
1. 7.2 
1. 7 . 3 
1. 7 .4 
1.8 
1.8.0 
Effects of lipid on adenylate cyclase 
activity and the B-adrenergic response 49 
Effects of modified membrane fluidity 50 
on B-adrenergic function 
Effect of specific lipids on the B-adrenergic 
system I: manipulation of membrane lipid 
composition in vivo 52 
Effect of fatty acyl chain composition on the 
B-adrenergic response 52 
Effect of cholesterol on adenylate cyclase 53 
Phospholipid polar headgroup modification 
and effects on adenylate cyclase 54 
Effect of specific phospholipids on the 
activity of the a-adrenergic system II: 
solubilisation studies 56 
Effect of specific phospholipids on the 
B-receptor 58 
Phospholipase studies 59 
Conclusion 59 
The C6 B-adrenergic system 60 
Desensitisation 63 
Effects of cell culture conditions on the 
B-adrenergic system 65 
Phospholipid methylation and the a-adrenergic 
response 
Stimulation of phospholipid methylation by 
B-adrenergic agonists 
Masking and unmasking of B-adrenergic 
receptors 
Evidence against a functional role for 
phospholipid methylation 
Summary 
Aims of this study 
67 
67 
71 
72 
75 
77 
7 
2.0 
2.1 
2.2 
2.3 
METHODS 
Cell Culture 
(a) Ce 11 Storage 
(b) Transfer of cells into culture 
(c) Cell passage 
(d) Polar headgroup manipulation 
(e) Measurements of cell growth 
(f) Photomicrography 
(g) Haematoxylin-Eosin staining 
Membrane Preparation 
(a) Cell harvesting 
(b) Membrane preparation 
Lipid analysis 
(a) Lipid extraction 
(b) Thin layer chromatography 
(c) Preparation of t.l.c. plates 
(d) TLC 
(e) Solvent systems 
(f) Character isa tion of the t.l. c. system 
(g) Zinzadze reagent 
(h) Ninhydrin stain 
(i) Dragendorff reagent 
(j) Periodate Schiff's reagent 
(k) Ferric chloride stain 
(1) Phosphorus determination 
(m) Cholesterol determinations 
(n) Free cholesterol assay 
(0) Enzymic assay 
(p) Fatty acid analysis 
79 
80 
84 
85 
8 
2.4 
2.5 
2.6 
2. 7 
RESULTS 
3.0 
3 . I 
3. I .1 
3.1. 2 
3.2.0 
3.2.1 
3.2.2 
3.2. 3 
Protein Content and Composition 
(al Protein assay 
(b) SDS polyacrylamide gel electrophoresis 
Physical Studies 
(al Fluorescence, depolarisation studies 
(b) Electron spin resonance studies on 
membranes 
(c) Electron spin resonance studies on 
live cells 
Cyclic AMP Assays 
(a) Cell culture 
(b) Preparation of binding protein 
(c) Assay procedure 
(d) Theophylline experiments 
Lipid methylation studies 
(a) Cell culture 
(b) Lipid methylation assay 
(c) Methionine uptake 
Cell Culture 
Growth of cells in media containing polar 
headgroup analogues 
(a) Effect on cell growth 
Effect on cell morphology 
(a) Photomicrographs 
Haematoxylin-Eosin staining 
Effect of base treatment on cell membrane 
composition 
Incorporation of bases into cell membranes 
Effect of base treatment on phospholipid 
polar headgroup composition 
Cholesterol:Phospholipid ratios in base 
treated cells 
9 
100 
102 
109 
116 
120 
120 
123 
123 
130 
130 
133 
137 
3.2.4 
3.2.5 
3.2.6 
3.3.0 
3 . 3 . 1 
3. 3.2 
3.4.0 
3.5.0-
3 . 5 . 1 
3.5.2 
3.5.3 
3.5.4 
3.6.0 
3.6.1 
3.6.2 
3.6.3 
3.6.4 
3.6.5 
3.7.0 
3 • 7 • 1 
Protein:Phospholipid ratios in cells with 
modified phospholipid polar headgroup 
composition. 
(a) Cells 
(b) Membranes 
S.O.S. polyacrylamide electrophoresis 
of membrane proteins 
Fatty acid composition of base-treated 
cells 
Physical properties of cell membranes 
with modified phospholipid polar head-
group composition 
Fluorescence depolarisation studies 
Electron spin resonance studies 
Summary of results in Sections 3.0-3.3.2 
Effect of polar headgroup alterations on 
cAMP accumulation 
Effect of theophylline on cAMP accumulation 
in cells with modified polar headgroup 
composition 
Time course of cAMP accumulation in cells 
whose membranes are enriched in PDME 
Summary of results in Sections 3.5-3.5.3 
Lipid methylation 
Cell density and lipid methylation 
Lipid methylation and the B-adrenergic 
response 
Effect of cAMP analogues on rate of lipid 
methylation 
Distribution of incorporated radioactivity 
during lipid methylation 
Summary of results in Sections 3.6.0-3.6.4 
Effect of phospholipid polar headgroup 
modification on lipid methylation 
Effect of polar headgroup modification on 
the distribution of [3 Hl-methyl groups 
incorporated during lipid methylation 
10 
140 
142 
142 
146 
146 
147 
153 
154 
154 
156 
159 
159 
159 
163 
165 
165 
168 
169 
169 
3 . 7 . 2 
3 . 7 . 3 
3.7.4 
3 . 7 . 5 
3.8.0 
3.8.1 
3.8.2 
3.8.3 
3.8.4 
3.8.5 
3.8.6 
4.0 
4.1 
4.2 
4.2.1 
4 . 3 
4.3.1 
4.4 
5.0 
5.1 
5.2 
6.0 
Effect of phospholipid polar headgroup 
modification on the rate of lipid 
methylation 
Effect of propranolol on isoproterenol-
11 
170 
induced demethylation in DME treated cells 172 
Methionine uptake in cells with modified 
phospholipid polar headgroup composition 174 
Summary of results in Sections 3.7 - 3.7.5 177 
Lipid methylation and cyclic AMP accumulation 
in high passage cells 178 
Production of high passage cells 178 
Appearance of high passage cells 181 
Measurements of high passage cell size 
Effect of high passage number on the 
S-adrenergic response 
Effect of high passage number on lipid 
methylation 
Summary of results in Sections 3.8-3.8.5 
181 
181 
182 
183 
DISCUSSION 184 
Phospholipid polar headgroup modification 
and its effect on the B-adrenergic response 185 
Lipid methylation in C6 cells 187 
Methyl transferases and lipid methylation 189 
Phospholipid polar headgroup modification 
and its effects on lipid methylation 190 
Demethylation in cells enriched in PDME and 
PNME in response to isoproterenol 192 
S-Adrenergic responsiveness and lipid 
methylation in high passage C6 cells 195 
CONCLUSIONS 198 
Phospholipid polar headgroups and the 
B-adrenergic response 199 
Lipid methylation~ 
desensitisation? 
a role in B-adrenergic 
SUGGESTIONS FOR FURTHER WORK 
201 
206 
APPENDICES 
Appendix I: Haematoxylin-Eosin staining 
Appendix II: Preparation and use of lipid stains 
Appendix III: SDS polyacrylamide gel electrophoresis 
Appendix IV: Cocktails for liquid scintillation 
spectrometry 
Appendix V: Gas liquid chromatograms of fatty acid 
methyl esters from C6 cell preparations 
Appendix VI: Excitation, emission and absorption 
spectra of D.P.H. 
Appendix VII: 
~\'f'" .. \d~ ~ " \ \ \ 
References: 
Composition of reagent B (Protein assay) 
C;"\.\lu\~~\'\ ~\ ('\\.\.\"'\~~ 0\ \'\Q."\\l\~~~ \)\w'r\\'I::I\\~'C.\~ \)fl\ 
\'\ -~\"Q ... 5~-Q'~\'- (~LQ \'~( 
Acknowledgements: 
publications arising from this work. 
1, 
210 
211 
213 
215 
218 
219 
222 
226 
?~I.::,~ 
227 
'2.t.r"2-
INTRODUCTION 
"It is easier to collect anecdotes, 
the tall tales 
That travellers, some centuries ago, 
brought home 
lJ 
Of wisecracks and the drolleries of fools, 
Than to travel in the mind to that place 
Where the map becomes reality, where 
cracks are gullies" 
Ruthven Todd 
1.1 THE C6 GLIOMA CELL LINE 
The c6 glioma (AT CCL107) is a stable cell line 
derived from a nitroso-methylurea-induced tumour isolated 
from rat brain (for a review, see Pfeiffer et al., 1978). 
14 
This 
cell is believed to be of astroblast character, but the exact 
glial affinities of the cell line have been questioned (aenda 
etal.,197l). C6 cells express the glial markers, S-lOO 
protein and glial fibrillary acidic protein, which suggests 
that they are of astrocytic character. However, they also 
express the oligodendroglial marker enzyme 2'~3'-cyclic nucleo-
tide phosphohydrolase, as well as the astrocyctic marker 
glutamine synthetase. Parker et ale (1980) have described 
markedly high cyclic nucleotide phosphohydrolase ~Qtivity in 
early passage (21 to 26) cells whereas glutamine synthetase 
activity was low in these early passage cells. 
was reversed in high passage (82 to 88) cells. 
This relationship 
On the basis 
of these differences in marker enzyme activity and in morpho-
logical appearance, they suggested that in early passages.C6 
show oligodendrocytic character which transdifferentiates to 
astrocytic character in late passages. 
C6 cells possess adrenergic receptors which are coupled 
to adenylate cyclase, and which respond to stimulation with 
B-adrenergic agonists by increases in their cyclic-3 ': 5' -adenosine 
monophosphate (cAMP) content of "heroic magnitude" (Gilman and 
Nirenberg, 1971). Much is known about the B-adrenerqic-adenylate 
cyclase system of C6 cells (re~~ew.ed in Pfeiffer et al., 1978). 
Mechanisms of cAMP accumulation and desensitisation of the 
response to prolonged stimulation have been recorded; these 
15 
mechanisms will be considered in greater detail later. 
The C6 cell possesses other receptors, some of which 
are coupled to adenylate cyclase. Benzodiazepine receptors 
are present (Syapin and Skolnick, 1975). Dopamine receptors and 
prostaglandin receptors have been identified (. "~.Ii\oI(w'<-~ ~'" \!Q.\,,(CS'-.Ii( <& \-\(\.\\'\rl'~l\'t) 1(\IC) 
which, like benzodiazepine receptors, are coupled to adenylate 
cyclase. Histamine and adenosine receptors are also present 
but they are not coupled to adenylate cyclase. 
The lipid composition of C6 cells has also been 
extensively studied (Robert et al., 1976 ; Eichberg, 1976) 
In general terms, much is known about the C6 cell system and 
several reviews are available (Benda, 1978; Pfeiffer et al., 1978; 
Van Calker and Hamprecht, 1980). 
1.2 PHOSPHOLIPID BIOSYNTHESIS 
1.2.1 Introduction 
Thudichum emphasised the importance of phospholipids 
in his book "A T~eatise on the Chemical Constitution of the 
Brain" (1884). He made extensive studies of the lipid compo-
sition of many tissues, which demonstrated that phospholipids 
comprised approximately 47% of the total lipid content of the 
human brain. 
The difficulties in preparing pure individual lipid 
classes precluded detailed study of their physiological role 
and prevented studies to challenge the prevalent notion that 
phospholipids had only a structural role, and were metabolically 
32 p , inert. However, Hevesey (1947) observed that as inorganic 
orthophosphate could be rapidly incorporated into tissue 
phosphatides in vivo and in vitro. McMurray et al. (1957) 
16 
32 demonstrated that P, as labelled ATP, was incorporated into 
rat brain phosphatides faster than 32 P from labelled inorganic 
orthophosphate. This suggested that phosphate incorporation 
proceeded by an energy-dependent process. These studies 
illustrated that dynamic turnover of phospholipid occurs, and 
stimulated further studies on phospholipid metabolism. 
It is now clear that membrane phospholipids are 
continually turned over; both the polar head group and the fatty 
acyl chains are subject to rapid modification. These lUodifica-
tions are the means by which the physical and chemical properties 
of the membrane are changed in response to environmental or 
physiological changes. Thus, phospholipid metabolism is also 
a homeostatic mechanism. In many tissues, phospholipids play 
an important role in the transmission of biological signals 
(Crews et al., 1982; Berridge, 1983) and regulation of cell-surface 
phenomena. 
The biosynthetic pathways of phosphatidylcholine (PC) 
formation are of most importance to the studies in this thesis. 
In the following pages, the principal pathways are discussed. 
1.2.2 The CDP-choline pathway 
The most important means of PC biosynthesis in 
mammals is by the CDP-choline pathway (Fig. I). Experiments by 
Kornberg and pricer (1952) showed that phosphorylcholine is 
incorporated as a unit into the PC of rat liver preparations. 
The phosphorylcholine is derived from the transfer of a phosphoryl 
group from ATP catalysed by the enzyme choline kinase (ATP:choline 
phosphotransferase, EC 2:7.1.3 7 ). 
Kennedy and Weiss (1956) made the important discovery 
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that cytidine triphosphate (CTP), but none of the other nucleo-
side S'-triphosphates, is essential for the incorporation of 
phosphorylcholine into PC in chicken liver preparations. Tne 
transfer of a cytidyl group from CTP to phospnorylcho1ine is 
catalysed by cytidyl~ransferase (CTP:cholinephosphate cytidyl~l 
transferase EC2.7.7.1S) with the release of pyrophosphate 
(Borkenhagen and Kennedy, 1957). 
The transfer of the phosphorylcnoline from CDP-choline 
to l,2-diacylglycerol is carried out by choline phosphotrans-
ferase (CDP-cnoline:l,2-diglyceride cholinephosphotransferase 
EC2.7.8.2), first described by Kennedy and Weiss (1956) in 
chicken liver. Cytosine monophosphate is released, and CTP 
regenerated from it using ATP as a phosphate donor. It is now known 
that phosphotidylethanolamine (PE) is formed by a similar path-
way. 
The ethanolamine and choline kinase activities appear 
to be due to different enzymes in the cytosol from rat liver 
preparations (Brophy et al., 1977). Cytidylyltransferase is 
found in both the microsomal and cytosolic fractions in rat 
liver preparations (Choy et al., 1977) and it shows high substrate 
specificity (Carter and Kennedy, 1966). 
Choline and ethanolamine phosphotransferases are 
exclusively microsomal in liver (Ostrow and Getz, 1973). Freysz 
et al. (1982) have presented evidence that suggests that in 
brain microsomes, the choline phosphotransferase is embedded 
in the outer leaflet of the bilayer, and that the ethanolamine 
phosphotransferase is on the inner leaflet. This may be a 
contributory factor to the maintenance of an asymmetric distri-
bution of PE and PC. Studies in vivo (Akesson et al., 1970) 
1~ 
suggest that choline phosphotransferase shows a preference 
for dienoic and tetraenoic diglyceride species, whereas ethanol-
amine phosphotransferase is more active with tetraenoic and 
hexaenoic species, although differences in substrate solubilitieS 
make these type of experiments difficult to interpret. However, 
Kahno and Ohno (1975) avoided these problems, and were able to 
show that ethanolamine phosphotransferase preferentially utilised 
hexaenoic species, whereas the choline phosphotran~erase showed no 
substrate preference between diglycerides. This may account for 
the relatively high level (more than 20%) of hexaenoic fatty 
acids normally found in rat liver PE (White, 1973). 
The substrate specificities of the enzymes of phos-
pholipid biosynthesis may be one of the means of tailoring phos-
pholipid molecules for their roles in the maintenance of membrane 
fluidity. However, the constant amounts of phospholipids in a 
given membrane, despite turnover, suggests that both catabolic 
and anabolic processes regulate membrane lipid composition. 
1.2.3 Regulation of PC Biosynthesis 
Although the CDP-choline pathway had been elucidated 
by the mid-1950's, it was the mid-1970's before it was clear how 
the pathway was regulated (for review, see Vance and Choy, 1979). 
The regulatory step is now known to be the conversion 
of phosphocholine to CDP-choline, which is catalysed by cytidylyl-
transferase. One of the first definitive studies of this 
reaction was performed by Paddon et ale (1979). HeLa cells 
were pulse-chased with [3 H)choline. The [3 H)choline was very 
rapidly converted to phosphocholine. When the disappearance of 
label from phosphocholine was monitored, it was found that it 
2u 
was transiently associated with COP-choline which was 
immediately converted to PC. 
Cytidylyltransferase from rat liver is associated 
with both the microsomal and soluble fractions. In the cytosol, 
the enzyme exists in two different forms. The major form (L-form) 
5 has a molecular weight of 2 x 10 and requires a lipid fraction 
for full activity. The presence of lysophosphatidylethanolamine 
(LPE), phosphatidylserine (PS), or phosphatidylglycerol (PG) stimulates 
the enzyme activity seven-fold. Diacylglycerol appears to cause 
aggregation of the L-form to high molecular weight aggregates, 
which show increased enzymic activity, LPC :appeam to inhibit the 
L-form. CTP has been proposed as an additional regulator of the 
enzyme (Vance and Choy, 1979). 
Sundler and Akesson (1975) showed that the rate of PG 
synthesis is also influenced by the availability of diacylglycerol, 
and by its fatty acid composition. Both PE and PC are synthesised 
in mammals principally by the COP-base pathway, however there are 
three other pathways of minor importance to consider for PC 
production. 
1.2.4 Base Exchange 
A number of major phospholipid types, including phos-
phatidylserine (PS), phosphatidylinositol (PI), PC and PE can 
have their polar headgroup (base) exchanged with a different 
base:-
2+ Ca 
PE + choline ~PC + ethanolamine 
2+ The base exchange enzyme is stimulated by Ca , and is usually 
found in greatest concentration in the microsomes (Porcellati 
et al., 1971). The reaction is not dependent on high-energy 
compounds, and operates best in the brain at alkaline pH s. 
It is similar to the reverse reaction of phospholipase D. 
Although the specificity of the enzyme(s) involved 
21 
is questionable, Miura and Kanfer (1976) claim to have success-
fully separated base exchange enzymes specific for ethanolamine, 
serine and choline. PE appears to be the best donor in brain 
preparations, and ethanolamine and serine are the free bases 
most frequently utilized in several systems (Saito and Kanfer, 
1973), so the pathway is of negligible importance for PC 
synthesis. In fact, Plagemann (1971) has shown that base exchange 
is of little importance for PC biosynthesis in Hepatoma cells in 
culture. 
Base exchange is of interest, since it seems that PE 
derived from PS by base exchange can be N-methylated to PC. 
Mozzi et al. (1982) have described such a system in microsomes 
derived from rat brain cortex. 
1.2.5 Acylation of Lysophosphatidylcholine 
Merkle and Lands (1963) showed that liver preparations 
contain selective acyl CoA:phospholipid acyltransferases that 
are able to bring about acylation of LPC: 
LPC + Acyl CoA ~ PC + CoA. 
Similar enzymes are present in other tissues. Lands and Hart 
(1965) showed that enzymes acting on l-acylglycerol-3-phosphoryl-
choline (l-acyl-GPC) could be distinguished from 2-acyl-GPC. 
The pattern of acyltransferase activity varies considerably, 
both with different fatty acids and with different acyl acceptors. 
Presumably the well known preferential esterification of 
22 
unsaturated fatty acids at position 2 of l-acyl-GPC, and of 
saturated fatty acids at position 1 of 2-acyl-GPC, is the result 
of the selective specificity of these acyltransferases. LPC is 
only present in minor amounts in biological membranes, due to 
its disruptive properties, and so acylation of LPC is unlikely 
to contribute significantly to the bulk PC content. The enzyme 
responsible seems to be microsomal in location (Fisher et al., 
1982) . 
1.2.6 The N-Methylation Pathway of Phosphatidylcholine Synthesis 
PC can also be formed by a successive methylation of 
the primary amino group of PE, via mono and dimethylated 
derivatives. These reactions are catalysed by two methyl-
transferases which use S-adenosyl-methione as a methyl donor 
(SAM) . The pathway was first demonstrated in rat liver cells 
by Bremer and Greenberg (1961) and has been recorded in many 
different systems (Mato and Alemany, 1983). Mozzi and Porcellati 
(1979) and Blusztajn and Wurtman (1981) have demonstrated the 
presence of the pathway in rat brain. 
In 1976 Katyal and Lombardi (1976) showed that the 
methylated intermediates, PDME and PNME, were present in lipid 
extracts from rat liver. Since then a vast amount of work has 
been done by Axelrod's group (see Hirata and Axelrod, 1980, for 
review) . It has been suggested that two methyltransferases 
exist (Hirata and Axelrod, 1980; 
Crews et al., 1980). 
Mozzi and Porcellati, 1979; 
2+ In adrenal medulla homogenates, the addition of Mg 
stimulated the incorporation of radioactive methyl groups from 
SAM. Thin-layer chromatography of lipid extracts showed that 
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the methyl groups were incorporated into PNME, PDME and pc. 
It was suggested that two methyltransferases with different 
properties were responsible for the incorporation of label into 
these intermediates. Methyltransferase I converts PE to PNME, 
2+ 
requires Mg , has a low Km for SAM (about 2 ~M) and an optimal 
pH of 7.0. Methyltransferase II catalyses the stepwise methyla-
tion of PNME to PDME to pc. This enzyme has a high Km for SAM 
2+ (100 ~M), a pH optimum of about 10.0, and no Mg requirement. 
These enzymes are located in the microsomes and mitochondria of 
the adrenal medulla. Similar activities have been found in a 
variety of systems (Hirata and Axelrod, 1980). 
Experiments with phospholipase C, trypsin and 
erythrocyte ghosts indicated that PE and phospholipid methyl-
transferase I (PMT I) are distributed on the inner leaflet of the 
membrane, whilst PMT II and PC are localised in the outer leaf-
let. It was suggested that methylation causes a rapid translaca-
tion of phospholipid across the membrane. This enzymatically-
stimulated flip-flop occurred rapidly (within 2 min.), and was 
suggested to be responsible for such a diverse range of events 
as the maintenance of membrane lipid asymmetry, calcium ion 
fluxes, membrane fluidity changes, and cell surface receptor 
function (Hirata and Axelrod, 1980). These events will be 
considered in detail later. 
Audubert and Vance (1983) have argued that erroneous 
conclusions have been drawn from these studies on Km's, and that 
a single methyl transferase enzyme with a pH optimum of about 10.0 
is responsible for all three methylations. 
1.2.7 The Relationship between the N-Methylation and 
CDP-Choline Pathways of PC Biosynthesis 
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Phospholipid methylation is another means by which PC 
can be produced, and has been suggested as an alternative source 
of PC production when choline deficiency reduces the output of 
the CDP-choline pathway in the liver (Mato and Alemany, 1983). 
In the liver, where the pathway was first discovered by 
Bremer and Greenberg (1961), it is estimated that as much as 
20% of liver PC is synthesised by this pathway (Sundlerand 
Akesson , 1975). The liver shows the highest methylation path-
way activity of all the body tissues, and much useful work has 
been done with liver membrane preparations and hepatocytes in 
order to understand the function of the pathway, and its rela-
tionship to the CDP-choline pathway (reviewed by Mato and Alemany, 
1983) . 
It seems that the methylation and CDP-choline pathways 
are regulated by similar agents, but in an antagonistic fashion, 
Pelech and Vance (1982) showed that a cAMP-dependent protein 
kinase is involved in the regulation of cytidylyltransferase. 
Incubation of hepatocytes with cAMP analogues for 
5h reduced the activity of cytidylyltransferase, however by ISh, 
the activity of the cytidylyltransferase was stimulated (Pe1ech 
and Vance, 1982). Similarly, (Pelech et al., 1981) CPT-cAMP, 
a cAMP analog, decreased PC synthesis from [3 H]choline by 40% 
and these effects were potentiated by phosphodiesterase inhibitors. 
The transmethylation pathway is stimulated by some 
cAMP analogues. Mato et al. (1982) found that cAMP stimulated 
methylation when added in the presence of micromolar ATP, which 
suggests the involvement of a cAMP-dependent protein kinase. 
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d 2+. i 1 . Hormones an Ca ~onophores st mulate methy at~on 
but inhibit the CDP-choline pathway (Alemany et al., 1982). 
Methylation inhibitors such as deaza adenosine stimulate the CDP-
pathway (Pritchard et al., 1982), and choline deficiency stimulates 
methylation, concomitant with a decrease in COP-pathway activity 
(Schneider and Vance, 1978). Maziere et ale (1982) have also 
demonstrated a coordinated regulation of the two pathways. 
In virus-transformed hamster fibroblasts, they were able to show 
that COP-pathway activity is depressed, while there is an 
increase in methylation pathway activity . 
. 
So it seems that the two pathways are regulated 
in a coordinated manner,. and that the methylation pathway provides 
an auxiliary system for PC production in times of dietary choline 
deficiency. PC turns over within 10 hours in the liver, and it 
may be necessary to have an auxiliary synthetic system to main-
tain the PC content of the cells. 
1.2.8 Other Functions of N-Methylation of PE 
Because of the importance of choline for acetylcholine 
production, interest has been focussed on the pathways of free 
choline production in the brain. The methylation pathway has 
been studied, as a possible additional means of choline produc-
tion. Experiments by Ansell and Spanner (1982) showed that the 
methylation pathway in brain tissue in vitro and in vivo, is of 
negligible importance as a source of choline. In experiments 
in which [1,2- l4 C]DME was injected intracerebrally into rats 
this was shown to be phosphorylated and incorporated into PDME, 
which was formed at a rate of about 5 nmol/g brain/h. However, 
only a small amount of this was methylated to PC in 7h. The 
amount of PC formed by methylation in synaptosomes is 
2.6-10 pmol/mg protein/h, compared with around 2700 pmol/mg 
protein/h in the liver, so quantitatively, the pathway is 
unlikely to be of much significanc~ for choline production. 
The enzymes responsible for phospholipid methylation 
do not appear to display rigid substrate specificity. Mogelson 
and Sobel (1981) have demonstrated that ethanolamine plasmalogens 
in rabbit myocardial membranes can be N-methylated, although at 
a slower rate than that of phosphoglycerides. Phospholipid 
methylation is stimulated by a variety of membrane and cell 
surface events. Some of the cases documented are described 
in Table ~, together with their presumptive function. Phospho-
lipid methylation associated with the 8-adrenergic response is 
dealt with in section 1.7.0. 
1.2.9 Non-polar Lipid Methylation 
It is clear that a large percentage of the methyl 
3 groupS of L-[methyl- H]methionine are incorporated into the 
neutral lipid fraction (Zatz et al., 1982). 
Zatz examined the fate of label 
incorporated into human red blood cells. It waS found that 
over 50% of the radioactivity Was incorporated into the non-
polar lipid fraction, and in particular, into fatty acyi 
methyl esters. Zatz et ale (1981) found 90% of the non-polar-
located label in ubiquinone in rat basophilic leukemia cells, 
retinal cells, and parotid cells. Ubiquinone appears to be 
methylated by catechol-o-methyltransferase, whilst fatty acid 
methyl esters are formed by fatty acid carboxymethyltransferase. 
It is clear that lipid methylation is not limited to phospho-
lipids, but rather, that events which increase the rates of 
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TABLE 1 EFFECTS OF DIFFERENT ADDITIVES ON PHOSPHOLIPID N-METHYLATION 
System Stimulus Effect on P'resum,etive Reference 
Rate of Function 
Methylation 
Pancreatic Islets Glucose Stimulation Insulin release I'" 0.-\<;';> ~ I\\-Q.\",,"j 
(1983) 
Glioma Cells Isoproterenol Stimulation cAMP production Munzel & Koschel 
( 1982) 
Red Blood Cells Immunoglobulin E Stimulation Crews et al. 
(1980 b) 
Mast Cells Immunoglobulin E Stimulation Histamine Hirata & Axelrod 
release (1980) 
Dictyostelium cAMP Stimulation Chemotaxis Alemany et al. 
discoideum (1980) 
Neurites Nerve growth Stimulation Pfenninger & 
factor Johnson ( 1982) 
Pituitary Corticotropin Stimulation Hook et al. 
release (1982) 
factor 
Chicken Differentiation Stimulation Zelenka et al. 
embryos (1982) 
Rat brain Carbamyl choline Stimulation Increase in GABA Giesinget & 
explants receptor Gerken (1982) 
affinity 
Rat cerebellum S-Adenosyl Stimulation Increase in aff- Perri et al. 
methionine inity of B-adre- (1983) 
nergic, benzo-
diazepine & GABA 
receptors 
Rat brain Ageing Stimulation Maintenance of Crews et al. 
synaptosomes membrane (1981) 
fluidity 
Rat brain Dopamine Stimulation cAMP production? Leprohon et al. 
neurons (1983) 
Lymphocytes Mitogens Stimulation Mitogenesis Hirata & Axelrod (1980) 
Glioma cells Benzodiazepine Stimulation cAMP production Strittmatter 
et al. (1979) 
Dictostyleum Calmodulin Stimulation Chemotaxis? Gil et al. (1980) 
discordeum 
Erythrocyte S-Adenosyl Stimulation Increase in Strittmatter 
methionine Ca 2+/Mg2+ ATPase et al. (1979b) 
activity 
Table 1 (continued) 
TABLE 1 (continued) 
s;istem Stimulus Effect on presumEtive Reference 
Rate of Function 
Methylation 
Neutrophils Attractant. Inhibition Chemotaxis Hirata et al. 
(1979) 
Neutrophils Phagocytosis Inhibition Gil et al. 
(1981) 
Macrophages Attractant Inhibition chemotaxis Pike et al. 
(1979) 
Platelets Aggregation Inhibition Shattil et al. 
(1981) 
Neuroblastoma Deaza-adenosine Inhibition Neurite Murato & 
Cells extension Manard (1982) 
Liver microsomes Glucagon Stimulation No effect on Kraus-Friedmann 
calcium flux & Zimniak 
(1983) 
Lymphocytes Mitogens No ef f'ee t Mitogenesis Moore et al. 
(1982) 
Kidney cortex S-Adenosyl Stimulation No effect on Chauhan et al. 
methionine fluidity or (1982) 
membrane transport 
function 
3u 
methylation cause a general increase in lipid methyl transferase 
activity. 
1.3 THE 8-ADRENERGI'C SYSTEM 
1.3.1 Components of the System 
It is now accepted that the a-adrenergic system 
consists of three components. These are listed in Tables 2 
and 3.· The hormone receptor (R) is exposed at the cell surface 
and binds ligands with specificity and high affinity. The R 
protein has a hydrophobic portion inserted into the membrane 
which probably interacts with the G-protein. The G-protein 
mediates the R protein stimulation of the catalytic (C) protein, 
and is subject to the influence of mono- and divalent cations. 
The C protein is exposed on the cytoplasmic side of the membrane. 
Hormonal stimulation, mediated by Rand G proteins, or stimula-
tion of the G protein-C protein complex by NaF results in an 
increase in the rate of cAMP synthesis. For this to occur in 
intact cells, the three components, which are mobile in the 
plane of the bilayer, must couple together (Cuetrecases, 1974). 
There is a continuous low basal activity of adenyl ate cyclase 
in the unstimulated cell, but hormonal stimulation elicits up 
to thousand-fold increases in cAMP production. 
Investigations on the structure and function of the 
a_adrenergic-adenylate cyclase system have employed a variety 
of genetic, physical and biochemical approaches, such as cell 
fusion, solubilisation, targe·t site analysis, kinetic and 
ligand binding studies (for review see Stadel et al., 1982). 
At least three proteins are involved in the ~-
• 
3,i 
adrenergic system. This has been shown by genetic and cell 
fusion studies. The C protein can be inactivated by N-ethyl 
maleimide, without effect on hormone binding in avian erythrocytes. 
(Schramm and Naim, 1970). 
More definitive evidence that separate Rand C 
proteins couple in the plane of the bilayer to yield an active 
adenylate cyclase was provided by Orly and Schramm(1975). In these 
elegant experiments, Friend cells which lack the R protein, 
but have G and C proteins, were fused with turkey erythrocytes 
containing C units inactivated by N-ethylmaleimide. 
Hormonal stimulation was reconstituted by cell fusion 
(reviewed, Ross and Gilman, 1980). This is evidence which 
supports the "mobile receptor" hypothesis 
1.3.2 The B-Adrenergic Receptor 
B-Adrenergic receptors are divided into two classes, 
on account of their ability to bind pharmacological agents that 
show different degrees of stimulation of cAMP production. 
The Be receptor - stimulation of adenylate cyclase 
activity by S-antagonists follows the order of potency: 
isoproterenol > noradrenalin > adrenalin 
and is blocked by the antagonist practolol. These Bireceptors 
are present in cardiac and adipose tissue. The B2-receptor-
stimulation of cAMP accumulation order of potency is: 
isoproterenol > adrenalin > noradrenalin 
and is blocked by propranolol (Fig. 3 ). These reoeptors are 
located in the bronchi and striated muscle. In both types of 
receptors, the (-)-isomers of the antagonists are more potent 
than the (+)-isomers. 
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Fig.3: B-ADRENERGIC AGONIST AND ANTAGONISTS 
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Recently, the mammalian 82 -adrenergic receptor has 
been purified SO,OOO-fold, after solubilisation by digitonin 
from canine lung tissue. A major band, due to a protein of 
52,000 daltons, on SOS polyacrylamide gel electrophoresis 
gels was shown to be the B-receptor binding site on account of 
3 its binding of [ HJ-labelled photo-affinity probes for the 
B-adrenergic receptor (Kirolovsky and Schramm, 1983). 
Cherksey et ale (1981) presented evidence which 
suggests that the B-adrenergic receptor of frog erythrocytes is 
bound to the cytoskeleton, and that agonist, but not antagonist, 
binding releases the receptor and allows it to interact with 
the G and C units. 
1.3.3 The Guanine Nucleotide-Binding Regulatory Protein 
Much is known about the molecular characteristics 
of the G-protein, principally since it is relatively easy to 
purify from membrane preparations. The protein binds guanine 
nucleotides, a property which was utilised by Pfeuffer (1977) 
to identify the protein as a 42,000 dalton protein in pigeon 
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erythrocyte membranes labelled with [ PJG~p-y-azidoanilide. 
Similarly, various studies using cholera toxin in order to 
32 AOP-ribosylate membrane proteins using [ P]NAO, identified the 
G protein as a 42,000-45,000 dalton protein in a variety of 
systems (reviewed in Ross and Gilman, 1980). 
Cassel and Selinger (1976) discovered that turkey 
erythrocyte membranes contain a GTPase activity, stimulated by 
catecholamines. Braun et ale (198l) have shown that the G-
protein contains two GTP-binding sites, one of which has a 
GTPase activity. This may be of importance to the model 
proposed by Cassel and Selinger (1977), and Ross and Gilman 
(1980), who proposed that a 'regulatory GTPase cycle" controls 
hormone-stimulated adenylate cyclase activity. 
On the basis of results obtained by target-si~e 
analysis, Rodbell (1980) has proposed that the G unit exists 
in two different forms. In the G stimulatory form, coupling 
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of R with the G unit results in a complex which will activate 
adenylate cyclase. On the other hand, stimulation of certain 
receptors, e.g. a-adrenergic receptor, leads to an R-G complex 
which inhibits adenylate cyclase. A separate population of G 
inhibitory proteins have been proposed. This forms the basis 
for a dual regulation of the C protein by inhibitory and stimu-
latory hormones mediated by RG complexes (the disaggregation-
coupling model). 
The cytoskeleton of the cell appears to be involved 
in regulation of adenylate cyclase on account of its linkage 
to the G protein (Rasenick, 1981). Agents such as cis unsatura-
ted fatty acids, and colchicine which disrupts microtubules 
enhance mobility of the G protein, and increase its binding to 
the catalytic unit. This suggests that the G unit is bound to 
microtubules in the absence of hormonal stimulation. 
Recent work by Gilman's group (Northup et al., 1983) 
has demonstrated that the G protein can be resolved by gel 
filtration into two subunits (Tables 2 and 3 ) . 
The resolved a subunit was able, when activated with 
guani.dine nucleotide analogues, to activate purified prepara-
tions of C protein. The a subunit binding to the a.C complex 
promotes a slow deactivation of the activated C unit. 
TABLE 2: PROTEIN COMPONENTS OF HORMONE-SENSITIVE 
ADENYLATE CYCLASE 
Hormone receptor (R) 
Contains hormone binding site on extracellular 
face. One or more different r~ceptors per target cell. 
Catalytic protein (C) 
2+ Activity with Mg .ATP less than 10% of activity with 
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2+ Mn .ATP. Not stimulated by hormones, fluoride or guanine 
nucleotides. Molecular weight = 190,000. Sensitive to 
mild heating, low concentrations of sulphydryl reagents. 
Guanine nucleotide-binding regulatory protein (G) 
Confers upon C ability to use Mg 2 +.ATP as substrate. 
Mediates regulation of C's activity by fluoride and 
guanine nucleotides. 
Binds guanine nucleotides and fluoride. 
Probable GTPase. 
Contains 41,000-45,000 dalton cholera toxin substrate. 
More stable to heat or sulphydryl reagents than is C. 
The G protein consists of two subunits (a and a) on 
binding of R-H, the a subunit dissociates. 
The a subunit activates the C unit. A slow re-association 
of the a.a complex terminates activation of C. 
TABLE 3 
Source 
Rat renal 
medulla 
MOLECULAR WEIGHT OF COMPONENTS OF THE 
ADENYLATE CYCLASE SYSTEM (IN DALTONS) 
Hormone G-~rotein C-~rotein 
receptor 
1.59 x 105 
Bovine cerebral 
105 cortex 2.2 x 
S49 lymphoma 7.5 x 104 4.5 x 104 2.5 x 105 
S49 lymphoma ex subunit 
(cyc- clone) 5.15 x 104 
± 3,300 
13 subunit 
5.22 x 104 
± 2,500 
4 105 Rat liver 4.5 x 10 1.8 x 
Rat testis 1.9 x 105 
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Accordingly, they have proposed a model in which the 
hormone-promoted dissociation from the ~ subunit provides a 
mechanism for inhibitory regulation of the C unit: 
L 
~.13 ~ L.~.13 co-
2+ J~ Jt Mg 2+ Mg 
a+13 ~ 8 + L.~# L.a.C· 
..::-
L C 
where L is an activating ligand (GTPyS) 
and C· represents the active C unit. 
Thus the rate of activation of G is inversely related 
to ~.13 concentration, and is reduced by 8 which has a low 
affinity for activating ligands. The dissociation of ~.B is 
the slow step in the activation of G. 
1.3.4 Adenylate Cyclase [ATP pyrophosphate-lyase (cyc1ising), EC 
4.6.1.1] . Much less is known about the physical properties of 
the C protein, because of the difficulty in obtaining pure 
preparations of the protein. Details of the size of C proteins 
from different sources are given in Table 3. Nothing is known 
about the subunit composition of the C protein, although partial 
specific volume determinations make it seem likely that C has a 
large hydrophobic surface area. This is supported by the ability 
of cholate-solubilised C to be reincorporated into monolamellar 
phospholipid vesicles upon the removal of detergent (Ross, E.M., 
unpublished) . 
The MnATP-dependent adenyl ate cyclase activity of C 
is sensitive to several proteases and sulphydryl reagents (Ross 
and Gilman, 1978). Cysteine residues appear to be involved in 
both catalysis and G-C interaction, since both activities can 
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by destroyed by N-ethylmaleimide (Ross et al., 1978). 
other Components 
2+ 2+ Mg and Mn have stimulatory effects on adenylate 
cyclase, as does a diterpenoid compound called forskolin. The 
exact site to which these agents bind is not known, but evidence 
collated by Rodbell (Rodbell, 1983) suggests that a distinct 
unit proximal to the catalytic unit contains all these sites. 
Brooker et al. (1983) have demonstrated the presence ofa compo-
nent which is essential for forskolin-stimulated cAMP accumulation 
in C6-2B cells. This component has a shorter half-life than the 
other three components, and is turned over rapidly. Blocking 
protein synthesis causes a progressive loss of forskolin 
stimulation, presumably due to loss of the labile component. 
In certain cells, in particular brain cells, adenylate cyclase 
is present in calmodulin-dependent and calmodulin-independent 
forms (Bradham and Cheung, 1980). The dependent forms are 
activated by calmodulin or calcium independently of the G protein. 
Another influence on adenylate cyclase activity is 
2+ Ca whether acting via calmodulin, or by itself it stimulates 
adenylate cyclase at low concentrations, but inhibi~ at higher 
2+ 2+ 
concentrations, possibly due to competition for Mg and Mn 
sites. (Bradham and Cheung, 1980). Ca 2 + also stimulates phos-
phodiesterase resulting in an increase in the rate of cAMP 
hydrolysis. (Lin and Cheung, 1980). 
Studies by Rodbell and Martin's groups using target 
size analysis of the glucagon-activated adenylate cyclase 
system, indicate that R-G complexes exist in large molecular 
weight oligomers (Rodbell, 1980; Martin, 1983), whether 
similar oligomers exist in the 8-adrenergic adenylate cyclase 
system, remains to be seen. 
Although not usually classed as a component of the 
8-adrenergic adenylate cyclase system, 3 ': 5' -cyclicAMP 
phosphodiesterase [EC3.1.4.17] is worthy of mention. This 
enzyme hydrolyses cAMP, so terminating the hormonal response. 
It is mainly located in the cytosol, and catalyses the reaction: 
H 2 0 
3 ': 5' -cyclicAMP --... 5'-AMP 
1.3.5 Mechanism of S-adrenergic Activation of Adenylate Cyclase 
The theory which fits in best with the majority of 
experimental data to explain adenylate cyclase activation is 
the "collision coupling" theory of Tolkovsky and Levitski (1978). 
This theory was derived from an algebraic treatment of kinetic 
data from experiments in which different components of the 
S-adrenergic system were investigated. 
Hormone binding to Rand GTP binding to G induce 
activation of C to its cAMP producing state C' thus 
Hormone 
ATP ~ cAMP + ppi 
GTP,Mg 2 + 
The hormonal signal (H) is terminated upon GTP hydrolysis to 
GDP and Pi at the GTPase site. Reactivation requires removal 
of GDP, binding of a new GTP molecule, and the continued 
presence of hormone. Thus the steady state level of activated 
adenylate cyclase is determined by the relative rate of 
conversion of inactive enzyme (C) to active enzyme (C') which 
is termed the 'on reaction':-
transient 
complex 
The rate of GTPase activity determines the rate of deactivation 
of the enzyme (the 'off reaction'). 
The steady state level of activated enzyme is 
described by the amount of enzyme in the activated state or 
'on reaction', and that in the 'off reaction' state:-
C C' 
[CTOTAL] = [C] + [C'J. 
Therefore at steady state: KOFF [C' ] 
The model accounts for a number of properties 
of the system, and is a useful means of predicting what the 
order of coupling of the components is. 
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The 'on reaction' kinetics in the presence of 
p[NH]ppG are always first order, and KON is always a saturating 
function of the hormone concentration. These findings support 
the view that G is complexed with C at all times. The results 
obtained by target si~e analysis (Martin, 1983) do appear to be 
in agreement with the collision coupling model. In these studies 
the existence of a transitory HRGC complex was found, its 
existence having been predicted by the collision coupling 
model. 
Other models for adenylate cyclase activation have 
been produced (Ross and Gilman, 1980; Stadel et al., 1982) but 
do not appear to have gained the popularity of the collision 
coupling version. 
Apart from the termination of response by GTP hydro-
lysis, when intact cells are continuously exposed to S-agonist, 
there is a progressive decrease in the ability of the S-
adrenergic system to respond. This densensitisation, as it is 
called is due to subtle changes in the responsiveness of the 
components of the system, and is dealt with in section 1.6.1. 
It probably represents a method of preventing cellular damage 
by over-exposure to B-agonists. Comprehensive reviews have 
been written on this subject by Leftkowitz and co-workers 
(Lefkowitz et a1., 1980). 
1.4 ROLE OF PHOSPHOLIPIDS IN MEMBRANES 
Phospholipids contribute to membrane structure, as 
well as regulating the function of proteins contained within, 
or loosely attached to the membrane. 
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There is a considerable variety of phospholipid 
species, each with its own distinct polar headgroup and fatty 
acyl composition. If phospholipids had merely a structural role 
to play, then one would not expect to find such a diverse variety 
present. Consequently, these different phospholipids must have 
a role in modulating membrane protein function. 
Phospholipids could control membrane proteins by two 
possible means. Specific interaction between given phospho-
lipids and membrane proteins could occur. Alternatively, 
phospholipids could exert effects by virtue of their physical 
and chemical properties, which influence the environment in 
which membrane proteins are located. 
The first possibility, that phospholipids specifically 
interact with membrane proteins found favour a decade ago when 
studies on solubilised membrane-bound enzymes began to have some 
degree of success. It was found that, in some cases, enzymic 
activity could be restored by adding back a given lipid, or 
mixture of lipids. (Fourcans and J.ain, 1974). The problem 
about this type of approach is that one cannot unequivocally 
demonstrate that the required lipids act on the protein directly so 
¢&usi~g specific alterations in tertiary structure rather 
than general effects on the hydrophobic packaging of the protein 
molecule. Differences in the physical state of the lipid species 
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themselves at a given temperature make it difficult to compare 
the efficacy of different lipids in restoring membrane protein 
function. 
In an attempt to demonstrate the effect of specific 
phospholipid headgroups on enzyme function, different strategies 
have been devised. These methodologies include: detergent-
mediated lipid substitution; the insertion of defined lipids by 
supplementing the growth medium with polar headgroups, or 
precursors (discussed in sectionl.52); phospholipase treat-
ment; and dietary manipulations. However all these methods 
are capable of modifying other parameters other than headgroup 
composition, and so results obtained by such tactics have to 
be appraised with caution. For example, changes in headgroup 
composition may also alter membrane physical properties, or 
fatty acyl chain and cholesterol content (reviewed in Houslay 
and Gordon, 1983). 
These drawbacks have been considered in greater detail 
in reviews by Sandermann (1978) and Houslay and Gordon (1983). 
These approaches are not invalidated by these criticisms, but 
it is essential that experiment design takes these other effects 
into account. 
To date the only membrane-bound enzyme which shows 
an unambiguous preference for specific phospholipid polar head-
groups is the mitochondrial S-hydroxybutyrate dehydrogenase 
which requires the choline group of PC in order to bind its 
+ 
co-enzyme, NAD (Isaccson et al., 1979). 
It has been observed that this enzyme, cytochrome C 
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2+ 2+ 
oxidase and the Ca Mg ATPase can all be activated more 
effectively by a mixture of lipids than by ~ ":,:\'(\..:J~ ~h\f~y"'<;)\'~\~ 
This may be of significance in vivo, since biological 
membranes are almost exclusively heterogenous in lipid compo-
sition. When presented with mixtures of phospholipids, only 
2.5-4 molecules of PC were required per polypeptide chain for 
activation of 8-hydroxybutyrate (Gazzotti et a1., 1975). 
Possibly the enzyme is activated by a combination of non-specific 
lipid:protein interactions and specific binding to high affinity 
sites. 
Another membrane protein, for which there now appears 
to be good evidence to suggest specific phospho1ipid:protein 
interactions is the proteolipid protein, the major integral 
protein from myelin. Negatively charged phospholipids such 
as PA and PS bind with highest affinity to the delipidated 
pro t e in. (B r 0 ph yet a 1 ., 1 98 3) . 
Before discussing approaches to the study of phospho-
1ipid:protein interactions, I shall briefly list some concepts 
of membrane structure, protein and lipid mobility which are 
relevant to this thesis. 
1.4.1 Lipid:Protein Interactions 
The fluid mosaic model of Singer and Nicolson (1972) 
is now generally accepted. Proteins and lipids both display 
varying degrees of mobility in the lateral plane of the bilayer; 
in addition proteins show a rotational diffusion, and to a 
lesser degree lipids show a slow, transverse motion across the 
bilayer (flip-flop). This area has been reviewed by Edidin 
(1981) . 
4$ 
The lateral mobility of proteins in the membrane is 
of particular importance for the a-adrenergic adenylate cyclase 
system, since it requires the coupling of receptor, G protein 
and adenylate cyclase units for activation of cAMP production. 
The freedom of motion of membrane proteins is influenced, in 
turn, by the freedom of motion or fluidity of the membrane 
lipid molecules. 
Fluidity comprises two distinct parameters: lipid 
order which is a structural property, and lipid motion which 
is a dynamic property. The fluidity of a lipid membrane is 
influenced by the polar headgroup and fatty acyl chain composi-
tion of the phospholipids and the cholesterol, and protein 
content of the membrane. 
At the top of the acyl chain, near to the polar head-
group, motion is highly anisotropic, whereas the section of the 
acyl chain nearest to the core of the bilayer undergoes relatively 
isotropic motion. 
Electron spin resonance (ESR) is a useful technique 
with which the physical properties of the membrane can be 
studied because nitroxide spin labels can be located near the 
polar headgroup (as with 5-doxyl stearic acid), or close to 
the bilayer core (using 16-doxyl stearic acid). Using 5-doxyl 
stearic acid spin labels, one can study the extent of anisotropic 
motion, from which structural (order) parameters can be derived. 
The l6-doxyl stearic acid spin label on the other hand, allows 
measurements of the rates of motion within the bilayeri 
consequently a more complete assessment of the physical 
properties of the membrane can be derived (Schreier et al., 
1978) • 
4G 
The problem with fluorescent probe molecules such 
as diphenylhexatriene, is that they are sensitive to both the 
structural and dynamic properties of the bilayer, and cannot 
differentiate between changes in these two individual components 
of fluidity. 
The degree of methylation of the phospholipid polar 
headgroup, from PE to PC in particular, has been shown to cause 
a significant decrease in the phase transition temperature of 
model membranes, due to steric effects of the headgroup disrupting 
packing. Thus, changes in the membrane polar headgroup composi-
tion might be expected to cause significant changes in membrane 
fluidity (Vaughan and Keough, 1974; Jain and Wagner, 1980). 
1.4.2 Effect of Lipid Physical Properties on Membrane 
Protein Function 
Since membrane proteins are contained within a lipid 
matrix, it follows that changes in the physical properties of 
the lipid, either by composition changes, or by the effect of 
external factors such as temperature, or cations (Kimelberg, 
1977) would be likely to alter membrane protein activity. 
First, it might be wise to consider what types of 
lipid:protein interactions there are. Much of this work has 
been done on membrane-bound enzymes, since their enzymic 
activity is a convenient index by which to measure the effects 
of alteration in the nature of these lipid:protein interactions. 
This topic has been extensively covered in good reviews 
(Freedman, 1981; Lenaz, 1977). 
Apart from specific phospholipid:protein interactions, 
covered in later sections, the physical properties of lipids 
play several roles in membrane protein function. Some of the 
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more important roles include: 
1. Anchorage of the protein to the membrane; 
2. Maintaining the protein in a conformation 
appropriate to the function of the protein -
particularly important for membrane bound enzymes; 
3. Orientating the protein in the membrane 
+ + (e.g. Na /K ATPase); 
4. Providing an appropriate environment for processes 
requiring non-polar media. 
Thus, changes in lipid physical properties could 
modulate membrane protein function. 
1.4.3 Boundary Lipid 
Apart from the influence of the bulk lipid on 
membrane proteins, the proteins may also be influenced by a 
small population of lipid molecules which interact directly 
with the protein, the boundary lipid. 
Jost et ale (1973) demonstrated, using electron spin 
resonance techniques, that the cytocnrome C oxidase interacts 
with a small population of lipid molecules. The boundary lipid 
was calculated to be comprised of 30-35 mol. of phospholipid 
per mol of protein. 
It was suggested that these phospholipids, rather than 
the bulk lipid modulated the properties of the enzyme. 
The existence of boundary lipid is controversial 
(see Quinn, 1981). Watts (1981) has offered a plausible 
explanation for the differing conclusions drawn from ESR and 
NMR studies. He has suggested that the detection of boundary 
lipid by ESR, and the failure to observe this lipid population 
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by NMR is due to the different time regimes sampled by the 
two spectroscopic techniques. One role of boundary lipid was 
suggested to be the maintenance of the protein in a conformation 
compatible with its activity (Watts, 1981). It is interesting 
to speculate that phospholipid methylation could modify membrane 
protein function, despite its limited capacity for PC production, 
if it were to change the composition of boundary lipid. 
Much evidence for a physical effect of lipids on 
membrane proteins has come from the study of Arrhenius plots 
(Kimelberg, 1977). These studies indicate that phase changes 
in the lipid can cause changes in the activation energy of 
enzyme-catalysed reactions manifested by changes in the tempera-
ture at which breakpoints in the plot occur. These results have 
to be interpreted with caution, since some alterations in 
activity appear to be due to thermal effects on the protein 
itself. 
1.4.4 
(Jain and Wagner, 1980). 
Modification of Lipid Composition in vivo as a means 
of Studying Specific Lipid-protein-rnteractions 
The problems of solubilisation of membrane proteins 
have been discussed. Because of the difficulties encountered with 
this approach,the modification in vivo of membrane lipid 
composition has offered an alternative approach which would not 
appear to cause damage to the proteins, since they are not sub-
jected to harsh chemical treatments. Membrane-bound proteins, 
as the name suggests, are intended to function within the hydro-
phobic environment of a biological membrane. 
For complexes such as the a-adrenergic adenylate 
cyclase system, the membrane provides the correct orientation 
49 
for the function of the complex. Modification of membrane 
lipid in vivo allows the complex to be studied in an intact 
membrane, rather than each element having to be taken in 
isolation. 
By growing cells in the presence of fatty acids, 
polar headgroup precursors or by fusing cells with liposomes 
containing defined phospholipid or cholesterol mixtures, the 
lipid composition can be readily manipulated. The principal 
problem with this strategy is that often variables other than 
the one under study are also altered. Apart from unintended 
changes in membrane composition, or cell growth, changes in 
the physical properties of the cell membranes can occur. 
Changes in the physical properties are often compensated for 
by cellular processes which lead to a 'homoviscous adaptation' 
(schroeder, 1978) which maintain the normal physical state of 
the membrane in spite of the perturbation. 
This technique is also a useful tool for studying 
the lipid dependence of a variety of cellular processes. Table 4 
lists some effects of phospholipid polar headgroup manipulation 
on a variety of different cell functions. Possible mechanisms 
for the incorporation of polar headgroup precursors have been 
suggested. (Sundler and Akesson, 1975; Yavin, 1977). 
1.5 EFFECTS OF LIPID ON ADENYLATE CYCLASE ACTIVITY 
AND THE B-ADRENERGIC RESPONSE 
As discussed in section 1.4, lipid composition can 
affect membrane bound enzyme activities through either specific 
effects of given lipids, or by general effects on membrane 
physical properties. 
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The main approaches have been: 
(i) solubilisation of the protein, and adding back defined 
lipid mixtures to the protein preparation to study 
their effects on the restoration of protein function 
(ii) the removal of specific lipids by phospholipase 
treatment, and determining the effect on activity in 
membrane preparations 
(iii) modification in vivo of lipid composition and 
observing the effects on protein function. 
The results of modifications in vivo on the a-adrenergic response 
wi 11 be described in section l.~ ~ Bearing in mind the draw-
backs of solubilisation and phospholipase treatments, I would 
like to discuss the conclusions drawn from such studies in this 
section. Before describing the effects of specific lipids on 
the a-adrenergic response, I shall describe some studies in 
which the physical state of the membrane was modified by the 
application of exogenous agents such as anaesthetics, since 
these agents exert their effects by changing the physical state 
of the lipid components of the membrane. These studies have 
been summarised by Houslay and Gordon (1983). 
1.5.1 Effects of Modified Membrane Fluidity on e-Adrenergic 
Function 
Many studies have come from the laboratory of Houslay 
describing the effect of benzyl alcohol on adenylate cyclase 
activity in preparations of rat liver membranes (Houslay and 
Gordon, 1983). Benzyl alcohol is a small, water soluble mole-
cule which readily partitions into bilayers, with its aromatic 
nucleus directed into the apolar core of the bilayer, and its 
hydroxyl group orientated in the polar headgroup region of the 
phospholipids. When inserted into the bilayer, it increases 
the fluidity and decreases the lipid phase transition tempera-
ture. Since benzyl alcohol is a neutral molecule, charge effects 
on the phospholipid polar headgroups on protein molecul~ can be 
ruled out. 
When 40 mM benzyl alcohol is added to liver plasma 
membranes, the hormone response of adenylate cyclase to glucagon 
was activated twofold, although the effect on basal activity is 
small. Considerable effects on NaF and guanine nucleotide 
stimulation of activity were observed. NaF-stimulation was 
inhibited at low benzyl alcohol concentrations (10 mM), and 
was believed to be due to a disruption of the polar headgroup 
packing of the bilayer. A reduced stimulation by guanine 
nucleotides implied a change in the conformation of the enzyme, 
or altered interaction with bilayer lipids, perhaps analogous 
to the effects described by Bakardjieva (1982) of phospholipid 
substitutions on receptor function. The increased hormonal 
response was probably due to increased fluidity of the bilayer 
relieving physical constraints on the enzyme imposed by lipids, thus 
increasing the conformational flexibility of the enzyme, and so 
increasing its activity. 
However, at high benzyl alcohol concentrations all 
activities are inhibited, although fluidity was increasing. 
This may be due to displacement of boundary lipids by benzyl 
alcohol. The results of these studies imply that enzyme activity 
is constrained by its lipid environment, but that increased 
fluidity can disrupt the organisation of lipid-protein domains 
essential for normal function, and eventually, disrupt 
boundary lipid conformations with a resultant loss of enzyme 
activity. 
Increased lipid fluidity has also been caused by 
increases in temperature, and presumptive effects of lipid 
fluidity on protein function have been claimed on account of 
changes in the position of breakpoints in Arrhenius plots. 
However, there is much disagreement about the meaning of such 
data since some of the differences in the position of the 
breakpoints are undoubtedly due to thermal effects on the protein 
itself. (Houslay and Gordon, 1983). 
1.5.2 Effect of Specific Lipids on the a-Adrenergic System 
I: Manipulation of Membrane Lipid Composition in vivo 
-
In this discussion I shall concentrate on the effect 
of membrane lipid modification on a-adrenergic function, and I 
shall describe, in turn, the effects of fatty acyl chain modi-
fication, cholesterol content and phospholipid polar headgroup 
manipulation. 
1.5.3 Effects of Fatty Acyl Chain Composition on the 
S-Adrenergic Response 
Orly and Schramm (1975) investigated the effects of 
fatty acids of different chain length and degree of un saturation 
on adenyl ate cyclase activity in turkey erythrocytes. Certain 
of these fatty acids stimulated a 3-fold activation of cate-
cholanine-stimulated adenylate cyclase activity at 37°C, and 
as much as l6-fold activation at 20°C. The most potent activator, 
cis-vaccenic acid, caused an increase in membrane fluidity as 
detected by fluorescent probes. However, there was no close 
correlation between the increase in fluidity and activation of 
adeny1ate cyclase (Hous1ay and Gordon, 1983) suggesting that 
they do act directly on adenylate cyclase as well. This 
approach does not, however, seem particularly useful, since 
membrane physical properties are so drastically altered. 
1. 5.4 Effects of Cholesterol on Adenylate Cyclase 
Various studies have been made on the role of 
cholesterol on adenylate cyclase (for review, see Houslay and 
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Gordon, 1983). All these studies have involved treating intact 
cells with cholesterol-rich 1iposomes, or by using cell mutants 
defective in cholesterol biosynthesis. The problem with this 
approach is that it is likely that the cells will adapt to 
these alterations by altering their phospholipids c:.C),,,,,~\;)~\~U(\ . 
Techniques have been developed using 1iposomes to 
increase or decrease the cholesterol content of rat liver plasma 
membranes. (Hous1ay and Gordon, 1983). Some interesting 
results have been obtained by this approach. 
Basal activity seems to be relatively insensitive to 
increased cholesterol concentrations. On the other hand, 
glucagon, glucagon + GTP and NaF stimulated activities are 
decreased dramatically if the cholesterol-phospholipid ratio is 
increased or decreased from the range 0.65-0.72. This implies 
that cholesterol plays an important role in the regulation of 
adenylate cyclase. 
Increased cholesterol levels seem to increase the 
order parameter of the 5-doxyl stearic acid spin probe. There-
fore it may be that cholesterol inhibits the enzyme partly by 
rigidifying the membrane, or by decreasing the number of 
cholesterol-poor domains available to the enzyme. This could 
result in increased protein-protein interaction by restricting 
the availability of phospholipids to the enzyme. 
The decreased activity in cholesterol-poor membranes 
could be due to lack of interaction of cholesterol with the 
• 
.. .. 
!lot 
enzyme itself, or due to the release of phospholipids inhibitory 
to the enzyme from complexes with cholesterol. 
1.5.5 Phospholipid Polar Headgroup Modification and 
Effects on Adenylate Cyclase 
Phospholipid polar headgroup manipulation is carried 
out by supplementing the growth medium of cells in tissue 
culture with polar headgroups. These are rapidly incorporated 
in the corresponding phospholipids, and this technique has 
proved successful in a number of different cell types (Table 4). 
Apart from my own work, it seems that this technique 
has not been extensively utilised in the study of B-adrenergic 
function. Only two papers have appeared which have described 
the effects of polar headgroup manipulation on adenylate cyclase 
activity. These are discussed below. 
Engelhard et al. (1976, 1978) grew LM fibroblasts 
in the presence of the polar headgroups choline and ethanolamine 
(Engelhard et al., 1976) or in the presence of ethanolamine, 
NME, DME, 3-aminopropanol or 2-amino-l-butanol. (Engelhard 
et al., 1978). 
In all cases the fatty acyl chain composition 
remained unchanged. No changes were found in the protein 
composition of membranes from the treated cells, as assessed 
by SDs-polyacrylamide gel electrophoresis, although supplemented 
membranes showed an increase in viscosity, as measured by 
fluorescent depolarisation measurements of the probe diphenyl-
hexatriene. (Engelhard et al., 1976). 
These modifications caused significant changes in 
basal, NaF- and prostaglandin El (PGEl)-stimulated adenylate 
cyclase activity. Basal activities were increased in all the 
Table 4 : Effect of Polar Headgroup Manipulations on Cellular Functions 
System 
Neuroblastoma 
cells 
Neuroblastoma 
cells 
LM fibroblasts 
LM fibroblasts 
Plasmacytana 
cells 
LM fibroblasts 
infected with 
virus 
LM fibroblasts 
LM fibroblasts 
Yeast cells 
P1asmacytana 
cells 
Mouse liver 
cells 
Phospholipid(s) Enriched Effect 
PNME, PDME or PE No change in cholesterol 
or fatty acid 
composition. Increase in 
phospholipid content 
PNME or PDME Increase in total 
cellular phospholipids 
PNME, PDME or PE No effect on membrane-
bound enzyme s. Sterol 
content decreased. 
LPC content increased. 
PNME, PDME or PE No change in physical 
properties measured by 
fluorescence 
depolar1sation 
PNME, PDME or PE Increase in rate of 
basal phospholipid 
methylation 
PNME, PDME or PE Increased release 0 f 
viral glycoprotein 
PNME or PDME 
PNME, PDME or PE 
PE 
PNME, PDME or PE 
PE:PC ratio 
increased 
Reduced endocytosis 
No change in physical 
properties of membranes 
(fluorescence 
depolarisation) • 
Fatty acid composition 
of incorporated phospho-
lipid intermediate in 
saturation between PE 
and PC. 
Reduction in rate of 
amino acid uptake 
Changes in golgi 
structure and reduced 
IgG secre t ion 
Reduction in membrane 
fluidity measured by 
fluorescence 
depolarisation. 
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Reference 
Robert et a1. t 
(1978) 
Yavin 
(1977) 
Schroeder 
et a1. 
(1976' a) 
Schroeder 
et al., 
(197~) 
Maeda et a1., 
( 1980a) 
Maeda et ale 
(1980b) 
Schroeder 
(1981) 
Schroeder 
(1978) 
Trivedi et 
a1., (1982) 
Nakano e t a1. 
(1982) 
Boyle and Dean 
(1982) 
treated cells, but this could be abolished by solubilisation, 
indicating that the stimulation was due to specific phospho-
lipid protein interactions. The magnitude of NaF-stimulation 
was decreased in all the base-treated membranes relative to 
choline-treated cells. A similar pattern was observed for the 
PGE
l 
+ GTP stimulation, although when stimulated with PGE 1 , the 
cAMP response was unchanged, except for NME-treated membranes 
which showed an increase in the degree of stimulation. 
(Engelhard et al., 1978). No correlation could be found between 
the viscosity changes and the basal and PGE1-stimulated 
activities. A good correlation was found, however, between 
these activities and the PE:PC ratio in the treated membranes 
(Engelhard et al., 1978). 
Solubilisation abolished the basal activity increases 
due to the bases. No correlation could be found between the 
degree of NaF- and PGE l + GTP stimulation of activity and the 
viscosities of the treated cells. Taken together, these results 
Suggest that the differences in activity were due to specific 
phOSpholipid:protein interaction, and not merely a result of 
physical changes in membrane properties. 
1.5.6 Effects of Specific Phospholipids on the Activity 
of the S-Adrenergic System II:Solubilisation Studies 
Since these studies have been carried out on detergent-
solubilised enzyme preparations, it is argued, that the effects 
observed are due to the preference of the enzyme for individual 
phospholipids or phospholipid mixtures of defined composition, 
and not subject to the effects of changes in membrane fluidity. 
Two studies are of particular interest since, unlike earlier 
studies, they employed nonionic detergents. It has been demonstrated 
• by Johnson and Sutherland (1973) that nonionic detergent itself 
can activate brain adenylate cyclase. 
In a study by Hebdon et ale (1981), rat brain adenylate 
cyclase was solubilised using sodium deoxycholate. In thi s form, 
2+ 2+ 
enzymic activity was undetectable with either Mg or Mn in 
the absence of nonionic detergent or specific phospholipids. 
Maximal restoration of activity to both cations was found with 
PC, SM, PNME, or LPC liposomes. Nonionic detergents such as 
Triton ~-lOO and Nonidet P40 were also able to restore full 
activity. PE and PDME were capable of partially restoring full 
activity (40-60% and 10-20% respectively). All other lipids 
were without effect. When a second phospholipid was mixed with 
PC in the ratio 75% PC:25% of the other phospholipid, maximum 
activity was observed. This decreased, as the amount of PC was 
reduced. 
Ross (1982) presented results which are in agreement 
with those of Hebdon's group, insofar as the importance of PC 
is concerned. In a preparation of rabbit hepatic adenylate 
cyclase which was free of endogenous lipids PC was found to be 
important for the interaction of C with the G protein. 
2+ The lipid-free enzyme was stimulated by Mn , and by 
forskolin. The addition of purified G protein to the preparation, 
and stimulation with the activator GTPyS or NaF resulted in 
slight increases in activity • 
However, when dimyristoylphosphatidylcholine (DMPC) 
was added or several other species of PC were added, an eight-
fold stimulation by the activator-liganded G protein was observed. 
Since the basal and forskolin activities were unaffected by PC, 
• n ~o 
it was suggested that PC is important primarily for the 
regulatory interaction of C with G, rather than the intrinsic 
activities of either protein. 
The detergents Lubvol l2A9 and Triton X-100 could 
not substitute for PC, and there seemed to be a preference for 
DMPC, Dipalmitoyl-, l-Palmitoyl, 2-01eoyl- and Dielaidoyl PC 
species were much less effective. The presence of the choline 
moiety alone, in trials with LPC, was not sufficient for activity. 
This suggests that PC is specifically required by the enzyme. 
In contrast to previous studies, (Rubalcava and Rodbell, 1973), 
acidic and negatively charged phospholipids had no effect on the 
restoration of activity. 
It seems that one can tentatively conclude from these 
two studies that adenylate cyclase does show a specific require-
ment for PC. 
Houslay and Palmer (1979) have reported that low 
concentrations (0.001-0.01 mM) of Lysomyristoyl PC stimulated 
the activity of adenylate cyclase in rat liver plasma membrane 
preparations, although at higher concentrations (0.5-1 mM) the 
enzyme was inhibited. Glucagon stimulation of the enzyme was 
more susceptible to inhibition than the NaF stimulation. It 
seems that the coupling of the R-G complex was perturbed, since 
no effect on glucagon-binding was observed. 
1.5.7 Effect of Specific Phospholipids on the a-Receptor 
Kirolovsky and Schramm (1983) prepared a del~pidated 
a-adrenergic receptor and reconstituted it with defined phospho-
lipids to investigate whether specific interactions occurred. It 
was found that PE restored maximum agonist binding. In contrast 
to earlier studies by Rubalcava and Rodbell (1973), acidic phos-
pholipids proved ineffective in restoring binding ability. 
• 1.5.8 Phospholipase Studies 
Some of the earliest studies to investigate the 
question of phospholipid specificity were performed using 
phospholipase~ (Rubalcava and Rodbell, 1973). Treatment of 
liver plasma membranes with phospholipase C from Bacillusc~eus 
causes a preferential hydrolysis of acidic phospholipids (PS). 
The polar headgroup is removed, leaving diacylglycerol in the 
membrane. The enzyme from Clostridium perfringens hydrolyses 
neutral phospholipids preferentially. Treatment of the membranes 
with the Bacillus enzyme caused a loss of the glucagon-stimula-
tion of adenylate cyclase, however, even after substantial 
hydrolysis, the Clostridium enzyme had little effect on the 
hormonal response. 
This was interpreted by these workers to imply that 
certain acidic phospholipids were necessary for the hormonal 
response. However, these type of experiments cause perturbation 
of the structure and properties of the membrane, and have proved 
difficult to reproduce (Ross and Gilman, 1980). 
1.5.9 Conclusion 
The results of these studies indicate that activity 
of the hormone-stimulated adenylate cyclase is influenced by 
both the physical properties of the membrane, and possibly by 
specific phospholipid requirements. The coupling between the 
receptor, G protein and C protein seems to be the process most 
sensitive to these factors. 
Phospholipid specificity itself, and any resultant 
changes in membrane physical properties could be a subtle means 
of regulating the response of the C protein to hormonal stimulation. 
A means of modulation could be the protein-catalysed exchange of 
• one phospholipid for another or, for example, if PC was 
hydrolysed to yield LPC, an increase in activity of the C 
protein might be expected. In view of the importance of specific 
lipid classes, possibly in close association with the protein, 
rapid interconversion of PE to PC by phospholipid methylation 
could ostensibly be a method of regulating the hormone response 
of the C protein. The role of phospholipid methylation on the 
a-adrenergic response is considered in section 1.7. 
1.6 THE C6 a-ADRENERGIC SYSTEM 
The B-adrenergic system of C6 cells has been thoroughly 
studied and excellent reviews have been written. (Pfeiffer et 
al., 1978; Van Calker and Hamprecht, 1980). The latter review 
is particularly extensive. 
Stimulation of cAMP accumulation in C6 cells was first 
described by Gilman and Nirenberg (1971). A significant increase 
in cAMP accumulation was observed when (-)-isoproterenol 
to.O l - 100 ~M) was administered. Noradrenalin and adrenalin, 
but not a-adrenergic agonists, also resulted in a stimulation 
of cAMP accumulation. This accumulation was enhanced by 1 mM 
theophylline, an inhibitor of phosphodiesterase. 
Extremely high concentrations of isoproterenol 
-3 (> 10 M) slightly depressed the response, and stimulation was 
maximal in the concentration range 0.1-1 ~M. The stimulation of 
cAMP content rose 40-fold within 30 seconds, and was maximal 
(200-fo1d) 5-15 min. after addition of the drug. The cAMP content 
decreased thereafter, but was still 40-fold greater than the basal 
level after one hour of exposure to the drug. All these effects 
were blocked by a-adrenergic, but not a-adrenergic, antagonists. 
6l 
The B-adrenergic receptors of C6 cells were studied 
using [3 H]-dihydroalprenalol (DHA) (Van Calker and Harnprecht, 
1980). The number of B-sites was found to be 10,000 per cell, 
and they exhibited the same specificity profile as the a-receptors 
which mediate cAMP accumulation. Later work by this group 
(Homburger et al., 1981) demonstrated that C6 contains both B1 
and B2 receptors, but that only the B2 receptor effectively 
stimulated adenyl ate cyclase. Occupation of all the receptor 
sites is necessary for a maximum cAMP response to be achieved 
(Van Calker and Hamprecht, 1980). 
The number of receptors expressed by cells in culture 
is influenced by various factors. Dibner and Insel (1981) showed 
that the presence of serum in the growth medium reduces the 
number of receptors measured by DBA binding studies. In a sub-
clone of C6, the C6 T3VA line, transformation by virus caused a 
three-fold decrease in the number of DHA binding sites, and a 
significant decrease in the maximum stimulation of adenylate 
cyclase by isoproterenol, which appeared to be due to an incomplete 
coupling of the receptors to adenylate cyclase 
et al., 1982). 
(Higashida 
The adenylate cyclase phosphodiesterase and cAMP-
dependent protein kinase activities of C6 cells have been studied 
by various groups, and extensively characterised (Van Calker 
and Hamprecht, 1980). The mechanism of adenylate cyclase control 
and coupling with the B-adrenergic receptor was studied, and 
found to conform to the collision coupling model of Tolkovsky and 
Levitski (1978). 
The adenylate cyclase of C6 exists in two forms, one 
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of which shows an absolute calcium dependence, the effects 
of which are mediated by calmodulin. Brostrom et al. (1976) 
observed a biphasic response of C6 adenylate cyclase to calcium. 
Both the basal and noradrenalin-stimulated activities were 
2+ 2+ increased by < I UM Ca , but higher concentrations of Ca 
(100 UM) inhibited the enzyme. When calmodulin was added to 
the membrane preparations, the calcium concentration required 
for activation was lowered, and in solubilised enzyme prepara-
tions calmodulin was shown to be tightly bound to the enzyme. 
These findings indicate that calcium probably plays a significant 
role in the regulation of the a-adre~ergic response in C6 cells. 
A large percentage of the C6 adenylate cyclase is calcium 
dependent. 2+ a-Adrenergic stimulation of C6 cells in Ca -free 
medium reduced the magnitude of the response by 60-70\. 
(Brostrom et al., 1982). The number of a-receptors, as measured 
2+ by DHA binding, did not change, confirming that Ca effects 
occur at the level of the adenylate cyclase itself. 
Phosphodiesterase exists in two forms with different 
K sand V S for cAMP. 
m max 
(Van Calker and Hamprecht, 1980). 
Schultz et al. (1972) showed that noradrenalin stimulation of 
cAMP content was followed by an increased rate of cAMP degrada-
tion, due to the induction of both the high and low K forms of 
m 
phosphodiesterase. Induction of the phosphodiesterase activity 
appeared to be due to the presence of cAMP itself, since the 
effect could be mimicked by adding dibutyrl cAMP. De novo RNA 
and protein synthesis was required for the increase in activity, 
since cycloheximide and actinomycin D blocked the effect. 
(Van Calker and Hamprecht, 1980). 
B-adrenergic stimulation also causes a rapid activa-
tion of other enzymic activities: noradrenalin stimulation 
changes the pattern of protein phosphorylation and induces a 
subcellular redistribution of protein kinase activity. (Van 
Calker and Hamprecht, 1980). Previous studies showed that the 
increase in cAMP content due to a-receptor stimulation caused 
a 2- to 4-fold increase in protein kinase activity. (Van 
Calker and Hamprecht, 1980). 
Other effects, apparently caused by elevated intra-
cellular cAMP levels have been described. Doore et al. (1975) 
noted that a-adrenergic stimulation is followed by a release of 
cAMP into the medium. Introducing the cAMP analogue dibutyrl 
cAMP into cells in culture, caused a progressive increase in 
the release of prostaglandins PGE I and small amounts of PGA 
and PGF 2a . (Hamprecht et al., 1973). Although PGE l was shown 
to stimulate cAMP accumulation in the glioma clone C6-BU-l, 
(Van Calker and Hamprecht, 1980) it is not clear what the 
physiological significance of this prostaglandin release is. 
A consequence of elevated intracellular cAMP is an increase in 
phosphodiesterase activity, which is one of the mechanisms by 
which desensitisation occurs. 
1.6.1 Desensitisation 
Noradrenalin stimulation causes increases in intra-
cellular cAMP content which is followed by an increased rate of 
cAMP degradation, due to the induction of both the high and low 
K forms of phosphodiesterase (Van Calker and Hamprecht, 1980). 
m 
This appeared to be a direct result of cAMP itself as the effect 
could be mimicked by dibutyrl cAMP. The refractoriness to 
receptor-mediated increases in cAMP content, also extends to 
stimulation by prostaglandin El , which also fails to elicit 
maximal cAMP accumulation, thus the desensitisation observed 
in C6 cells appears to be of the heterologous type. 
Desensitisation consists 'of three distinct stages; 
a loss of coupling between the recept~rs and the G protein:Cprotein 
complex, followed by a loss of hormone receptors, and an increased 
rate of cAMP degradation (Perkins, 1983). 
The role of cAMP itself, in bringing about desensitiza-
tion has been well described by Koschel (1980). Elevation of 
the intracellular cAMP content using phosphodiesterase inhibitors 
caused a subsequent refractoriness of adenyl ate cyclase to 
challenge by a-agonists. The number of a-receptor sites was 
unchanged by this treatment, nor was the stimulation of the 
adenylate cyclase complex by either NaF or guanine nucleotides 
affected. This suggests that the desensitisation is caused by 
an inhibition, or defect in coupling of the receptors to the G 
protein. It was suggested that loss of hormone receptors 
occurred as a secondary event, and not by a cAMP-mediated 
mechanism. 
Some evidence to suggest that cAMP-independent 
desensitisation occurs has been presented by Franklin and Twose 
(1979). Cells were pre-incubated with B-agonists that caused 
cAMP accumulations of only 1\ of the maximum caused by iso-
proterenol. The cells were then challenged with isoproterenol 
and found to be desensitised. These results suggest that 
occupation of the receptor by an agonist can cause desensitisation 
in the absence of significant rises in intracellular cAMP. 
The increase in phosphodiesterase activity, appears to 
occur as a later event. Several hours pre-incubation with 
noradrenalin were necessary before a 53% increase in phospho-
diesterase activity was observed. (Franklin and Twose, 1979). 
Studies by Fishman et al. (1981) have confirmed the 
view that desensitisation to B-agonists in C6 cells is caused 
initially by a defect in the coupling between the receptor and 
the C/G complex. The mechanism by which cAMP causes this 
decoupling is unknown. Kinetic studies by Homburger et a1. 
(1982) show that the Koff constant of adenyl ate cyclase from 
desensitised membranes is increased, concomitant with a decrease 
in the coupling constant. Increased GTPase activity was 
suggested as a possible cause. 
The action of phospholipase A2 has also been implicated 
in the mechanisn of desensitisation. Cells exposed to isopro-
tereno1 for 2h showed an 80% decrease in cAMP production in 
response to a subsequent challenge. The number of B-receptors 
decreased by 20-30%, and an increase in the release of arachidonic 
acid into the medium was noted. The arachidonic acid release is 
modulated by phospholipase A2 . Phospholipase A2 inhibitors 
could prevent the desensitisation and loss of receptors, but 
addition of activators of the enzyme to cell cultures, caused 
receptor loss and refractoriness even in the absence of pre-
incubation with agonist. These results suggest that changes 
in the phospholipid environment of the B-receptor could be 
respon~ib1e for the receptor loss (Mal10rga et a1., 1980). 
1.6.2 Effects of Cell Culture Conditions on the a-adrenergic 
System 
Differences in the activity of various components of 
the B-adrenergic system have been observed due to the effects of 
age, and of cell density. 
Phosphodiesterase activity is influenced by the 
stage of growth of C6 cultures (Van Calker and Hamprecht, 
1980). During the rapid growth phase, phosphodiesterase 
activity was ~nly 50% of that observed in stationary phase 
cultures, when corrections were made for protein content. 
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Similar results were found by Morris and Makman (1975). 
These workers also demonstrated, that despite increased phospho-
diesterase activity, the magnitude of cAMP accumulation in 
response to either adrenalin- or NaF-stimulation was highest 
in confluent cell cultures. No change was found in the receptor 
affinity for hormones, so it was concluded that either synthesis 
de novo or activation of nascent receptor-cyclase units occurs 
with increased cell density. 
Mallorga et ale (1981) have investigated the effect 
of continuous subculturing on the 8-adrenergic system. Cells 
of high passage number (115-175) showed an inability to effect 
large increases in cAMP content in response to isoproterenol 
stimulation compared with low passage (39-80) cells. The defect 
was not due to any changes in the G and C proteins, as NaF and 
cholera toxin stimulation of cAMP accumulation was similar in 
both cell types. The receptor number of the low passage cells 
was 2-4 times greater than the high passage cells, and in the 
high passage cells phosphodiesterase activity was 2-3 times 
higher than in low passage cells. 
These studies illustrate the need to take cell density 
and passage number into account when assessing experimental 
results. 
6, 
1.7 PHOSPHOLIPID METHYLATION AND THE a-ADRENERGIC RESPONSE 
Hirata and Axelrod (1980) have proposed that phospho-
lipid methylation is a general mechanism for facilitating the 
transduction of biological signals across cell membranes. The 
purpose of this section is to review the evidence supporting a 
role for phospholipid methylation in the a-adrenergic response, 
principally from the laboratory of Hirata and Axelrod. Many of 
the experiments which will be described are contained in a 
comprehensive review by Hirata and Axelrod (1980), and many of 
the studies described are reviewed in that work. 
Contrasting evidence will be discussed at the end of 
this section. It is clear that a-adrenergic stimulation causes 
an increase in the activity of lipid methyltransferases, what 
is not clear is whether the methylation is an obligatory event 
for adenylate cyclase activation, or merely a simultaneous, but 
unrelated phenomenon. 
1.7.1 Stimulation of Phospholipid Methylation by a-Adrenergic 
Agonists 
When rat reticulocytes, previously loaded with 
S-adenosyl methionine (SAM) were stimulated by B-adrenergic 
agonists, phospholipid methylation was increased. The increase 
in labelling was dose-dependent and stereospecific for the 
(-)-isomer of a-agonists (Hirata and Axelrod, 1980). The 
value for half-maximal activation of methylation by isoproterenol 
was close to that required for half-maximal activation of 
adenylate cyclase in C6 cells and rat reticulocyte ghosts 
(Hirata and Axelrod, 1980). 
". In the intact C6 cell, using [3Hlmethionine as a 
methyl donor the order of potency for a-agonist stimulation of 
• 
68 
methylation was consistent with the effect being mediated by a 
8
2 
receptor, (Hirata and Axelrod, 1980), which is the receptor 
that mediates cAMP accumulation in the C6 cell. 
GTP, which plays an important role in the coupling of 
8-receptors to adenylate cyclase, shifted the dose response to 
the left by two orders of magnitude, suggesting a possible involve-
ment of coupling factors in enhancing phospholipid methylation 
(Hirata and Axelrod, 1980). Hashizume et ale (1983) have claimed 
that GTP is bound to, and inhibits, PMT I . When a 8-agonist is 
bound to the receptor, GTP is released from PMT I activating it. 
PMT ,on the other hand, is activated by the GTP released from 
II 
PMT
I
. Thus, constraints imposed on the PMT s by the 8-adrenergic 
receptor, are relieved by the binding of agonist to the receptor, 
causing activation of both of the PMT S. 
Isoproterenol-stimulated cAMP formation was markedly 
increased in reticulocyte ghosts, which had previously had SAM 
sealed inside them. No change in the number of 8-receptors was 
observed under these conditions (Hirata and Axelrod, 1980). 
This concentration of SAM was previously found to stimulate PMT , I 
producing PNME. From this they inferred that PNME production 
by phospholipid methylation promoted the coupling of S-receptors 
to adenylate cyclase (See Fig. 4.). 
The replacement of PE by PC, and vector\~\ translocation 
of the methylated phospholipid was found to increase the fluidity 
of the membrane of erythrocyte ghosts, as measured by the polar-
isation of fluorescence of l,6-diphenyl-l,3,S-hexatriene. The 
formation of PNHE was claimed to be responsible for the observed 
increase in membrane fluidity, and this could be abolished by 
Fig.4: Phospholipid Methyltransferases and 
their Relationship to the a-Adrenergic 
Receptor 
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the addition of S-adenosylhomocysteine (SAH) which blocks 
methylation (Hirata and Axelrod, 1980). 
1.7.2 Masking and Unmasking of 8-adrenergic Receptors 
When reticulocyte ghosts loaded with SAM were incubated 
for lh, the number of 8-adrenergic receptors increased by 40%, as 
measured by the binding of DHA. By varying the concentration of 
SAM, it was shown that activation of PMT11 and subsequent PC 
production was responsible for the increase in binding sites. 
The increase in sites could be blocked by SAH, since protein 
synthesis de novo is unlikely in the membrane preparation, the 
results suggest that PC synthesis unmasked cryptic receptor 
sites (Hirata and Axelrod, 1980). 
Similarly, when HeLa cells were treated with the 
methylation inhibitor 3-deazaadeno~ine, the number of a-adrenergic 
receptors, as well as isoproterenol-stimulated cAMP formation 
were decreased. Upon removal of the inhibitors by washing the 
cells, the a-adrenergic receptor number returned to normal 
(Hirata and Axelrod, 1980). The conclusion drawn from these 
studies was that PC produced by phospholipid methylation, can 
rapidly modulate the a-adrenergic response, by alteration in 
receptor number. 
Benzodiazepine receptors which are coupled to adenylate 
cyclase are present in C6 cells (Syapin and Skolnick, 1979). 
3 When C6 cells were incubated with [ H]methionine, benzodiazeplnes 
3 stimulated [ H]methyl group incorporation in a dose-dependent 
manner and this paralleled the increase in cAMP production. When 
benzodiazepines and a-agonists were added together, an additive 
stimulation of methylation was observed (Hirata and Axelrod, 
1980). This suggests that the two different receptors both have 
their own cluster of PMT s which are stimulated specifically 
by the ligand whose receptor they surround. 
There is some evidence that PMT s regulate receptor 
•. 'l 
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number in intact animals. Repeated injections of 3-deazaadenos1ne 
into rats resulted in a decrease in the S-adrenergic receptor 
number in the heart and the brain (Hirata at a1., 1980). 
To summarise, the essence of Axelrod's theory is that 
S-adrenergic receptors are associated with a small cluster of 
PMT s. Binding of agonist releases and activates the PMT s which 
cause a rapid translocation across the membrane of methylated 
phospholipids. The formation of PNME causes local fluidity 
increases which enhance coupling of the receptor and adenylate 
cyclase, facilitating transduction of the hormonally-transmitted 
signal. Methylation of PNME to PC uncovers receptor sites which 
are normally inactive, so amplifying the signal. 
1.7.3 Evidence Against a Functional Role for Phospholipid 
Methylation 
In the last three years considerable evidence has 
accumulated which argues against the proposals of Axelrod and 
his co-workers. The two aspects of phospholipid methylation 
which have proved most contentious are the PMT-induced changes 
in membrane fluidity, and the claim that phospholipid methylation 
is an essential step in hormone-stimulated cAMP formation. I 
shall deal with the fluidity question first. 
Vance and de Kruijff have raised several objections 
to there being any functional significance of PE methylation 
(Vance and de Kruijff, 1980). They have calculated that only 
0.00033% of the total PC in rat erythrocyte experiments was 
derived by PMT action, and that such small amounts of PC would 
- n 
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be unlikely to have any effect on the fluidity of the bulk 
lipid. They insist that some other explanation must be sought 
for the recorded fluidity changes. 
In a reply to these crit{cisms, Axelrod and Hirata 
(1980 ) argue that the small amounts of methylated lipid need 
not be important, if they are located in the boundary lipids 
around membrane proteins. The probe molecule that was employed, 
preferentially localises in the boundary of lipid domains, and 
is not necessarily reporting bulk lipid fluidity. Axelrod and 
Hirata maintain that the methylation reactions satisfy all bio-
chemical criteria of enzymic reactions, and therefore are 
unlikely (as claimed by Vance and de Kruijff) to be the product 
of experimental artefacts. 
However, since regulatory mechanisms exist to maintain 
an appropriate homoviscous membrane environment 
it seems unlikely that small amounts of PNME could affect 
fluidity when,as Schroeder (1978) has shown, 50% of the membrane 
phospholipid can be substituted for by PNME, without alteration 
in physical properties as measured by fluorescent probes. 
Several workers have shown that the hormone-stimulated 
cAMP formation can function normally in the absence of phospho-
lipid methylation. 
Koch et ale (1983) investigated the a-adrenergic 
response of three lines of myogenic cells. In all cell lines, 
isoproterenol stimulated cAMP synthesis, but no increases in 
phospholipid methylation were observed. Colard and Breton (1981) 
increased PMT activity in preparations of rat liver membranes by 
adding SAM to the incubation mixture. No increase in NaF-
stimulation or of GTP + glucagon stimulation of adenylate 
cyclase could be found. Schanche et ale (1982) blocked methyla-
tion using 3-deazaadenosine in rat liver membrane preparations, 
without any effect on glucagon-stim"ulated cAMP accumulation. 
Similarly Padel et al. (1982) blocked 88% of the methylation 
reaction in guinea pig and rat parotid gland preparations, with 
no effect on hormonal stimulation of cAMP accumulation. 
Doubts have also been raised as to the role of methyla-
tion on receptor modulation. Munzel and Koschel (1982) examined 
methylation in C6 cells persistently infected with subacute 
sclerosing panecephalitus virus (SSPE). In these cells the 
accumulation of cAMP in response to isoproterenol was impaired, 
and the stimulation of B-adrenergic methylation was completely 
abolished. However, the number of B-adrenergic receptors was 
comparable to that of normal C6 cells. 
In addition, in infected cells, the basal methylation 
was actually depressed by isoproterenol stimulation. This loss 
of methylated lipid could not be blocked by propranolol. 
Analysis of the location of label by t.l.c. revealed that the 
isoproterenol-stimulated demethylation in C6/SSPE cells was not 
due to a degradation of methylated PE, but rather an inhibition 
of PC synthesis by N-methylation. The results of these studies 
do not support any involvement of PC production by N-methylation 
in the control of B-receptor number. 
The sequence of events after hormone receptor stimula-
tion has also been questioned. Hirata and Axelrod (1980) maintain 
that phospholipid methylation is a pre-requisite for coupling of 
the receptor to the adenylate cyclase. Mato et al. (1982) have 
shown that although glucagon and vasopressin stimulate phospho-
~. . 
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lipid methylation in hepatocytes, the methyltr~nsfer~ses are 
located on membranes distal to the plasma membrane, and that 
stimulation of methylation is dependent on transmission of the 
2+ hormonal signal by the secondary meBsengers Ca and cAMP. 
Hormonal responses in methylation rate are abolished by main-
taining the cells in calcium-free media. The cAMP messengers 
appear to activate a cAMP-dependent'protein kinase, which in 
turn activates the methyltransferases. 
Similarly Pritchard et al. (1981) showed that analogues of 
. cAMP stimulate methylation in hepatocytes. If, as Hirata and 
Axelrod suggest, methylation is instrumental in controlling 
cAMP production, it seems strange that cAMP does not cause feed-
back-inhibition of methylation, but rather stimulates it. 
1.7.4 Summary 
It seems clear that phospholipid methylation 
accompanies B-adrenergic stimulation. Whether methylation is 
a prerequisite for, or a consequence of. cAMP accumulation is 
still unclear, as is any unquestionable physiological role for 
methylation. Possibly, much of the confusion has arisen from 
attempts to compare results from a diverse variety of systems 
and unite them into a common hypothesis. As Mato and Alemany 
(1983) have pointed out, the phospholipid, cholesterol and 
protein content of cells varies considerably. In particular, 
PC content varies from cell to cell type. PC comprises 30% of 
the phospholipids of rat erythrocytes, but constitutes only 5% 
in sheep erythrocytes. Thus it is not wise to make sweeping 
generalisations. The stimulation of phospholipid methylation 
that accompanies B-adrenergic stimulation could be explained by 
.. ~ , ., 
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two possible schemes. 
1. Methylation is an essential event in the transduction 
of B-adrenergically-mediated signals, and that methylation 
causes physico-chemical changes in membrane properties. 
2. Methylation is not directly involved in biological 
signal transduction, but by-products of the methylation 
pathway affect membrane-bound enzyme activities which 
result in a termination of the a-adrenergic response and 
in the desensitisation of the receptors. 
One aim of this project is to test if either of these 
possibilities are plausible. 
.. ""1 , , 
1.8 AIMS OF THIS STUDY 
The goal of this work was to manipulate the membrane 
lipid composition of intact C6 cells in tissue culture in order 
to study the effects of modifying the membrane lipid environment 
on the B-adrenergic response. The intention was to grow C6 cells 
in media containing the bases ethanolamine, N, N,'-
dimethyl ethanolamine (DME) and N -monomethylethanolamine (NME). 
I could reasonably expect, from previous reports, that rapid and 
extensive modification of the phospholipid composition of the 
cell membranes might occur, without toxic effects on the cells. 
Since the B-adrenergic system is membrane-bound, it 
was hoped that I might infer how the phospholipid composition 
of the membranes affects the 8-adrenergic function in an intact 
organism. The changes in polar headgroup composition might also 
be accompanied by changes in acyl chain composition and sterol 
content, if membrane fluidity did not change. Therefore, it 
was important to investigate the physical properties of the 
modified membranes. 
The second aspect of this project was to study the 
role of phospholipid methylation in modulating B-adrenergic 
responses. For this reason the choice of bases was such that 
when they were incorporated into the membrane, they would enrich 
the membrane in intermediates of the phospholipid methylation 
pathway. ~his would amplify the magnitude of the 
response of the pathway. The effect of an amplified phospho-
lipid methylation response on cAMP accumulation in response to 
B-adrenergic stimulation could then be studied. This would allow 
me to test some of the postulates of Hirata and Axelrod (1980) 
concerning the effect of these intermediates on the physical 
properties of the membrane lipid. 
METHODS 
Hexagram 43: Renewed Advance 
He who resolves to proceed must first 
exhibit the culprit's guilt in the royal 
court, appealing for sympathy in an 
earnest and sincere manner. At the 
same time he must be conscious of the 
peril his actions place him in. Then 
let him proceed and he will be accompanied 
by good fortune. 
The Book of Changes 
2.1 CELL CULTURE 
The cells used in this study were from the C6 rat 
glioma (Benda 1978), American Tissue Culture Collection 
No. CCLI07, obtained from Flow Laboratories. All cells used 
in these experiments were between passage numbers 44 to 54, 
unless stated otherwise. 
Cells were maintained as monolayers in petri dishes 
of tissue culture grade \"()J;\,\"v:,().~~ (90 x 15mm), containing 20mls 
of growth medium. The growth medium was Dulbecco's Modification 
of Eagle's Medium (Dulbecco and Freeman, 1959) containing 
penicillin (100 IU/ml), streptomycin (lOO~g/ml) and L-glutamine 
(4mM). Growth medium was supplemented with bovine foetal 
calf serum (5% v/v). All growth media and sterile plasticware 
were purchased from Flow Laboratories, Irvine, Scotland. 
All cell culture manipulations were carried out under 
stringent aseptic conditions in a Laminar flow hood (Microflow) 
which was cleaned with "Lysol" (Gallenkamp) before and after 
manipulations. Cells were grown in an atmosphere of 5% CO 2/9S% 
air (v/v) at 37°C. pipettes and glassware were sterilised by 
autoclaving. 
(a) Cell storage 
Cells were stored in plastic ampoules immersed in 
liquid nitrogen. An auxiliary supply was kept in a -70°C freezer 
as a safety measure. 
Petri dishes of confluent cells were prepared for 
storage as follows. The monolayers were removed by trypsinisation, 
transferred into culture tubes and collected by centrifugation. 
The cell pellets were resuspended in 40% Foetal Calf serum 
(v/v) in Dulbecco's modified Eagle's medium (O.Sml of serum for 
each plate of cells in the pellet). After trituration, the cell 
suspensions were transferred to storage ampoules kept on ice 
(O.Sml/ampoule) . A solution of 20\ dimethylsulphoxide (v/v)(O.5ml) 
in Dulbecco's modified Eagle's medium was carefully layered onto 
the serum in the ampoules. After sealing the ampoules, the 
contents were gently mixed, and transferred to a polystyrene 
box with sides 4cm thick. 
-70°C freezer for2h. 
in the liquid ~itrogen. 
This was closed, and placed in a 
After that, the ampoules were placed 
(b) Transfer of cells into culture 
An ampoule containing the cells was removed from the 
liquid nitrogen and warmed between gloved hands, before being 
thawed in a waterbath at 37°C. These operations were carried 
out wearing gloves and a face visor for protection in case of 
explosion of the ampoule on removal from the liquid nitrogen. 
When the contents were thawed, the ampoule was removed 
from the waterbath and washed with 70% ethanol (v/v) and allowed 
to dry in the aseptic conditions within the flow hood. The 
ampoule was opened, and the contents transferred to a plastic 
culture tube. Slowly, and with gentle agitation, Smls of growth 
medium, prewarmed to 37°C, were added to the tube. The tube was 
capped and gently inverted. Another Smlswere added in the same 
manner, the tube gently inverted, and the contents poured into 
a petri dish (90 x ISmm). The dish was swirled to disperse the 
contents. Another lOmls of growth medium were added, before the 
dish was placed in the incubator, and the cells were grown to 
confluency. 
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(e) Cell passage 
Trypsin (2.5% v/v) was thawed and mixed well. 
The medium was removed from petri dishes containing confluent 
cells by aspiration. Trypsin (2ml) was added to each dish, and 
the plate swirled so that the liquid covered all the cells. 
After one minute the liquid was removed, and the plate allowed 
to incubate at room temperature for 5 minutes, or until the 
cell monolayers began to detach from the plastic. 
medium (5mls) was added to inhibit the trypsin. 
Growth 
The cell suspension was then transferred into culture 
tubes, which were sealed and centrifuged for 5 minutes at room 
temperature in an MSE minor, speed, position 1. The super-
natant was discarded, and the cell pellet resuspended in complete 
growth medium. The cell suspension was mixed with an appropriate 
amount of growth medium such that the contents of a single petri 
dish were split between five new petri dishes, each containing 
20mls of cell suspension. This split ratio of 1:5 was used for 
all subsequent experiments. The petri dishes were replaced in 
the growth incubator and allowed to reach confluency before use 
in experiments. Growth medium was changed every three days. 
(d) polar head group manipulation 
The bases ethanolamine , N ,N' ,-dimethylethanolamine 
(DME) (both Analar grade, B.D.H.) and N-monomethylethanolamine 
(NME) ,(Fluka A.G.)were made up in water as stock solutions (50mM). 
The pH was adjusted to 7.0 using 13M hydrochloric acid, and the 
solutions sterilised by autoclaving. 
The sterile base solutions were added to complete growth 
medium to a final concentration of 5mM. Cells were grown in this 
medium for 24 hours, unless stated otherwise. 
(e) Measurements of cell growth 
Cells were grown in Linbro trays and the original 
plating density was noted using the haemocytometer. A low 
7 initial density (1 x 10 cells/well) was found to be best for 
accuracy in plotting growth curves. Duplicate wells were used 
for each timepoint in the study. 
After removal of the medium, the cells were washed 
twice with saline 0.9% (v/v) , and trypsin (O.Sml) was added to 
each well. After 2 minutes incubation at 37°C, cells were 
washed from the wells using complete growth medium until no 
cells were found remaining when the well was examined under the 
microscope. 
The cell suspension was transferred to culture tubes 
and spun on the bench centrifuge for 5 minutes to pellet the 
cells. The cell pellet was suspended in an appropriate volume 
(l-Smls) of saline containing 50% (v/v) Trypan blue to identify 
non-viable cells, and an aliquot was counted by haemocytometer. 
The cell numbers recorded were of intact, unstained cells only. 
Care was taken to keep Trypan blue off the skin, as it is 
considered to be carcinogenic. 
(f) Photomicrography 
Examination of the cell cultures was necessary to 
ensure that manipulations were made at the correct time and 
stage of growth. An "Olympus" CK inverted stage microscope 
with phase contrast optics was used to examine the cultures. 
Morphological changes in treated cells were recorded 
by monochrome micrography, using an "Olympus" C-35 camera, 
PM-10M adaptor and "Olympus" light meter. Pan FSO ASA film 
(Kodak) was used to record the observations. 
Colour photographs were taken using the same camera 
system, but it was attached to an "Olympus" BHB microscope, 
since a higher magnification was required to see the fine nuclear 
structure. Tungsten 160 ASA film (Kodak) was used for these 
studies. 
(g) Haematoxylin-Eosin staining 
Haematoxylin-Eosin staining (HE staining) was used to 
determine whether base treatment affected cell ultrastructure. 
Nuclei and nucleoli are shown clearly against a counter-stained 
cytoplasm. 
Cells were grown on coverslips. The coverslips were 
cleaned by boiling in O.lM sodium hydroxide, rinsed overnight 
in tapwater, rinsed 3 times in distilled water, and sterilised 
by heat in glass petri dishes. 
After growth in the presence of bases, the coverslips 
containing cells were removed, rinsed twice with Dulbecco's 
phosphate buffered saline (PBS) pH 7.4, and the cells fixed in 
a 2.5% (v/v) solution of glutaraldehyde (EM scope) in PBS over-
night at 4°C. 
The monolayers were stained with HE (Drury and Wal11n~ton, 
(1980) and then mounted on glass microscope slides for photography 
using D.P.X. (B.D.H.). The preparation of reagents for HE 
staining is detailed in the Appendix. 
2.2 MEMBRANE PREPARATION 
Membranes for gas liquid chromatographic analysis of 
fatty acid, electron spin resonance, or any other determinations 
were prepared as follows. 
(a> Cell harvesting 
Petri dishes of confluent cells were harvested by 
washing twice with Dulbecco's phosphate buffered saline pH 7.4 
(PBS) after removal of the growth medium by aspiration. The 
cells were scraped from the dish using a blunt spatula, and 
washed into centrifuge tubes with PBS. The cell pellet was 
collected after centrifugation (38,000 x g. for 20 mins. at 4°C). 
Cell pellets were stored at -20°C until required. 
(b> Membrane preparation 
A crude membrane preparation was made from the cell 
pellet by resuspending the pellet in PBS and sonicating the 
suspension for 15 seconds, on ice, with an MSE sonicator. The 
suspension was centrifuged (38,000 x g. for 20 mins. at 4°C). 
The membrane pellet was retained and stored at -20°C until 
required. 
2.3 LIPID ANALYSIS 
<a> Lipid Extraction 
Cell or membrane pellets were collected in 15ml glass 
centrifuge tubes for lipid extraction. After decanting the 
supernatant, chloroform/methanol (2:1, v/v), (3mls) was added 
to each tube, which was vortexed to break up the pellet. After 
10 minutes at room temperature, O.lM potassium chloride (1.2mls) 
was added to each tube, and the tube vortexed. The tube was 
spun at full speed in an MSE bench centrifuge for 2 minutes 
to accelerate phase separation. 
The upper aqueous phase was removed by aspirating along 
with cell debris and O.lM potassium chloride/50% (v/v) methanol 
h6 
(l.2mls) was added to each tube. The tubes were vortexed, 
centrifuged, and the aqueous phase removed. This was repeated. 
The chloroform phase was transferred to a glass screw cap tube 
and methanol was added dropwise until one phase was obtained. 
This was evaporated to dryness using oxygen-free nitrogen. 
The residue was dissolved in chloroform/methanol (1:1 v/v) and 
stored under nitrogen at -70°C for analysis. 
Analar grade. 
(b) Thin layer chromatography 
All solvents were 
Before an attempt could be made to modify the lipid 
composition of the C6 cells, a thin layer chromatography (t.l.c.) 
system had to be found which would resolve the transmethylation 
pathway phospholipids. An unsatisfactory result from l-dimen-
sional systems (Hirata et ale 1979b} prompted me to try 
2-dimensional t.l.c. 
(c) Preparation of t.l.c. plates 
Glass plates (20 x 20cm) were washed, and all trace of 
grease removed by wiping with acetone. Silica G. (Merck) (60g) 
was mixed with "Florisil" (Merck) (lg) in a conical flask. 
"Florisil" aids in the resolution of acidic phospholipids. 
Distilled water (l20mls) was added, and the flask was shaken well 
for 30 seconds. The slurry was applied to the clean glass 
plates, clamped in a Shandon casting stand, as a layer 0.4mm 
thick. The plates were allowed to dry for 1 hour before activa-
tion by heating in an oven at IOOoc for 1 hour. 
(d) T.L.C. 
The activated plates were marked with 2 margins scratched 
into the silica at right angles to each other, and 2cm from 
the edge of the plate. A lipid extract from control cells was 
spiked with PNME and PDME (Sigma) and applied to the plates. 
PDME and PNME alone were applied to other plates run in the same 
solvent systems, for comparison. The plates were then developed 
in tanks equilibrated with different solvent systems. 
The plates were developed in the first dimension solvent 
system until the solvent front reached the margin. The plates 
were then removed and solvent was removed with a hot air stream. 
When the first solvent was removed, the plate was allowed to 
cool, turned at right angles to the direction of the first 
development, and developed in the second dimension system. When 
the solvent reached the margin, the plate was removed, blown dry, 
and retained for further analysis, or placed in a tank containing 
Iodine vapour to visualise the lipids. All lipids appeared as 
yellow spots. The plates were compared to determine whether a 
given 2-dimensional solvent system was capable of resolving PNME 
and PDME from endogenous C6 lipids. 
(e) Solvent systems 
1. (Brophy et ale 1978). 
1st Dimension 
2nd Dimension 
Chloroform/methanol/water/Ammonia 35% (v/v) 
58:35:5:2.5 (v/v) 
Chloroform/acetone/methanol/glacial acetic acid/ 
water 
40:15:13:12:18 (v/v) 
This system resolved the endogenous lipids well, but failed 
to resolve PDME or PNME from PE. 
2. (Maeda et al., 1980a) . 
1st Dimension 
2nd Dimension 
Chloroform/me~hanol/water 
65:25:4 (v/v) 
Butanol/acetic acid/water 
6:2:2 (v/v) 
PNME and PDME were resolved from the endogenous lipids, but PI 
was poorly resolved from PS. 
3. A system I devised. 
1st Dimension Chloroform/methanol/water/ammonia 
58:35:5:2.5 (v/v) 
2nd Dimension Propionic aCid/n-propylalcohol/chloroform/water 
2:2:1:1 (v/v) 
This system resolved all the endogenous lipids well, as well as 
resolving PNME and PDME (Plate 1). It was used for all 
subsequent t.l.c. 
(f) Characterisation of the t.l.c. system 
To ensure that the resolved lipids were correctly 
identified, the identity of all the spots was confirmed by co-
chromatography with authentic standards, and by the use of 
specific chemical tests. 
The following chemical tests were employed: 
(g) Zinzadze reagent 
This identifies the spots due to phospholipid, and 
distinguishes them from neutral lipid (Plate 2). 
(h) Ninhydrin stain 
Lipids containing free amino groups (PS and PEl were 
identified using this reagent (Plate 3). 
(1) Dragendorff reagent 
A test specific for lipids containing choline groups. 
(PC, LPC and SM) (Plate 4). 
(j) Periodate-Schiff's reagent 
Lipids containing vicinal diol groups (PI, PG and 
glycolipids) were identified using this reagent. PG stained 
very weakly. (Plate 5). 
(k) Ferric chloride stain 
The red-violet spot in the top left-hand corner of 
Plate 1: Lipids stained with iodine 
Plate 2: Phospholipids stained with Zinzadze reagent 
Plate 3: Phospholipids containing primary amino 
groups (Ninhydrin Stain) 
Plate 4: Phospholipids containing choline (Dragendorff 
reagent) 
Plate 5: Phospholipids containing vicinal diol groups 
(Schiff's reagent) 
Plate 6: Cholesterol (Ferric chloride stain) 
Plate 1: 
Plate 2 : 
Sl 
Plate 3 : 
Plat e 4 : 
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PLATE 5: 
PLATE 6: . 
Plate 6 indicates the location of cholesterol and cholesterol 
esters on the t.l.c. plate. 
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Full instructions on the recipes for, and use of these 
reagents is given in the appendix. 
(1) Phosphorus determination (Ref. Rouser et al. 1972) 
Phospholipid content was determined by measuring the 
amount of phospholipid phosphorus present. This method was used 
for both lipid extracts and phospholipid spots on t.l.c. plates. 
Thick wall glass test tubes were soaked for 2 hours in 
chromic acid, rinsed well with distilled water and dried. 
50-10a~1 of lipid extract was added to the tubes and washed to 
the bottom with methanol, which was evaporated at 100°C. 70% 
(v/v) perchloric acid (6WUI) was added to each tube. Acid was 
also added to sufficient tubes for the blank and standard curve. 
It is vitally important that all the solvent is evaporated 
otherwise an explosion may occur on heating with perchloric acid. 
All tubes were then heated with marbles on top of the 
tubes, in a heating block (Tecam Dri-block DB-3H) for 1 hour at 
Standards were not added until after the acid digestion. 
Standards (30-400nmol) were added from a standard of 
The final volume of all the tubes was brought to 
3.95mls with distilled water. a.5ml of 2% (w/v) aqueous ammonium 
molybdate was added to each tube and mixed well. Ascorbic acid 
(10%, w/v) was freshly prepared, and 0.5ml added to each tube. 
After mixing, the tubes were placed in a boiling waterbath for 
exactly 5 minutes each tube. 
the tubes. 
No marbles were placed on top of 
The tubes were allowed to cool and the absorbances 
read, within 1 hour, at 800nm. 
using the reagent blank. 
The spectrophotometer was zeroed 
The phosphorus content of spots from t.l.c. plates 
was measured by scraping the spots revealed by iodine staining 
into tubes and digested as before. A small amount of silica 
gel was added to the zero standard, since silica increases the 
absorbance. The protocol was followed as before. Before noting 
the absorbances, tubes containing silica gel were centrifuged 
for 5 minutes in a bench centrifuge. 
pipette for absorbance measurements. 
(m) Cholesterol Determinations 
Aliquots were removed by 
Two different methods were used to measure the 
cholesterol content of membrane lipid extracts. These methods 
detect free cholesterol only, but since cholesterol esters are 
present in only very minor amounts, I felt that for the purposes 
of these studies they could be disregarded. 
I began by using a chemical method (Huang et al. 1961), 
but then switched to an enzymic method (Ott et al. 1982), since 
it was more sensitive. 
in triplicate. 
In either analysis, samples were assayed 
(n) Free Cholesterol Assay (Ref. Huang et al. 1961). 
This is essentially a modification of the standard 
Liebermann-Burchard method. 
Reagents 
Concentrated sulphuric acid (lOrols) was added dropwise 
to acetic anhydride (60mls) and stirred, ensuring that the 
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temperature did not rise more than 10°C. Glacial acetic acid 
(30mls) was added and anhydrous Na 2So 4 was dissolved in the 
mixture. Care must be taken in the addition of sulphuric acid, 
rapid addition will result in the glass vessel shattering. The 
reagent was found to be stable for two weeks. 
A standard was made by dissolving cholesterol (Sigma) 
in 99% (v/v) ethanol to give a 1mg/m1 solution. 
Procedure 
Lipid extracts and standards (20-200~g cholesterol) 
were evaporated to dryness using nitrogen, and the residue 
dissolved in 200~l of glacial acetic acid. The reagent (Smls) 
was added, and the tubes incubated for 20 minutes at 25°C. The 
absorbances were measured at 6l0nm, and a standard curve 
constructed. 
Colour stability of the assay was poor, and colour 
begins to fade after 30 minutes. A spectral scan (SSO-620nm) 
indicated the A to be 6l0nm. The assay was found to be 
max 
linear up to 500~g cholesterol, but as can be seen in fig.5 
the sensitivity is low, which is why the enzymic method was 
adopted. The possibility of phospholipid interference was 
tested for by spiking unknown samples with cholesterol and 
checking that the increment in cholesterol content was correct 
compared with un spiked controls. No trace of interference by 
phospholipid was noted for either the chemical or enzymic methods. 
(0) Enzymic Assay (Ref. Ott et al., 1982) . 
A cholesterol oxidase kit (Cholesterol C-system, CHOP-PAP 
method) was purchased from Boehringer Mannheim Gmbh Diagnostica, 
and employed as in the method of Ott et al. (1982). 
Fig.S: Cholesterol assay calibration curves 
• Enzymatic method (Ott et al., 1982) 
A = Chemical method (Huang et al., 1961) 
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The reagent was made up according to the manufacturer's 
instructions, but Triton X-lOO was added to a concentration of 
0.5% (v/v). 
Aliquots of membrane lipid extracts and cholesterol 
standards in ethanol were dried down under nitrogen in the assay 
tubes. Reagent (2mls) was added to each tube, the tubes mixed, 
and incubated at 20°C for 30 mins. Absorbances were read at 
SOOnm, and a standard curve constructed. 
the assay was 20~g-lSO~g of cholesterol. 
for at least one hour. 
Calculation of cholesterol content 
The useful range of 
Colour remained stable 
Cholesterol content was converted from ~g to ~mols to 
allow cholesterol:phospholipid ratios to be derived. The 
molecular weight of cholesterol was taken to be 386. 
(p) Fatty acid analysis (Nordoy and Lund, 196B). 
Fatty acid analysis on lyophilized membranes was done 
by a modification of the method of Nordoy and Lund (196B). 
Fatty acid methyl esters were prepared by the addition of 
methanol (4ml) containing H2S0 4 (1.5% v/v) and butylated hydroxy 
toluene (0.01%, w/v) to a dry membrane sample (l.5-2mg protein). 
After incubation at BOoC for 1 hour under argon, the fatty acid 
methyl esters were extracted three times with 3ml of light 
petroleum (b.p. 35°-60°C) containing butylated hydroxy toluene 
(0.01%, w/v). The pooled extracts were washed twice with 2ml 
of KHC0 3 solution (2%, w/v). The extract was then dried with 
anhydrous Na 2S0 4 and evaporated under argon. 
Gas liquid chromatography 
The methyl esters were dissolved in diethyl ether and 
identified by chromatography on a Pye Model 104 gas liquid 
chromatograph equipped with a column containing 15% EGSS-Y on 
Diatomite CQ (Field Instruments Co. Ltd., Middx) at 194°C or 
one packed with 15% EGSS-X on Diatomite CQ (Field Instruments 
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Co. Ltd., Middx.) at 178°C. The fatty acid methyl esters were 
identified by comparison of their retention times with those 
of standards (Chromatography Services, Merseyside). 
Quantification was done by triangulation. The peaks 
were triangulated, and the peak area calculated by multiplying 
the height by the width at half the peak height. Fatty acid 
composition was expressed as the % of the total area that each 
individual peak occupied. 
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2.4 PROTEIN CONTENT ANO COMPOSITION 
(a) Protein Assay (Ref. Lowry et al., 1957) . 
This method is a modified version that includes sodium 
dodecyl sulphate (SOS) in the incubation mixture to solubilise 
membrane proteins. 
Protein samples were sonicated to ensure homogeneity, 
and pipetted into assay tubes in duplicate. The sample volume 
was made up to 200~1. A standard was prepared by making a 
lmg/ml solution of bovine serum albumin (Fraction V, Sigma) in 
the same buffer as the samples were in. Standards (30-200~g) 
were added to the assay 250~l of 1M NaOH/0.25% (w/v) SOS was added 
to each tube and the tubes were incubated for 15 minutes at 60°C. 
Reagent B (2.5mls) was added to each tube, mixed and incubated 
for 15 minutes at room temperature. 
is given in the appendix. 
The composition of reagent B 
Finally 250~l of Folin-Ciocalteu reagent (B.D.H.) 
freshly diluted (1:1) v/v with distilled water, was added and 
the tubes mixed. The tubes were left to stand for 45 minutes 
at room temperature, and the absorbances read at 750nm. 
(b) SOS Polyacrylamide gel electrophoresis (Ref. Laemmli, 197~. 
Analysis of membrane protein composition was performed 
by S.O.S. gel electrophoresis in 12% acrylamide slab gels. For 
recipes for gel preparation, see appendix. 
Membrane preparations from C6 cells (0.7mg protein) in 
250~1 of PBS were pelletted by centrifugation at 40,000 x g 
for 20 minutes at 4°C. 
160~1 of 4% (w/v) SOS, 
To the resulting pellet was added 
20~1 of 2-mercaptoethanol, and 80~1 
of sample buffer. The mixture was heated at 100°C for 5 minutes 
in a boiling waterbath. 40~1 of the mixtures containing the 
samples were added to the sample wells in the gel. The 
running conditions are detailed in the appendix. 
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2.5 PHYSICAL STUDIES 
(a) Polarisation of fluorescence of l,6,-diphenyl-l,3,5,-
hexatriene (Ref. Shinitsky and Barenholz, 1974). 
Reagents and procedure 
A crude membrane preparation made as described 
earlier. 1,6-Diphenyl-l,3,5,-he~atriene (DPH, Sigma) was 
made up as a 200~M stock solution in tetrahydrofuran. 
The membrane preparation was resuspended in buffer, 
containing l50mM NaCl, 5mM MgCl 2 and 100mM Tris-HCI pH B.O, 
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to a protein concentration of 2mg/ml. DPH stock solution (25~1) 
was added, the tube mixed and incubated in the dark for 1 hour 
Duplicates were run for each sample. 
The membrane suspensions were removed at the end of 
the incubation period, washed once with incubation buffer, and 
pelletted by centrifugation at 40,000 x g for 15 minutes at 4°C. 
The membrane pellets were resuspended in incubation buffer to a 
final protein concentration of approximately 0.1mg/ml, and used 
for polarisation of fluorescence measurements. 
Spectrofluorimetry 
The measurements were made on a Perkin Elmer MPF-3 
fluorescence spectrophotometer fitted with a Hitachi polarisa-
tion accessory. The sample cell was maintained at 27°C for 
these measurements. 
The optimum settings for slit widths, excitation and 
emission wavelengths were obtained by following the instructions 
in the instrument manual. Excitation and emission wavelengths 
used were 360 and 470nm respectively. The excitation slit 
width used was Snm, and the emission slit width was lOnm. 
The excitation and emission spectra obtained are 
1fiJ 
illustrated in figs. 19 and 20 . In the excitation spectrum, 
a peak was observed at 700nm. This was suspected to be arte-
factual. A scan of the absorbance spectrum of DPR (fig. 21 
revealed no absorbance anywhere near that wavelength. 
polarisation values 
The steady state polarisation values (P) were calculated 
using the following equation:-
P = 
(0,0) - t(0,90) 
(0,0) + t(0,90) 
The notation refers to the orientation in degrees of the two 
polarising filters with respect to each other. The first figure 
in the brackets refers to the orientation of the filter 
over the emission slit. Thus, one can measure 
the fluorescence parallel to the electric vector of the plane 
polarised light emission (0,0) and the fluorescence perpendicular 
to that vector (0,90). 
The term t is a constant to take into account light 
scattering within the machine, and is calculated from:-
t 
(90,0) 
(90,90) 
Electron spin resonance studies 
(b) Studies on membranes 
Stearic acid with the 4,4-dimethyl-3-oxazolidynyloxy 
(doxyl) group attached to either carbon 5 (S-doxylstearic acid) 
or 16 (16-doxylstearic acid) was purchased from Syva Assoc., 
California. Stock O.86mM solutions were prepared in ethanol. 
spin-labelled stearic acid was incorporated into membrane 
10~ 
preparations by first drying the spin label (4.4nmol) at the 
bottom of small glass test-tube to which was added 100~1 of 
membrane suspension (l~mol phospholipid). After incubation 
for 10 minutes at room temperature the membranes were removed 
and centrifuged at 35000xg for 30 minutes. The membrane pellet 
was resuspended in 50~1 of 100mM NaCl/1mM EDTA/2mM Hepes (pH 7.4) 
and transferred to a capillary for electron spin resonance (ESR) 
measurements. 
ESR spectra were recorded with a JEOL JES-PE-1X Or a 
Varian E3 spectrometer equipped with a nitrogen flow tempera-
ture control system. The temperature of the sample was monitored 
with a thermocouple placed close to the sample. The order 
parameter (S) can be calculated for 5-doxylstearic acid under-
going rapid motion from the equation:-
where A 
.'/ 
S = 
are half the separation of the outer and 
inner hyperfine splittings (fig. 6 ) respectively and A and 
zz 
A are the hyperfine splitting tensors in the z and the x 
xx 
direction respectively. 
(Schreier et al., 1978). 
A value of 26.3G was taken for A -A 
zz xx 
The correlation time (T) was calculated for 16-doxyl-
stearic acid undergoing rapid isotropic motion from the equation:-
(Kive1son, 1960) 
where W is the peak to peak width and h is the height of 
o 0 
the centre line and h_l is the height of the high field line 
(fig. 7 ) . 
Fig.6: Electron spin resonance spectrum of 
5-doxylstearic acid incorporated into 
C6 cell membranes 
2AII = Outer hyper fine splitting 
2A.L = Inner hyperfine splitting 
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Fig.7: Electron spin resonance spectrum of 
l6-doxylstearic acid incorporated into 
C6 cell membranes 
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(b ) Live cells 
The cells were grown in petri dishes (9cm diameter, 
1.6-2.0mg protein). Cells were incubated in Medium 199 (lOml) 
for 25 minutes and incubated for a further 30 minutes in the 
presence of the drugs. 10 minutes before the end of the 
incubation in the presence of the drugs, 3~1 of an ethanolic 
solution of 5-doxyl stearic acid (5-(4',4'-dimethyl-oxazolidine-
N-oxyl) stearic acid) (50~g, Syva Research Chemicals) were added. 
Cells were harvested by scraping with a rubber policeman, 
centrifuged at 1000 rpm for 5 minutes and then transferred to 
a capillary for the electron spin resonance measurements. Spectra 
were recorded with a JEOL JES-PE-lX spectrometer equipped with a 
temperature control system. In order to minimize internalization 
and destruction of the spin-labelled fatty acid, spectra were 
recorded at 30°C. There was no significant contribution to the 
spectra from unincorporated label and repeat scans on the same 
sample showed little diminution in signal intensity over a 15 
minute period. The molecular order of the spin-labelled fatty 
acid was assessed by measuring the hyperfine splitting of the 
outer extrema of the electron spin resonance spectra (Hubbell 
and McConnell, 1971; Pang, 1980). 
2.6 CYCLIC AMP ASSAYS (Ref. Brown et al. 1971) 
cAMP. 
A competitive protein binding assay was used to determine 
The binding protein was prepared from fresh specimens 
obtained from the slaughterhouse. The procedure for the assay 
is essentially that of Brown et al. (1971) with some modification. 
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(a) Cell cuI t u r e 
C6 cells were subcultured from confluent 90mm dishes. 
For basal cAMP determinations the contents of one plate were 
split between five other plates and grown for 2 days, after 
which they were incubated in the presence of various bases for 
24 hours. Final protein content was 1.40-2.0mgs/dish. 
Cell cultures for isoproterenol stimulation were 
established by passaging the contents of one 90mm dish between 
30mm diameter dishes. The initial cell density was 0.8-1.2 x 106 
cells/well. These cultures were allowed to grow for 2-3 days, 
before a further 24h growth in medium containing the bases. The 
final protein content was 0.8-l.lmg protein per cell. Triplicate 
dishes were established for each condition. 
The cells were washed twice with pre-warmed (37°C) 
medium 199, and 3m1s of 199 were added per 30mm dish, or 10m1s 
to a 90mm dish. 
Isoproterenol HC1 (200~M) was freshly prepared in 
distilled water and added to the cultures to a final concen-
tration of 10~M. The cultures were replaced in the incubator 
for 30 minutes, unless specified otherwise. 
Incubations were stopped by washing the cells with 
ice-cold saline (0.9%) w/v, and the cAMP extracted with O.lM HC1 
(1m!) . After 30 minutes the acid extract was removed and 1yo-
philized. The cAMP content was measured by the protein binding 
method. The protein content of the cellular residue was measured 
by the method of Lowry et a1. (1957), after precipitation with 
10% (w/v) trichloroacetic acid. 
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(b) Preparation of binding protein 
Bovine adrenal glands were obtained from a local 
slaughterhouse. The glands were removed from the carcase within 
20-30 min of death, and brought to the laboratory on ice. 
The adrenal cortices were dissected and scraped free 
of fat and connective tissue. The cortices were chopped and 
homogenized in 1.S volumes of ice-cold Littlefield's medium 
(0.2SM sucrose, 2SmM KC1, and SmM MgC1 2 in SOmM Tris-HCl, 
pH 7.4). The homogenate was centrifuged at 12S0xg for IS min 
at 4°C. The pellet was discarded, and the supernatant was 
centrifuged at SOOOxg for IS mins at 4°C. The supernatant was 
decanted and strained through muslin to remove fat droplets. 
The filtrate was stored in aliquots (lml) at -20°C. It was found 
that binding capacity of the preparation increased over a period 
of months upon storage at -20°C. 
Binding protein was serially diluted and assayed for 
its ability to bind cAMP in the absence of added cold cAMP. A 
binding protein dilution was chosen such that the zero standard 
would bind SO% of the added tracer (Chard, 1978) to optimise 
the sensitivity of the assay. Each new batch of binding protein 
was tested in this way before use in the assay. 
(c) Assay procedure 
3 To each tube 62S nCt of [8- HJ -3 ': S' cyclic AMP (79 mCi/mg), 
Amersham,was added in SO~l of assay buffer (SOmM Tris-HCl pH 7.4 
containing 8mM theophylline, and 6mM 2-mercaptoethanol). 
Standards (O-lSpmol of cAMP) were added from a stock 
solution (lOOpM) in assay buffer containing ImM sodium azide. 
The lyophilized acid extracts to be assayed were 
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dissolved in assay buffer and an aliquot taken (30-l50~l) for 
assay. The volume in all tubes was brought to 200~l with assay 
buffer. Samples and standards were. run in triplicate. 
The total radioactivity added to the assay tubes was 
ascertained by determining the radioactivity in an aliquot 
(100~1) from tubes containing 50~l of tracer and l50~1 of buffer. 
No binding protein or charcoal was added to these tubes. An 
appropriate dilution of the binding protein was made, and 
binding protein (lOO~l) added to each tube, and vortexed. The 
tubes were covered, and incubated at 4°C for l! hours. 
A charcoal suspension was made containing BDH charcoal 
(0.5g) in assay buffer (5mls) containing 2% (w/v) bovine serum 
albumin (Fraction V, Sigma). The suspension was stirred 
constantly for at least 30min before use. At the end of the 
incubation, 100~1 of the suspension was added to each tube, 
the tubes were mixed and centrifuged (7000xg for 20 min at 4°C) 
within 3 min of addition of charcoal. 
An aliquot (200~1) of the supernatant was taken and 
added to 'Fisofluor' cocktail (5ml) and the radioactivity was 
determined. The radioactivity in the total counts tubes was 
determined from a 100~1 aliquot. 
The bound fraction (% bound) was calculated as follows:-
total radioactivity in standard or sample x 100 
total radioactivity added 
A calibration curve (fig. 8 ) was obtained by plotting the 
percentage of radioactivity bound in the standards against pmols 
cAMP. Values for cAMP content of the samples were derived 
from this curve. In practice the steepest, and therefore most 
Fig.8: Calibration curve for cAMP assay 
(Brown et al., 1971) 
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sensitive part of the curve was found to be between 1-10 pmols. 
(d) Theophylline experiments 
Cell culture was as described before, but during 
the incubation the medium 199 contained lmM theophylline 
(Sigma), which had previously been made up fresh as a 20mM 
solution, the pH of which had been adjusted to 7.0 with NaOH. 
All other procedures were unchanged. 
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2.7 LIPID METHYLATION STUDIES 
(a) Cell culture 
Cultures were established in six-well Linbro trays, 
which have 6 x 35mm diameter wells. It was important for the 
methylation experiments to have a comparable cell density. To 
this end standard plating densities were used. The cells from 
one confluent (90mm) dish were passaged into four Linbro trays 
by adding 3mls of cell suspension (0.2-0.5 x 106 cells/ml) to 
each well. The cultures were grown for 2 days or until the gaps 
between the cell bodies had just begun to close, before a 24h 
incubation with base-containing medium. 
(b) Lipid methylation assay 
The cells were washed twice with medium 199 pre-warmed 
to 37°C. Medium 199 (lml) was added to each well with 20~1 of 
3 [methyl- H'-J methionine (8SCi/mmol). 
One Linbro tray was used for each treatment. 4 wells 
were used for methylation measurements, and 2 wells were used 
for protein determinations. 
All trays were replaced in the incubator for 2Smin to 
equilibrate the label· with intracellular methionine. The 
unstimulated cultures were left in the incubator. Cells for 
drug treatments were briefly removed, the drugs were added, 
and the cells replaced in the incubator for a further 30min. 
At the end of the incubation, the medium was removed, 
and the cells were washed twice with ice-cold 0.9% (w/v) saline. 
Iml of 10% trichloroacetic acid (w/v) was added to each well to 
terminate the reaction. 
The cells were either stored frozen on the trays at -70°C, 
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or scraped from the wells, using a spatula, into glass centrifuge 
tubes. After centrifugation, 35000xg for 20 minutes at 4°C, the 
radioactively-labelled lipids were extracted from the cell 
pellet. Protein determinations were carried out on the remaining 
two wells by the method of Lowry et al. (1957). 
The lipid extract was either dried at 100°C prior to 
addition of liquid scintillation fluid (lOml), or subjected to 
analysis by t.l.c. 
The location of radioactive methyl groups was determined 
by scraping lipid-containing spots, visualized by iodine staining, 
into scintillation vials and adding a suitable cocktail. Radio-
activity in either case, was determined by liquid scintillation 
spectrometry. 
(c) Methionine uptake 
Cultures in Linbro trays were established, some were 
treated with medium containing base analogues for 24h. Three 
wells of the six well tray were used for methionine uptake 
determinations, and 2 wells were used for protein determinations. 
All wells were washed twice with medium 199, and medium 199 (lml) 
was added to each well. To each of the 3 wells was added 20~Ci 
of [m~thYl-3H] methionine (85 Ci/mmol, Amersham), and the cultures 
were returned to the incubator. At the end of the different 
incubation periods, the wells were washed twice with ice-cold 
0.9% (w/v) saline, after removal of the medium 199. The contents 
of methionine-treated wells were scraped into test tubes in a 
small volume (2 x 0.5ml aliquots) of saline. NCS tissue solubil-
izer (3ml, Amersham) was added to each tube and the tubes were 
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heated, with marbles closing their mouths at 45°C for 30min. 
The contents of each tube were tipped into a scintillation 
vial, and the incorporation of radioactivity was determined. 
RESULTS 
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"There are spaces 
where infringements are possible. 
There are notices that say: 
Trespassers will be welcome." 
Norman MacCaig. 
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3.0 CELL CULTURE 
Initial studies were conducted with tll(, aim of 
obtaining satisfactory cell growth on the minimum amounts of 
foetal calf serum. The purpose of this was twofold: first, 
serum is extremely expensive, and it was hoped that less could 
be used, secondly, it has been shown that the number of S-
adrenergic receptors in C6 cells is reduced by the presence of 
serum (Dibner and Insel, 1981). 
The effect of different concentrations of serum on 
cell growth is displayed in Fig.9. 5% (v/v) Foetal calf serum 
appeared to give the best cell growth. I decided that the 
benefits of reduced serum usage would be outweighed by decreased 
growth rates, and consequent increases in medium consumption. 
An attempt to substitute for serum was made by using Iscove's 
modified Du1becco's medium, obtained from Flow Labs (Iscove, 
1978) . This medium was supplemented with: 100mg/litre Soybean 
lecithin, lmg/litre transferrin, and 100mg/litre bovine serum 
albumin. This supported C6 growth in the absence of serum, but 
at slower rates, so I decided to continue using 57, (v/v) foetal 
calf serum in Dulbecco's modified Eagle's medium. 
3.1.0 GROWTH OF CELLS IN MEDIA CONTAINING POLAR HEAD GROUP 
ANALOGUES 
In order to modify the phospholipid polar headgroup 
composition, cells were grown in media supplemented with bases 
as described in section 2.1. I found that bases added to a final 
concentration of SmM in the growth medium resulted in rapid and 
extensive changes in the phospholipid polar headgroup composition 
without any evidence of toxic effects on the cells. After 24h 
Fig.9: Dependence of rates of C6 cell multiplication 
on the concentration of foetal calf serum in 
the growth medium. 
o = Cells grown in 5% (v/v) serum 
o = Cells grown in 1% (v/v) serum 
~ = Cells grown in media without serum 
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growth in the presence of 5mM DME approximately 30% of the 
total phospholipid phosphorus consisted of PDME (see Table 5). 
These results were similar to those presented by 
Finkel and Volpe (1979) for the incorporation of DME into PDME. 
The rate of cell growth is illustrated in Fig.10. Initially 
the polar headgroup analogues caused a slight decrease in growth 
rate relative to the control. This lower growth rate was only 
maintained in the cells grown in the presence of ethanolamine. 
Cells grown in the presence of DME and NME reached 
stationary phase at a cell density comparable to that of the 
controls, although after 4 days the growth rate of the treated 
cells declined rapidly. Most experiments never continued 
longer than 2 days in the base-containing medium, and most 
involved exposure of the cells to bases for only 24h. 
3.1.1 Effect on Cell Morphology 
Plate 8 shows cells grown in DME-supplemented medium. 
After 24h, the cells became rounded and lost their extended 
processes; gaps between the cell bodies were observed in what 
were previously continuous monolayers. No such effect was found 
with either NME or ethanolamine, but photomicrographs of single 
cells indicated that a loss of processes had occurred, although 
not to the same extent as with DME treatment (Plates 7-10). 
3.1.2 Haematoxylin-Eosin Staining of Base Treated Cells 
Since morphological changes appeared to occur, I was 
interested to see if the base treatments were causing any effects 
on the microscopic structure of the cells. Haematoxylin-Eosin 
staining was employed to determine whether any changes in the 
relative size of the nuclear components and cytoplasm had 
12~ 
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PLATE 11 
PLATES 7 -11: C6 CELLS VIEWED BY PHASE - CONTRAST 
MI CROSCOP Y X200 
PLATE 7 : Control Cell s 
PLATE 8 : Cells exposed to 5mM DME for 24h 
PLATE 9 : Cells exposed to 5mM NME for 24 h 
PLATE 10: Cells exposed to 5mM Ethanolamine for 24 h 
PLATE 11: Cells exposed to 2 50mM Dimethysulphoxide for 72h 
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PLATE 12: C6 cells stained with Haematoxylin-Eo~in XSoo . 
PLATE 13: C6 cells in media containing SmM DME, grown for 24hstained 
with Haematoxylin-Eosin xSOO. 
PLATE 14: C6 cells grown in redia containing 5rrM NME for 2411 
and stained with Haenatoxylin-Eosin X500. 
PLATE 15: C6 cells grown in rr.edi:a containing 5Irll- Etlfanolamine for 
2411 and stained wi th Haematoxylin-Eosin X500 
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Growth of C6 Cells in the presence of polar head group precursors 
(0-0, control; _,dimethylethanolamine; 0-0, monomethylethanolamine; 
_,ethanolamine) 
1 2 3 4 5 
Days in culture 
Fig.10. Growth rates of C6 cells in the presence of 5mM 
polar headgroup analogues; control, (0): 
N,N'-dimethylethanolamine, (.); N-monomethyl-
ethanolamine, (D): ethanolamine, (.). 
Cells were grown in 20 cm 2 dishes and harvested 
after trypsinization. Viable cells were counted 
using a haemocytometer. 
1:10 
occurred. Plates 12-15 illustrate the results of those studies. 
The "rounding-up" of the DME-treated cells is apparent. 
with little change in the shape of the NME- and ethanolamine-
treated cells. No change in either the cell size, the shape or 
distribution of the nucleoli were observed. This is of 
importance, since any disturbances in nuclear function could 
have far-reaching effects that could extend further than just 
modification of the function of membrane-bound receptors or 
membrane-bound enzymes. The nuclei of the ethanolamine treated 
cells did not stain as intensely as the other cells, including 
the controls. This correlates with the reduced growth rate 
observed with ethanolamine treatment. 
3.2.0 EFFECT OF BASE TREATMENT ON CELL MEMBRANE COMPOSITION 
3.2.1 Incorporation of Bases into Cell Membranes 
A study of the rate of headgroup incorporation was 
made for growth in the presence of DME. Cells were harvested 
and the lipid extract subjected to analysis by t.l.c. as 
described in Section 2.3. Changes in the major components of 
the phospholipid composition were measured, and are presented 
in Fig.ll. No change was observed in the amounts of the 
minor components (Sphingomyelin, LPC, PI, PS and PA). 
After 24hrs, the changes in phospholipid composition 
had almost reached a maximum, and this length of incubation was 
used in all other experiments. 
From Fig.ll it is clear that the increase in PDME was 
at the expense of PC and PE. PC decreased from 57% to 27%, and 
PE content declined from 27% to 17% of total phospholipid phos-
phorus. 
Fig.ll: Growth of C6 Cells in medium containing 
5mM DME: Effect on major components of the 
phospholipid composition. 
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Plates 16-19 show the gradual change in cell shape 
caused by DME treatment. It is clear from Plate 16 that within 12 
hours of treatment, changes in the shape of the cells had 
occurred. Rounding of the cells continued beyond 24 hours of 
treatment (Plate 19), although no significant changes were 
observed after 48 hours. 
The morphological changes were found to be reversible 
if the base-containing medium was replaced with normal growth 
medium. After 72 hours in normal medium, the cells had almost 
completely reverted to normal shape. 
3.2.2 Effects of Base Treatment on Phospholipid Polar Head-
group Composition 
Cells were grown for 24 hours in medium containing 
DME, NME or ethanolamine and the resulting changes in phospho-
lipid composition were measured. The results of these experi-
ments are presented in Table 5. NME and DME treatments caused 
the corresponding phospholipids PNME and PDME to accumulate to 
~ 32% of the total phospholipid phosphorus, without any change 
in the PI, PS and LPC content. An inverse relationship was 
found between the sphingomyelin content and the number of 
methyl groups on the polar headgroup nitrogen of the base 
supplement with which the cells were treated. The increase in 
sphingomyelin content in the base treated cells may reflect an 
attempt by the cells to maintain the percentage of choline 
phospholipids in the cells. 
Ethanolamine treatment caused an increase in the 
PE content from 27% to 37%, whilst there was only a small 
decrease in the PC content of these cells (from 49% to 46%) 
13~ 
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PLATE 19 
PLATES 16-19: TIME CUJRSE OF 'mE WRPHOUXJICAL ClIANGES IN C6 CEllS 
GlOfN IN MEDIA CXNl'AINING 5nM IllE VIEWED BY PHASE-
CIm'RAST MICXlSOl?Y X200 
PLATE 16: Ob growth 'in med1lJ11 containing Il.1E 
PLATE 17: 12h. growth in ned1un containing !lI1E 
PLATE 18: 24h g.rowth in l!Sd1an containing ThlE 
PLATE 19: 48h grotrth in medium containing Il.fE 
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TABLE 5 
Phospholipid polar headgroup composition of C6 cells 
grown in medium containing bases or DMSO 
Molar % of Phospholipid Phosphorus ± SEM 
SU1212lement PE PNME PDME PC PS PI SJ2hin2°-
myelin 
None (3) 27.4 49.4 6.6 9.5 5.6 
± 0.4 ± 0.5 ± 0.4 ± 0.4 ± 0.6 
DME ( 3) 17.8 32.6 27.5 6.8 8.9 6.4 
± 0.2 ± 1.5 ± 7 .7 ± 0.5 ± 1. 2 ± 0.4 
NME ( 3) 16.8 31.0 27.7 5.6 7.0 10.5 
± 0.8 ± 1.2 ± 0.8 ± 1.1 ± 0.5 ± 0.5 
Ethanol- 37.1 46.5 5.2 7.0 10.0 
amine ( 3) ± 0.3 ± 1.4 ± 0.6 ± 0.5 ± 0.7 
DMSO (4 ) 20.3 54.5 5.8 7.6 7.3 
± 1.1 ± 4.0 ± 0.6 ± 1.3 ± 1. 7 
LPC was found to be ~ 2% of the total phospholipid phosphorus in each 
case. 
Cells were grown for 24h in medium containing SmM bases (OME, NME and 
ethanolamine) or for 3 days in medium supplemented with 250mM DMSO. 
Lipids were extracted and analysed by TLC. 
Numbers in brackets indicate the number of measurements. 
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PA 
1.8 
± 0.6 
3.67 
± 0.6 
1:17 
However, there was a small but significant decrease in the 
amounts of PS and PI, concomitant with an increase in the sphingo-
myelin content of these cells. 
An attempt was made to increase the amount of PC in 
the membrane. Zwingelstein et al. (1982) showed that a large 
increase in the amount of PC could be obtained by growing Friend 
cells in 250mM dimethylsulphoxide(DMSO) for 3 days. However 
with C6 cells, this treatment resulted in very little increase 
in the PC content (Table 5). Interestingly, DMSO caused changes 
in the shape and packing of the C6 cells (Plate 11). 
3.2.3 Cholesterol:Phospholipid Ratios in Base-treated Cells 
Since Finkel and Volpe (1979) found that DME treat-
ment caused a reduction in the activity of hydroxymethylglutaryl-
CoA reductase, a key regulatory enzyme of cholesterol biosynthesis, 
it was thought that the amount of cholesterol in the membranes of 
these cells might decrease. This could have important 
consequences for both the physical properties of the membranes 
and the activity of membrane-bound enzymes. 
This possibility was investigated using two different 
methods of cholesterol determination. As the important para-
meter for the maintenance of membrane fluidity is not the 
cholesterol content per se, but rather its value relative to 
phospholipid, the cholesterol:phosph~lipid ratios in the various 
cells were compared. 
First, the cholesterol:phospholipid ratio was measured 
during the time course of DME-incorporation. This was done by 
measuring the phospholipid phosphorus content of harvested cells 
as described (Section 2.3). Cholesterol content was determined 
using a modified Liebermann-Burchard method. The results of 
this study are presented in Table 6. 
TABLE 6 
Cholesterol Content of Membranes Prepared from C6 Cells 
Grown in Medium containing 5mM DME 
139 
Supplement Cholesterol:Phospholipid Ratio ± SEM(mol:mol) 
None 0.33 ± 0.02 (5) 
24h with DME o . 37 ± 0.09 ( 5 ) 
48h with DME 0.33 ± 0.07 (5) 
Lipid .extracts were prepared from cell membranes. 
Statistical analysis (Students t-test p < 0.05) of 
these results indicated that no change had occurred in the 
cholesterol:phospholipid ratio after 48h exposure to DME. 
This study was extended to check the effects of NME, 
DME and ethanolamine treatment on the cholesterol-phospholipid 
molar ratio (Table 7). 
TABLE 7 
Effect of Modified Phospholipid Polar Headgroup Composition on 
Cholesterol content in Membranes prepared from C6 Cells grown 
in the Presence of 5mM bases for 24h 
Supplement Cholesterol:Phospholipid Ratio (mol:mol) 
None 0.40 
DME 0.38 
NME 0.37 
Ethanolamine 0.40 
The values are the means of determinations on two separate 
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samples. Lipid extracts were prepared from cell membranes. 
Cholesterol was determined by an enzymic method (Section 2.3) 
Phospholipid phosphorus was determined as described in the 
methods (Section 2.3). 
It would appear from the results in Table 7 that 
exposure to the bases, NME, DME or ethanolamine does not change 
the cholesterol:phospholipid ratio of C6 cells. 
The values obtained in Table 7 were obtained by 
using an enzymatic method to determine cholesterol. This was 
adopted since it was found to be more sensitive than the 
Liebermann-Burchard method (Fig.5). 
However, an unusual effect was noted with the 
enzymatic method. The cholesterol:phospholipid ratio of samples 
which had been stored for several months at -70°C increased. 
This was quite reproducible, and inexplicable. However, even 
under these conditions no change was observed in the cholesterol: 
phospholipid ratios of the treated cells compared with controls 
(Table 8). 
TABLE 8 
Effect of Modified Phospholipid Polar Headgroup Composition on 
Cholesterol content in Membranes prepared frOm C6 Cells grown 
in the presence of 5mM Bases for 24h. Membranes were stored 
for several months at -70°C. 
Supplement Cholesterol:PhosEholi~id 
(mo 1: mol) 
Ratio ± SEM 
None 0.53 ± 0.03 ( 3 ) 
DME 0.56 ± 0.02 ( 3 ) 
NME 0.58 ± o. 1 ( 3 ) 
Ethanolamine 0.57 ± 0.01 ( 3 ) 
• 
3.2.4 Protein:Phospholipid Ratios in Cells with Modified 
Phospholipid Polar Headgroup Composition 
Another important component which contributes to 
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membrane fluidity is the protein content of biological membranes. 
Changes in either (a) the protein content, or (b) the phospho-
lipid content, could be part of the mechanism by which 
"homoviscous adaptation" occurs. 
Yavin (1977) and Robert et al. (1978) found that in 
M-l Neuroblastoma cells the phospholipid content of cells with 
altered phospholipid composition increased. This might serve 
to maintain the physical properties of the membrane, or might 
have been simply a reflection of an increase in phospholipid 
synthesis de novo due to the incorporation of the polar head-
groups into the cell. 
The protein:phospholipid ratios were investigated 1n 
both whole \cells and membranes prepared from base-treated cells 
(Tables 9 and 10). 
TABLE 9 
Protein and Phospholipid content of C6 Cells grown in 
Medium containing smM DME 
SUpplement Cells/ 
Dish x 
166 
Mg Protein/ nmol Phospho-
]l06 cells lipid/lOG 
cells 
None 8.66±0.s8 0.22l±o.031 163.0±9.S 
DME (24h) 9.08±0.23 0.20l±0.025 l27.0±26.S 
DME (48h) 10.29±0.78 0.188±0.086 129.3±7.3 
Phospholipid: 
Protein Ratio 
7S2±s7 
688±28s 
670±32 
Values are the means of 3 separate samples ± SEM. 
141 
From Table 9 it is clear that no significant change 
occurred in cell number, protein content or phospholipid 
content in cells exposed to DME for up to 48h. The effects of 
NME and ethanolamine were not studied. These results differ 
from the findings of Robert et al. (1978). These workers found 
that exposure of neuroblastoma cells to DME, NME, or ethano-
lamine, resulted in an increase in the total phospholipid 
content. An increase in the phospholipid content does not 
occur in C6 cells when they are exposed to these choline ana-
logues. 
Since physical studies were carried out using 
membranes prepared from C6 cells treated with bases, I thought 
it important to check that no change was occurring in the 
membrane phospholipid:protein ratios. The results of this 
study are shown in Table 10. Crude membrane preparations were 
made from DME-treated cells, which had been incubated with base 
\ for 24 and 48 hours, as described in the methods (Section 2.1). 
TABLE 10 
Protein and Phospholipid Content of Membranes from 
C6 Cells grown in Medium containing 5mM DME 
Supplement Phospholipid:Protein Ratio ± SEM (nmol:mg) 
None 1091 ± 65 (3) 
24h with DME 1067 ± 123 (3) 
48h with DME 1089 ± 241 (3) 
From Table 10, it is clear that the growth of cells in 
DME had no effect on the membrane phospholipid:protein ratios. 
3.2.5 SOS Polyacrylamide Gel Electrophoresis of Membrane 
Proteins 
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To ensure that base treatment had no effects on the 
protein composition of the cells, the protein profile of membrane 
preparations was determined, as described (Section 2.4) by 
SDS polyacrylamide gel electrophoresis. 
The results are displayed in plate 20. No change 
was found in any of the band patterns, suggesting that base 
treatment had no effect on the gross protein composition in 
these treated cells. These results are in agreement with studies 
carried out on base treated LM cells (Engelhard et al., 1978) 
3.2.6 Fatty Acid Composition of Base-treated Cells 
The replacement of PC by phospholipids that contain 
fewer methyl groups on the nitrogen of the polar headgroup might 
be expected to have a rigidifying effect on the bilayer (Sklar 
et al., 1977). In model systems, Vaughan and Keough (1974) have 
demonstrated that removing methyl groups from dipalmitoyl PC 
raises the temperature of the phase transition temperature. It 
was therefore quite possible that substitutions of the polar 
headgroup with NME, DME, or ethanolamine might cause changes in 
the fatty acyl composition of membrane lipids. 
Fatty acid analysis on membranes was carried out 
using two different g.l.c. columns as described in the methods 
(Section 2.3). The results of these analyses are displayed in 
Table 11. 
It is clear that no change occurs in the fatty acyl 
composition, apart from a decrease in the amount of arachidonic 
acid in NME-treated cells. This was observed when analysis was 
carried out on either column. There were no other significant 
1 2 3 4 5 6 
PLATE 20: SDS Polyacrylamide Gel. Profile of Membrane 
Proteins prepared from C6 cells grown in media 
containing 5mM bases for 24h . 
Lanes 1 , 2 - Control Cells 
Lanes 3,4 - Cells exposed to DME 
Lanes 5,6 - Cells exposed to NME 
Lanes 7,8 Cells exposed to ethanol mine 
14J 
7 8 
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changes in fatty acyl composition. 
These findings are in agreement with the results of 
studies by Schroeder on LM cells {S(.'i-.~~~J~(~~01.1976b)except that 
I 
he did not find any change in the amounts of arachidonic acid. 
The changes I observed were, however, statistically significant 
at p < 0.05, calculated by the Students t-test. Similarly, 
Robert et al. (l978) found no change in the fatty acyl composi-
tion of M-l Neuroblastoma cells grown in the presence of NME, 
DME, or ethanolamine. The values which I obtained for the fatty 
acyl composition of control cells are similar to those described 
by Robert et al. (1977) for C6 cells. 
In LM cells, although base SUbstitution causes no 
changes in the total fatty acyl composition, further work by 
Schroeder (Schroeder, 1978) has shown that the fatty acyl 
composition of individual phospholipid classes were different. 
In particular, the fatty acyl composition of the phospholipids 
resulting from base treatments were intermediate in unsaturated 
fatty acyl content between that of the PE and PC in the 
membranes. 
The presence of butylated hydroxy toluene did not 
make any great difference to the fatty acyl compositions recorded 
for the control cells on either column. However, initial studies 
in which oxidation of 18:1 and 16:1 occurred prompted the use 
of this agent, to rule out any differences in fatty acyl compo-
sition resulting from oxidation. 
TABLE 11: Effect of Phospholipid Polar Headgroup Modification on Fatty Acyl Composition of C6 Cells 
grown in Medium containing SmM Bases for 24h. 
EGSSX Column 
Fatty Acyl 
composition % 
of Total ± SEM 
14:0 
16:0 
16:1 
17:0 
18:0 
18:1 
lS:2 
20: 1 + lS: 3 
20: 2 
20: 3w9 
20: 3w6 
20.4 
20: S 
22:4w6 
22:5w6 
22:Sw3 
22:6w3 
Supplement 
None DME NME Ethanol-
amine 
3.0±0.4 1.2S±0.04 1.06±0.4 3.03±0.32 
~ 
25.9±2.6 22.1S±0.4 23.1 ±2.4 21.7 ±l.S 
S.5±1.S 11.1 ±2.S 11.1 ±0.4 7.82±0.2 
0.34±0.OS 
15.S±2.0 IB.3 ±0.2 14.94±1.B 12.0 ±2.B 
36.4±1.1 3B.2S±0.4 41.6 ±4.S 43.6 ±0.6 
0.3±0.1 0.46±0.1 0.4S±0.3 0.S6±0.1 
0.4S±0.2 0.38±0.OS 0.6S±0.2 
0.B6±0.2 0.B6±0.37 1.02±0.1 0.77±0.2 
0.28 0.21±0.OS 0.24±O.03 0.37±0.4 
1.34±0.6 0.32±0.07 0.39±O.1 0.51 
3.28±0.6 2.76±0.S 1.S3±0.1 2.26±0.S 
0.98±0.2 0.49±0.2 
0.84±0.3 0.39±o.1 
1.27±0.4 0.1 ±0.3 
1.27±0.3 1.3S±O.S 
1.68±0.6 1.S6±O.4 
O.3B±O.l 0.66±O.2 
0.33±o.1 1.07±0.4 
0.96±O.1 
0.91±0.1 0.S8±0.1 
1.16±O.2 1.18±0.4 
EGSS-Y 
14:0 
16:0 
16:1 
17:0 
lS:O 
lS:l 
lS:2 
20:1+18:3 
20: 2 
20: 3w9 
20:3w6 
20:4 
20:5 
22:4w6 
22:5w6 
22:Sw3 
22:6w3 
Supplement 
None DME NME 
1.0±0.4 1.37±0.6 1.17±0.4 
20.9±1.6 19.83±O.8 23.3 ±0.4 
8.8±1.0 B.09±O.7 11.7 ±0.9 
1.o6±O.3 1.0 0.B8±0.2 
16.6±0.S 16.7±1.7 16.3 ±1.7 
3S.16±2.2 33.2±1.1 39.1 ±1.7 
Ethanol-
amine 
1. 71±0.3 
~,,~ ±2.S 
7.B ±0.9 
1.01 ±0.2 
16.1B±1.2 
37.3 ±O.l 
0.83±0.2 0.24±0.2 0.17 ±0.07 0.43±0.2 
0.71±0.2 0.26±0.07 0.15 ±O.04 0.27±0.l 
1.97±0.5 1.36±0.4 1.29 ±0.3 
1.73±0.4 1.34±O.4 0.46 ±O.2 
1.0 ±0.6 0.73±O.1 1.05 ±0.6 
5.7 ±1.7 3.78±O.4 1.4S ±O.l 
0.6B±O.1 0.35±o.01 0.41 ±O.l 
0.67±0.1 0.73±o.7 0.34 
0.61±0.1 0.93±O.2 0.71 ±0.2 
1.7S±O.6 0.97±O.2 0.61 ±O.2 
1.5S±O.3 1.16±O.3 0.B7 ±O.l 
0.79±0.4 
0.36±o.1 
0.57±0.l 
2.97±0.6 
0.41±0.1 
0.39±0.OS 
lo21±0.03 
0.BB±0.3 
1.62±0.4 
Values are the mean ± SEM of 3 determinations on 2 different samples prepared for each column as described in the methods 
(Section 2.3). 
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3.3.0 PHYSICAL PROPERTIES OF CELL MEMBRANES FROM CELLS 
WITH MODIFIED PHOSPHOLIPID POLAR HEADGROUP COMPOSITION 
3.3.1 Fluorescence Depolarisation Studies 
Hirata and Axelrod (1978) have claimed that phos-
pholipid methylation increases the fluidity of erythrocytes, as 
measured by the fluorescence depolarisation of l,6,-diphenyl-
1,3,5, -hexatriene (DPH). Therefore it was important to check 
whether the enrichment of the phospholipids with PDME, PNME or 
PE had any effect on the physical properties of the cell 
membranes. 
I decided to use the same incubation conditions 
employed by Hirata and Axelrod (1978), to incorporate the 
hydrophobic probe molecule 1,6-diphenyl-l,3,5,-hexatriene into 
membranes prepared from C6 cells exposed for 24 and 48h to DME. 
Measurements of the steady-state fluorescence polarisation were 
made. The values calculated were expressed as polarisation 
values (P) since objections have been raised to extrapolating 
values obtained in biological membranes to microviscosity values 
by using the Perrin equation (Kaunto et al., 1977; Lakowicz and 
Prendergast, 1978; Van Hoeven et al., 1979). 
The values obtained are tabulated below (Table 12). 
TABLE 12 
Fluorescent Depolarisation Values of DPH Incorporated into 
Membranes from C6 cells treated with 5mM DME 
Supplement 
None 
24h with DME 
48h with DME 
P Value ± SEM 
0.228 ± 0.008 
0.334 ± 0.046 
0.299 ± 0.079 
( 3 ) 
( 3 ) 
( 3 ) 
No significant difference (P < 0.05 Students t-test) was found 
in the P values of the treated cells compared with the control 
membranes. 
3 . 3 . 2 Electron Spin Resonance Studies 
Schreier et ale (1978) have stated that molecular 
order in lipid bilayers and the rates of lipid motion are 
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distinct parameters. Since electron spin resonance spectroscopy 
facilities became available to me, I thought that a more compre-
hensive study of possible changes in membrane fluidity could be 
made in the base-treated cells by measuring the order parameter 
of 5-doxylstearic acid spin label incorporated into membranes 
propared from base-treated cells. The rotational correlation 
times of lipid motion were derived using l6-doxylstearic acid 
spin label. 
Table 13 shows that at 37°C no change in either the 
order parameter (S) or the rotational correlation times (T) of 
the fatty acid spin labels were found in any of the base treated 
cell membranes, compared with controls. 
A more extensive study was carried out where the order 
parameters (Fig.12) and the correlation times (Fig.l3) of the 
spin labels were measured over the temperature range lSDC-40DC. 
No change in either parameter could be found relative to the 
control membranes. 
These results are therefore in agreement with the 
earlier study with DPH. 
Using parinaric acid and l,6-diphenyl-l,3,S,-hexa-
triene, Schroeder (1978) was unable to find any significant 
changes in the P values of LM cells treated with ethanolamine, 
NME, or DME. Thus, I am confident that no change in the physical 
properties of base-treated cell membrdnes had occurred. 
TABLE 13 
Order Parameters and Correlation Times for Spin-labelled 
Fatty Acids incorporated into Membranes with a modified 
Phospholipid Composition. 
The order parameters for 5-doxylstearic acid and the 
correlation times for 16-doxylstearic acid in membranes 
from cells grown in the presence of choline analogues were 
measured at 37°C as described in the Materials and Methods. 
14~ 
All values are for means of four separate experiments ± S.E. M. 
SUEElement Order Parameter Correlation 
time (x 1010S) 
None 0.59 ± 0.01 5.44 ± 0.30 
N,N'-Dimethyl-
ethanolamine 0.59 ± 0.02 5.72 ± 0.28 
N-Monomethyl-
ethanolamine 0.59 ± 0.01 5.68 ± 0.17 
Ethanolamine 0.58 ± 0.01 5.76 ± 0.10 
Fig.12: Temperature dependence of the order parameter 
of 5-doxylstearic acid incorporated into the 
membranes of control (-0-) cells and cells 
grown in medium supplemented with N-monomethyl-
ethanolamine (-e-). Membranes from cells 
grown in medium supplemented with N,N-dimethyl-
ethanolamine, or with ethanolamine showed a 
similar profile to the controls. 
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Fig.13: Temperature dependence of the correlation 
time of 16-doxylstearic acid incorporated into 
the membranes of control cells (-0-) and into 
membranes from cells grown in medium supplemented 
with N-monomethylethanolamine (-e-). Membranes 
from cells grown in medium supplemented with 
N' ,N'-dimethylethanolamine, or with ethanolamine 
showed a similar profile to the controls. 
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3.4.0 SUMMARY OF RESULTS PRESENTED IN SECTIONS 3.0-3.3.2 
1. The phospholipid polar headgroup composition of cells 
in tissue culture can be changed radically by growing the 
cells in media containing polar headgroup analogues. 
2. Phospholipids resulting from incorporation of the bases 
make up ~ 30% of the total phospholipid phosphorus, 
principally at the expense of PC and PE. No change in the 
amounts of the minor phospholipids occurred, except after 
growth in the presence of ethanolamine and NME, when there 
was a reduction in the amounts of minor lipids, and an 
increase in the amounts of the other choline-containing 
phospholipid sphingomyelin, in addition to the decrease in 
amount of PC in the cells. 
3. Cell growth was not significantly impaired under these 
conditions, with the exception of cells grown in the 
presence of ethanolamine, which grew more slowly and 
reached stationary phase at a lower density than did the 
other cells. 
4. Cell morphology changed as a result of phospholipid modi-
fication, but no change was observed in the relative sizes 
of the nucleus and cytoplasmic components. 
5. No major changes were observed in the fatty acyl compo-
sition of the modified cells compared to control cells. 
6. No difference was found in the physical properties of the 
modified cell membranes compared with control membranes, 
when compared by measurements of the fluorescent depolarisa-
tion of DPH, or by ESR with fatty acids spin labels. 
3.5.0 EFFECT OF POLAR HEADGROUP ALTERATIONS ON CYCLIC 
AMP ACCUMULATION 
The effect of polar headgroup on basal and iso-
proterenol-stimulated cAMP accumulation was determined and the 
results of these experiments are presented in Table 14. Table 
14 also shows the results of experiments in which the modified 
cells were treated with theophylline. These results are 
discussed in Section 3.5.2. 
3.5.1 Effects of Phospholipid Modification on cAMP Accumulation 
The basal cAMP accumulation of the cells was elevated 
by each of the phospholipid modifications. DME and ethanol-
amine treatment elevated the basal cAMP levels to a similar 
degree (I.S-fold) relative to the controls. NME treatment 
caused a greater increase in the basal cAMP levels (3.S-fo1d) 
However, when stimulated with isoproterenol, both the 
degree of stimulation of cAMP accumulation, and the amount of 
cAMP accumulated in the modified cells were significantly 
reduced relative to the control cells. NME and DME treatment 
had the greatest effects, causing a 5-6-fold decrease in the 
degree of stimulation of cAMP content by isoproterenol compared 
to control cells. Ethanolamine treatment reduced the degree of 
stimulation by isoproterenol to about one half of that foun~ 
in the control cells. 
3.5.2 Effects of Theophylline on Cyclic AMP in Cells 
with Modified Phospholipid Polar Headgroup Composition 
Exposure of the modified cells to theophylline, a 
cyclic AMP phosphodiesterase inhibitor, elevates the basal 
cAMP levels in all cells by 3-4-fo1d. The actual amount of 
cAMP accumulation in response to isoproterenol stimulation is 
TABLE 14 
Effect of Base Treatment on Cyclic AMP Accumulation 
cAMP accumulation(pmol cAMP/mg protein/3Omin ± SEM) 
Growth -theophylline +theophyll ine 
SUEElement basal + 10~M isoproterenol Stimulation basal + 10~ isoproterenol 
None 14.4:3.3(3) 806 ± 150 (3) 55.9X 45 (2) 685 ± 58 (3) 
DME 27.3 f"'\.t'i(Z) 288 ± 34 (3) 12.9x 89 ( :» 616 ± 179 (3 ) 
NME 50 :t 13 (3) 473 ± 58 (3) 9.5X 133 ( ~,) 595 ± 50 (3) 
Ethanolamine 23 ± 3 (3) 495 ± 62 (3) 2lX 92 (/) 533 ± 53 (3) 
Cells were grown for 24h in the presence of 5mM bases prior to assay for cAMP content. 
Cells treated with theophylline were grown for a total of lh in medium containing lmM theophylline and the 
theophylline was present in the medium throughout the experiment. 
Stimulation 
lS.2X 
5.9x 
4.SX 
S.9x 
...... 
e..n 
r-n 
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restored in cells with a modified phospholipid composition to 
control levels by theophylline. However, theophylline treat-
ment does not restore the degree of stimulation of cAMP accumula-
tion by isoproterenol compared with the controls. This lowering 
of the magnitude of isoproterenol stimulation of cAMP accumula-
tion is presumably attributable to the increased basal level in 
modified cells. 
The degree of stimulation of the basal rates of cAMP 
accumulation by theophylline in all cells was similar (~ 3-fold 
increase) . 
3.5.3 Time Course of cAMP accumulation in response to 
Isoproterenol in Cells whose Membranes are 
enriched in PDME 
The amount of cAMP accumulated by cells treated for 
24h with DME is less than the control cells (Section 3.5.1). 
However it was possible that the cells with altered phospholipid 
polar headgroup composition achieved their maximum cAMP accumula-
tion at an earlier or later time relative to the control cells. 
DME·treated cells showed the greatest decrease in 
cAMP accumulation relative to the control, so I decided to 
follow the time course of cAMP accumulation in these cells to 
check whether or not there was a difference in the time course 
of cAMP accumulation. 
The results of this study are presented in Fig.14. 
It is clear that the maximum cAMP accumulation in the DME 
treated cells is less than the control cells over the 60min of 
the incubation with isoproterenol, although the rates of cAMP 
accumulation and breakdown of cAMP are similar to the controls. 
Fig.14: Time course of cAMP accumulation in 
response to isoproterenol stimulation 
in C6 control cells (-0-), and in C6 
cells grown in medium containing 
N ,N'-dimethylethanolamine (-~-). 
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3. 5.4 Summary of Results presented in 3.5-3.5.3 
1. Basal levels of cAMP accumulation in C6 cells are 
elevated by phospholipid polar headgroup modification. 
2. The rise in cAMP content in response to B-adrenergic 
agonist stimulation is reduced to one-fifth of that in 
control cell values in cells exposed to DME and NME 
treatment, and to one-half of control values in cells 
with an elevated PE content. 
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3. The amount of cAMP accumulated in response to isoproterenol 
in cells with a modified phospholipid composition can be 
restored to levels similar to those of the control cells 
by theophylline. 
4. Theophylline is unable to restore the degree of stimulation 
of cAMP accumulation by B-agonists in cells with a modified 
phospholipid composition. 
5. The time course of cAMP accumulation in response to iso-
proterenol in DME treated cells is similar to that of the 
control cells. 
3.6.0 LIPID METHYLATION 
3.6.1 Cell Density and Lipid Methylation 
Initially, difficulty was experienced in getting 
reproducible lipid methylation results. This was due to several 
factors, but mainly due to the effects of cell density and to 
differences between the amount of cells in the cultures used 
for each condition. Initially, low cell densities were used, 
but it was found that during the washes after the incubations 
with methionine, the monolayer was damaged and cells were lost 
which altered the total protein recovered. Better cell adhesion 
was obtained with denser cultures, but this led to a loss of 
isoproterenol-stimulation of methylation. 
16\1 
Morris and Makman (1976) demonstrated that the 
responsiveness of the S-adrenergic system of C6 cells increased 
with increasing cell density in culture. This prompted an 
investigation of the effect of cell density on the methylation 
response, which is presented in Table 15. 
TABLE 15 
Effect of Cell Density on Lipid Methylation (methyl 
groups incorporated pmol/mg protein/S5min: SEY) 
condition 
Control 
Control + 101J,M 
isoproterenol 
Low density (0.36mg/ 
protein/well) 
115.2 ± 7 (4) 
183 ±5 ( 4) 
High density (> 1.Omg/ 
protein/well) 
40.6 flO (4) 
48. 7 ± 8 (4) 
From Table 15 it seems that both the basal methylation, 
and the degree of stimulation by isoproterenol are reduced in 
high density cultures. The basal methylation was 2.8 times 
greater in low density cultures than in high density cultures. 
The stimulation of methylation by isoproterenol was 1.S-fold 
in low density cultures, but only l.2-fold in high density 
cultures. 
In Fig.1S the rate of cell growth is related to the 
protein content of the cultures. It appears that in the low 
density cultures (0.36mg protein/well) the cells are still in 
the logarithmic growth phase, but that the high density cultures 
(> 1.Omg protein/well) are in stationary phase, and that both 
cell number and protein begins to decrease, possibly due to 
nutrient starvation. It appears that the optimum isoproterenol-
stimulation of methylation occurs when the cells are still under-
going rapid growth. 
Fig.15. Cell growth and protein content of C6 cell 
cultures established in linbro wells. After 
growth for various periods of time, the cells 
were detached by trypsinisation and counted by 
haemocytometer. The cell suspension was then 
centrifuged, and protein determinations carried 
out on the pellet. 
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For all subsequent methylation experiments the cells 
were used whilst still in the rapid growth phase (0.4-0.6 mg 
protein/well) . 
The assay was redesigned such that four wells of 
the linbro tray were used for methylation studies and the 
remaining two wells were used for protein determinations. This 
greatly improved the reproducibility of the assay. 
3.6.2 Lipid Methylation and the S-Adrenergic Response 
The results presented in Table 16 indicate that\:~1M\'\~\~(t"\\' 
is mediated by the S-adrenergic recep~or. ~8~~~\ Y"~v • :.. \'\ IS:.< y-~< C\ ~ ~V\ 
\",\..o;;,<~«(\~cn is stimulated by the B-adrenergic agonist isopro-
terenol, and hlocked by the B-adrenergic antagonist, propanolol. 
methylation is stimulated by B-adrenergic agonlsts at the 
same concentrations which result in an isoproterenol-stimulated 
rise in intracellular cAMP content. 
Hirata and Axelrod (1980) have claimed that 
stimulation of p~ospholipid methylation in reticulocytes leads 
to an increase in membrane fluidity, which is essential for the 
coupling of the S-receptor to adenylate cyclase. To test this 
claim, I incorporated 5-doxylstearic acid spin label into live 
cells in culture. The cells were then stimulated with isopro-
terenol at a concentration known, from previous experiments, to 
stimulate both lipid methylation and cAMP accumulation. At the 
end of the incubation, the cells were harvested intact and trans-
ferred to glass capillary tubes for electron spin resonance 
studies. 
The hyperfine splitting (2T~) of the outer extrema of 
the ESR spectra was measured. The larger the splitting, the more 
164 
ordered and the less fluid is the membrane. Table 16 shows 
that incubation of intact C6 cells with isoproterenol causes a 
rise in intracellular cAMP and that this is accompanied by a 
stimulation in the rate of ~\i1~~\ ~o(Oli.~ '~lV(f"(~~~~ However, under 
these conditions, no change was observed in the hyperfine splitting 
indicating that lipid methylation is unlikely to cause changes in 
the physical properties of ~ f\t\';,~ '''4\~v''~~'''~Furthermore, it seems 
unlikely that lipid methylation regulates the 8-adrenergic 
response by altering the motional properties of the lipid in 
the plasma membrane. 
On the other hand, propanolol clearly affects the 
physical properties of the membrane lipid in these cells, causing 
the membrane to become more rigid. 
TABLE 16 
Effects of isoproterenol and propranolol on ~~](\\~\~\ ~"w..\, \v\l\:>(rl::.(~~\)\\ I 
cyclic AMP accumulation and the physical properties of plasma 
membranes in intact C6 cells 
3 H-Methyl incorporated 
prnol per mg 
protein /55min)a 
None 32±4 (4 ) 
Isoproterenol(lO~) 75±10 (4 ) 
Isoproterenol(lO~) 
+ propranolol(500~) 36±5 (4 ) 
Propranolol(500~) 35±11 (4 ) 
a. \:1-\1 iV\Q~j\ ::)to,,-\, '''' l(;)( jXll'n-4-\\)" ± SEM 
b. cAMP measurements ± SEM 
c. Hyperfine splitting ± SD 
Cyclic AMP 2T~ 
(prnol per mg protein)b (Gauss)c 
/3Omin 
14±3 (3) 52.9±O.1 
806±133 (3 ) 52.9±O.1 
27±5 (3) 53.7±O.1 
13±1 (3) 53.9±O.1 
3.6.3 Effect of cyclic AMP Analogues on Rate of 
Lipid Methylation 
To determine whether cAMP could regulate lipid 
methylation cells were treated with either dibutyr1' cAMP or 
with theophylline in order to raise the intracellular cAMP 
content. The effect on lipid methylation was then examined. 
TABLE 17 
Ef f ec t of dibu tyr~\ CAMP and theophyll ine on the ra te 0 f 
lipid methylation. Values are ± SEM. 
Treatment Methyl group incorporation 
pmol/mg protein/55min 
None 
+lmM theophylline during 
assay incubation 
+lmM dibutyr cAMP for 
lh prior to assay incubation 
+2mM sodium butyrate for 
lh prior to assay incubation 
75.5 ± 2.1 ( 4 ) 
72.7 ± 3.9 ( 4 ) 
95.8 ± 6.0 ( 4 ) 
71.4 ± 6.2 ( 4 ) 
Theophylline treatment elevates intracellular cAMP content 
(Table 14), but did not have any significant effect on the 
rate of lipid methylation. However, dibutyr,/\ cAMP increased 
16~ 
the rate of methylation, and is known to elevate intracellular 
cAMP levels. The increased rate of lipid methylation did not 
appear to be an effect of butyric acid, since butyric acid on 
its own did not increase the rate of lipid methylation. 
3.6.4 Comparison of the Effects of Stopping Lipid Methylation 
Incubationswith Trichloroacetic acid or Phosphate 
buffered Saline on the Distribution of Incorporated 
Radioactivity in C6 Cells 
Moore et al. (1982) published work which showed 
that terminating the lipid methylation reaction in lymphocytes 
with trichloroacetic acid caused a greater incorporation of 
radioactivity into the cells, than when ice-cold phosphate 
buffered saline was used to stop the reaction. 
I was concerned that the use of acid might be the 
cause of artefacts which might be responsible for both the 
incorporation of radioactive methionine, and the pattern of 
incorporation of radioactivity into particular areas of the TLC 
plate. This possibility was investigated by measuring the 
rate of methylation and the distribution of radioactivity in C6 
cells that had been stimulated with isoproterenol. Incubations 
were stopped with either phosphate-buffered saline, or with 
trichloroacetic acid. The results of this study are presented 
in Table 18. 
The results shown in Table 18 indicate that although 
trichloroacetic acid increases the amount of radioactivity 
incorporated into the cells, the percentage of [3R J lab~l recovered 
from any particular area of the TLC plate was not altered. It 
is also clear that although isoproterenol stimulated an increase in 
methyl group incorporation, the percentage of label that went into 
individual phospholipids was not altered. Almost a third of the 
total label incorporated was found in the neutral lipids. 
Considerable amdunts of radioactivity were also found at the 
origin. 
Stopping the reaction with trichloroacetic acid appeared 
to increase the percentage of label found at the origin, and 
decreased the amount of label associated with the neutral lipids 
compared to when the reaction was stopped with phosphate buffered 
saline. 
[Methyl _3R] methionine (lO~Cv in medium 199 was 
extracted by the Folch method. The residue remaining after the 
solvent had been evaporated was re-dissolved in a mixture of 
phospholipid standards and subjected to TLC. It was found that 
~O.6% of the original radioactivity prior to extraction could 
be recovered from the TLC plate (data not shown). 
Most of the radioactivity was located in an area above 
PE and PNME in the direction of the first dimension. A lesser 
amount of radioactivity was found in a broad band parallel to the 
direction of the second dimension. 
This data indicates that the assignment of the recovered 
radioactivity in Table 18 to discrete phospholipids may not be 
reliable and that the majority of [3H] methyl groups incorporated 
into cells during"lipid methylation" may be due either to free 
[3R,] methionine or to other contaminants. 
Ibl 
of radioactivity in the phospholipid fraction, I continued to 
use trichloroacetic acid to stop the methylation reaction. 
TABLE 18 
A comparison of the effects of terminating the;(\"\,I(~-(~"'~(),j,o\~\41(\'\~il'J\ 
in C6 cells with trichloroacetic acid or with phosphate buffered 
saline on the distribution of [3 H] label recovered from TLC 
plates. 
% of [3H] label in each lipid fraction recovered from TLC plate 
~~ __ ~ __ ~ __ ~P~B~S ____ ~~ __ ~ TeA 
~thylation was measured by incubating cells in the 
presence of [methyl-3 H]methionine for 55min, and terminating 
the reaction with either lO%{v/v) trichloroacetic acid or 
phosphate buffered saline. Cell lipids were extracted and 
resolved by 2-dimensional TLC. After locating the lipid spots 
with iodine, they were scraped off the plate and the incorporated 
radioactivity determined. Values are the means from two individ-
ual samples for each condition. 
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3.6.5 Summary of Results presented in 3.6.0-3.6.4 
1. The magnitude of lipid methylation in C6 cells is 
dependent on the cell density of the culture. Lipid 
methylation is highest in low density cultures comprising 
cells in logarithmic growth, and lowest in cultures of 
cells which are in stationary phase. 
2. Lipid methylation is a 8-adrenergically mediated event 
and is stimulated by isoproterenol but plays no direct 
role in regulating the 8-adrenergic response by promoting 
fluidity changes in the cell plasma membrane. 
3 • Cyclic AMP may regulate lipid methylation 
in intact C6 cells. 
4 . Less than a third of the 3 [ H]-methyl groups incorporated 
into lipid by incubating C6 cells in the presence of 
L- [methy 1- 3H] meth ionine is loca I ised in Cl..'Q.~r". '0 \ ,*,Q.. \\,..<:" 
P\~\-Q.. ~ \..~~,t.'" \')~~~r"'c\',v"~ ~~I\\"<:\~ c..()-~~~-<'c\~. 
5. Although isoproterenol stimulates an increase in the 
incorporation of L-[methyl-3H1methionine, there is an 
increase in the amount of label incorporated into all of 
the lipid fractions examined. Thus, there are no differences 
in the percentage of label found in any particular fraction 
between control and stimulated cells. 
6. Terminating the lipid methylation reaction with trichloro-
acetic acid or phosphate buffered saline makes no difference 
to the percentage distribution of incorporated label. 
However the amount of label incorporated into cells termina-
ted by trichloroacetic acid is greater than when the 
reaction is stopped with phosphate buffered saline. 
3.7.0 EFFECT OF PHOSPHOLIPID POLAR HEADGROUP MODIFICATION 
ON LIPID METHYLATION 
3.7.1 Effect of Polar Headgroup Modification on the 
Distribution of [3HJ-Methyl Groups Incorporated 
during Lipid Methylation 
Cells were allowed to incorporate L-[methyl-3 H) 
16.1 
methionine for Ih, then the lipid fraction was extracted. The 
lipid components of the mixture were resolved by two dimensional 
TLC and the distribution of the incorporated radioactive 
methyl groups is shown in Table 19. 
TABLE 19 
The effect of polar headgroup manipulations on distribution of 
[3H]label incorporated into C6 cells during basal lipid 
methylation. 
SUP21ement Total d.p.m. 
recovered 
None 13280 (2) 
DME 26128 (2) 
NME 33495 ( 2) 
Ethanol-
amine 12647 (2 ) 
3 % of [ HJlabel recovered from TLC plate 
Neutral PC PDME 
lipid 
50 20 7 
32 60 6 
24 28 36 
54 19 7 
Location 
PNME 
3 
1 
3 
4 
PE 
4 
1 
1 
4 
Origin and other 
Phospholipids 
16 
8 
12 
Values are the means of radioactivity recovered from two separate plates 
per condition. 
Til a moun o f l abe l i n til ne utr a l lipid fra cti o n 
is dr as i a l ly r e d uc pd in the c el l s trea t e d with DME an d NME , 
as i s t h a mo unt 0 ra di o act iv ity f o u nd at th e origin. Etha nol-
amin e t r a tment do e s no a ppea r o h a ve much effect on t h e 
distrib utio n of l abel and ap art fr o m a slight increase i n t he 
n e u tral lipid fracti o n , t h e di str ibu ti on is very simila r to 
that in the control ce lls . 
The perc e n a g e o f lab e l r e co vered in the phospholipid 
fraction is doubl ed in the NME an d DME treated cells comp a red 
wi t h th e c o ntro l. This i ncr eas e appe a rs to be at the exp e nse 
of t h e percentage of lab e l recovered from the neutral lip i ds 
a nd from the or i gin . 
Base tr eatment ca us es an i ncrease in the amount of 
l a b el found in t h e subseque nt ph os p h olipid in the phospholipid 
methyl at io n pathway . DM E t reatm e n tr ebles the amount of 
radio act i vity recov er e d f ro m PC in th os e cells. NME tr eatment 
causes a five -fo l d in c rease in th pe rcentage of label in PDME, 
wit h on l y a mi nor incr ease in th e mo unt of label in PC. 
Ethanola min e , o n th e o th e r hand, do e s not show this eff e ct. 
3 . 7 . 2 Eff ec t of Pho sp h ol ip id Po l ar Headgroup Modification 
on the Rate of Lipi d Meth ylat ion 
Enrichme n t of me mbran es with PDME, PNME and P E will 
incr ease th e amo un t of su bs trat e f o r t he phospholipid me thyla-
t io n pat h \va y . Th erefor e I e xam in ed t he effects of polar h e ad-
gro u p sub s titution on th r a t e o f li p id methylation. Th e 
result s of these experime n ts ar e pr e se nted in Table 20. 
As might b e expe c t e d, e n ric h ment of the cell me mbranes 
with P E , PNME or PO ME in c rease d th ba sal rate of methyl at ion. 
NME tr ea me nt caus e d t h e re at es s timul a tion of basal me thylation 
TABLE 20 
The effect of phospholipid modification on the rate of lipid methylation in C6 cells 
incubated in the presence of L- [methyl,- 3H]-methionine. 
Treatment Basal 
None 70.9 ± 3.3 
DME 133.2 ± 6.4 
NME 210.4 ± 4.8 
Ethanol-
amine 95.7 ± 9.8 
( 4 ) 
( 4 ) 
(4 ) 
(4) 
Methyl groups incorporated pmol/mg protein/55min ± SEM 
Rate of methylation 
relative to control 
1.9 X 
2.9 X 
1. 3 X 
+ 10~M isoproterenol 
99.3 ± 4.6 
77.2 ± 10.3 
80.6 ± 6.2 
Not done 
Rate of methylation 
relative to basal rate 
130% 
57% 
38% 
Not done 
Cells were grown in linbro wells till almost confluent, then treated for 24h with medium containing. 
SmM bases. The rate of lipid methylation was then measured as described in Section 2.7. 
...... 
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by " .. q -fold. DME and ethanolamine were of similar potency 
and caused a 1.9 -fold and a 1.3 -fold increase in basal 
methylation respectively. 
More interesting is the observation that exposure of 
the cells with modified phosph91ipid polar headgroup composition 
c\~t.('~!.~ 'Y\ 
to isoproterenol causes ~methYl group ~ncorporation, i.e. a 
demethylation (Table 20). 
Both NME- and DME-treated cells showed a demethylation 
when exposed to isoproterenol, although the effect was most 
marked in the NME-treated cells. In both the DME- and NME-
treated cells the lipid methylation rate in the presence of 
isoproterenol decreased by 3-4-fold. 
This prompted me to determine whether this demethyla-
tion was mediated by the B-adrenergic receptor. 
3.7.3 Effect of Propranolol on Isoproterenol-induced 
Demethylation in DME-treated cells. 
Cells were grown in the presence of DME and were 
then stimulated with isoproterenol in the presence of propranolol, 
to determine whether the presence of a B-adrenergic antagonist 
could block the demethylation caused by isoproterenol. The 
results of the experiment are contained in Table 21. 
The results presented in Table 21 indicate that the 
isoproterenol-induced demethylation in cells whose membranes 
have been enriched in PDME cannot be blocked by propranolol, 
and is therefore unlikely to be an event mediated by the 
B-adrenergic receptor. Propranoklitself does not have any 
effect on basal methylation rates, although it blocks the 
isoproterenol stimulation of methylation in the control cells. 
TABLE 21 
The effect of propranolol on lipid methylation in 
control and DME-treated cells incubated in the presence 
of isoproterenol 
Treatment 
Control 
Control + 
500~ 
propranolol 
DME 
DME + 
500~ 
propranolol 
Methyl groups incorporated pmol/mg protein/ 
55min ± SEM 
Basal + lO~M isoproterenol 
63 . 66 ± 4. 6 ( 4 ) 100.98 ± 19.2 (4) 
Not done 75 ± 8 (4) 
90 • 8 ± 11. 7 ( 4 ) 73 ± 5.5 (4) 
84.08 ± 10.6 (4) 57.4 ± 4.5 (4) 
Cells were grown for 24h in media supplemented with DME 
prior to measurements of lipid methylation. 
17~ 
3.7.4 Uptake of Methionine in Cells with Modified 
Polar Headgroup Composition 
The rate of uptake of radioactive methionine 
li~ 
into cells was measured in order to check whether differences 
in the rates of lipid methylation could be accounted for by 
differences in the availability of methionine. 
Fig.l6 shows that the initial rate of methionine 
uptake (O-Smin) was greater under all conditions relative to 
the control cells. However, this enhanced rate of methionine 
uptake was not maintained, except by NME-treated cells, for 
up to 60min. Therefore in the DME and ethanolamine treated 
cells the enhanced methionine uptake at 60min was principally 
a result of the greater uptake in the first 5min of the 
incubation period. 
Since the increase in the rates of basal methyla-
tion (Section 3.7.2) are greater than the increased amount of 
methionine uptake in the cells with modified phospholipid 
polar headgroup composition, it seems that the increased 
rates of basal methylation are due to the greater availability 
of phospholipid substrate rather than enhanced methionine 
uptake. This is backed up by the observation that DME and 
NME treatment increases the percentage of radioactivity found 
in the phospholipid fraction (Table 9). 
Figure 16 
Uptake of L-[~ethYl-3H]-methionine by 
C6 cells after growth in the presence of 5mM bases for 
24 hours. 
tions. 
Each point is the mean 6f th~eseparate determina_ 
o = control cells 
6 DME treated 
o = NME treated 
• = ethanolamine treated 
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3.7.5 Summary of Results Presented in Sections 3.7-3.7.4 
1. Enrichment of C6 cell membranes with PDME, PNME and PE 
elevates the basal rate of lipid methylation. NMR treat-
ment causes the largest elevation of basal methylation. 
DME and ethanolamine treatments both approximately double 
the basal methylation rate. 
2. DME-and NM~treated cells show a redistribution of the 
location of 3 [methyl- H] label incorporated after incubation 
3 
with L-[methyl- H) methionine. There is an increase in 
the amount of label found in the phospholipid fraction 
at the expense of the percentage of the label found in 
the neutral lipid fraction. Base treatment results in 
an increase in the percentage of label found in the 
subsequent phospholipid of the phospholipid methylation 
pathway. Cells enriched in PE show similar distribution 
of label in the phospholipids as in control cells. 
3. Isoproterenol stimulates a demethylation in base treated 
cells, which is greatest in NME-treated cells. This 
demethylation does not appear to be mediated by the 
B-adrenergic receptor. 
4. Base treatment leads to an increase in methionine uptake 
when the cells are incubated in the presence of 
L-[methyl-3 H] methionine. NME-treated cells show the 
highest uptake, followed by ethanolamine and DME-treated 
cells. The increase in methionine uptake in the supple-
men ted cells is not sufficiently large to account for the 
increased basal methylation rates in the treated cells. 
3.8.0 LIPID METHYLATION AND CYCLIC AMP ACCUMULATION 
IN HIGH PASSAGE CELLS 
C6 cells are known to show marked changes in the 
responsiveness of their 8-adrenergic system when they reach 
liB 
high passage number (Mallorga et al., 1981). It is also known 
that ageing increases the methyltransferase activity of rat 
brain cells (Crews et al., 1979). It is known that the 8-
adrenergic responsiveness of high passage cells is greatly 
reduced (Mallorga et al., 1981), therefore I thought that high 
passage cells would be a good system with which to study further 
the relationship between lipid methylation and the B-adrenergic 
response. 
3.8.1 Production of High Passage Cells 
High passage cells were obtained by continually 
passaging cells until they were approximately double the passage 
number of the cultures that were normally used. This ensured 
that the high passage cultures that I obtained were similar in 
age to those used by Mallorga et ale (1981), and therefore likely 
to display reduced S-adrenergic responsiveness to isoproterenol. 
From passage number 71, the cells began to look less 
like the control cells. They began to look longer than the 
controls, more oblong in shape, and with numerous spidery 
processes. By passage 84, the majority of the cells were two 
times longer than the control cells. This enlargement of cell 
size was reflected in the shorter time required for the cells 
to reach confluency, compared with controls. Cells of passage 
number 102 were confluent in only 75% of the time required for 
cells of passage number 51. However, a decrease in the cell 
doubling time cannot be ruled out. 
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Plate 21 
Plate 21 : 
Plate 22 : 
Plate 23 : 
C6 cell of passage 103 stained with 
Haematoxylin - Eosin x500 
Confluent monolayers of c6 cells of passage 
103 X200 
Confluent monolayers of C6 cells of 
passage 5 2 x 200 
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Plate 22 
Plate 2 3 
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3.8.2 Appearance of High Passage Cells 
Plate 21 shows a cell of passage number 103, stained 
with haematoxylin~eosin. Compared with the early passage cells 
(Plate 16) it is clearly larger and less astrocytic in appear-
ance. The greater cytoplasmic-nuclear area is quite clearly 
visible, the nuclear contents also appeared to be more dispersed 
than in the early passage cells. 
3.8.3 Measurements of High Passage Cell Size 
Measurements of the size of the cells of passage number 
103 were made using a calibrated graticu1e. Two measurements 
were made, the length of the cell and its width at the broadest 
part of the cell. Cells of early passage number were measured 
in the same way for comparison: 
Passage number 50 
Passage number 103 
78.5 ± 7 x 11 ± 1 
179 ± 16 x 13 ± 2 
( 21) 
( 21) 
The high passage cells are clearly longer than early passage 
cells, but the breadth of the cells is similar. 
A curious effect observed in confluent cultures of 
high passage cells is the orientation of the cells along lines 
parallel to their long axis (Plate 22). This is possibly a 
consequence of the greater length imposing constraints on the 
way that the cells can pack together. This contrasts with the 
relatively random orientation of cells of early passage in 
confluent cultures (Plate 23). 
3.8.4 Effect of High Passage Number on the 8-Adrenergic Response 
The cAMP accumulation of high passage cells in 
response to isoproterenol was measured. 
in Table 22. 
The results are presented 
TABLE 22 
Effect of Passage Number on cAMP Accumulation in C6 Cells 
Passage Number 
52 
103 
cAMP accumulation (pmols/mg protein/30min 
± SEM ) 
Basal + 10~M isoproterenol 
20. 1 ± 2. 5 (3 ) 973 ± 152 (3) 
29.7 ± 6 (3) 370.9 ± 37 (3) 
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The basal cAMP accumulation of the early and high passage cells 
is similar, but the stimulation of cAMP accumulation in response 
to isoproterenol is clearly decreased in the high passage cells 
to about half that observed in the early passage cells. 
3.8.5 Effect of High Passage Number on Lipid Methylation 
The lipid methylation activity of the high passage 
cells was measured, and is recorded in Table 23. 
TABLE 23 
Effect of Passage Number on Lipid Methylation in C6 Cells 
Methyl groups incorporated ~mol/mg protein/55min 
± SEM) 
Passage Number Basal + 101lM isoproterenol 
52 32 ± 3.7 (4 ) 75.4 ± 10.6 (4) 
103 90 ± 16.1 (4 ) 70.3 ± 5.7 (4) 
The basal methylation in the high passage cells is nearly 
three-fold greater than that of the early passage cells. 
However there is a loss of the isoproterenol-stimulated increase 
in methylation, and similar to the base-treated cells, there 
appears to be an isoproterenol-induced demethylation. 
These results with the high passage cells are remark-
ably similar to those obtained for cells enriched in PDME. 
18J 
3.8.6 Summary of Results Presented in Sections 3.8-3.8.5 
1. Continuous passage causes an increase in the size 
of, and a change in the morphology of C6 cells in 
culture. 
2. The stimulation of cAMP accumulation by isoproterenol 
is significantly reduced in these cells. 
3. The rate of basal lipid methylation is three times 
greater than in early passage cells, but the iso-
proterenol-stimulation of methylation is lost, and 
instead isoproterenol causes a demethylation in high 
passage cells. 
18'.l 
DISCU3SICN 
"TiIre nay have the answers but the nap is here 
Now is the future that I never wished to see 
I was happy dreaming and had no fear: 
But now, fran the nap ~ a gtm is a.iIred at me" 
Ruthven Todd 
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4.0 The results of the modifications of cellular phos-
pholipid polar headgroup composition (Sections 3.0-3.3.2) have 
already been discussed in those sections. This section will 
therefore concentrate on discussing the summarised results of 
Sections 3.5.4, 3.6.5, 3.7.5 and 3.8.6. 
4. 1 Phospholipid Pol~r Headgroup Modification and 
its Effect on the a-Adrenergic Response 
(Sections 3.5-3.5.3). 
The elevated basal cAMP levels of cells with modified 
phospholipid polar headgroup recorded in Table 15 would appear 
to be principally due to an activation of adenylate cyclase by 
PDME, PNME or PE. These results are similar to those of 
Engelhard et al. (1978) who observed a similar pattern of 
activation of basal adenyl ate cyclase activity in LM cells. 
Both these results are in contrast to the work by Schroeder et 
al. (1916a)who found that enrichment of LM cell membranes with 
the same phospholipids did not alter the activity of either the 
+ + I Na /K ATPase or 5 -nucleotidase, both of which are plasma 
membrane-bound enzymes. 
Presumably the increased phosphodiesterase activity 
is due to an activation of the membrane-bound phosphodiesterase 
by the incorporated phospholipids. This is not an unreasonable 
assumption since Jard et al. (1972) have shown that 85% of the 
high Km form and 91% of the low Km form of phosphodiesterase 
activity in C6 cells is in the particulate fraction. It has 
also been shown that the decreased response of high passage C6 
cells to isoproterenol is due to an increase in activity of the 
phosphodiesterase (Fishman et al., 1981). 
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Since the magnitude of stimulation of cAMP accumula-
tion in response to isoproterenol in the cells exposed to bases 
is not restored to that of the controls by theophylline, it is 
possible that there is another reason for the reduced 8-adrenergic 
response in these cells. There are two possible explanations. 
Firstly, there might be a loss of receptors in the cells enriched 
in PDME and PNME. Bakardjieva(l982) has shown that manipulating 
the phospholipid composition causes a decrease in the number of 
8-adrenergic receptors and a reduction in the magnitude of the 
8-adrenergic response in Chang liver cells. No studies of the 
effect of exposure of cells to bases on the a-adrenergic receptor 
number have been published, and it is impdssible to predict if 
this might be the cause of the reduced response in C6 cells exposed 
to bases. Maximum cAMP accumulation in C6 cells in response to 
8-adrenergic agonists is dependent on occupation of all the 
available 8-receptors (Bockaert et al., 1973). 
The course of cAMP accumulation in cells exposed to 
DME (Fig.14) shows that the rate of cAMP accumulation in response 
to isoproterenol is similar to that of the control cells, but 
that the maximum intracellular cAMP content is lower than in the 
controls. This could point to a reduced number of 8-receptors 
in the cells exposed to DME. Another explanation is that the 
coupling between the 8-adrenergic receptor and adenyl ate cyclase 
might be perturbed by enrichment of the cell membranes with PNME 
or PDME. 
Theophylline reduces the maximum cAMP response to iso-
proterenol in control cells. This is difficult to explain but 
has been recorded by other workers (Gilman and Nirenberg, 1971; 
J"a r d eta 1 ., 19 7 2) . 
The low Km form of phosphodiesterase is activated by 
PI and LPC in rat adipocyte microsomes (Macaulay et al., 1983) 
and in rat brain (Wolf and Brostrom, 1976). The increased 
rate of phospholipid methylation in the cells with modified 
membrane composition (Table 20) could produce small amounts of 
LPC by phospholipase A2 activity on the newly formed PC. This, 
although undetectable on the t.l.c. plates could be sufficient 
to activate the phosphodiesterase. Houslay and Palmer (1979) 
have demonstrated that extremely low concentrations of LPC 
activate adenylate cyclase. If the same were true of phospho-
diesterase, it could explain the increased phosphodiesterase 
activity in these cells. 
4.2 Lipid Methylation in C6 Cells (Sections 3.6-3.6.4) 
Lipid methylation may be a misnomer since it appears 
• from Table 18 that most of the radioactivity incorporated is not 
associated with phospholipids of the N-methylation pathway. 
Considerable radioactivity was also found in areas of the TLC 
plates which did not correspond to endogenous C6 lipid. 
The increase in the rate of [3H]methyl group incorporation 
caused by isoproterenol may represent a general, non-specific 
increase in incorporation. If this is true then lipid methylation 
would be unlikely to have the physiological role claimed by 
Axelrod's group. However if the [3H] methyl group incorporation 
is due to incorporation into physiologically important phospholipids, 
some possible roles for it are discussed in the following sections 
and in section 5.2. 
[3H]uethyl group incorporation in C6 cells is a 
8-adrenergically mediated event and occurs under conditions in 
which 8-adrenergic stimulation of cyclic AMP accumulation occurs. 
This is in agreement with the conclusions of Strittmatter et al. 
(1979a) and of Hirata and Axelrod (1980). 
From the results presented in Table 15 it appears that 
both the basal and isoproterenol-stimulated rates of lipid 
methylation are dependent on the cell density of the cultures 
being examined. Morris and Makman (1976) have shown that the 
amount of cAMP accumulation in response to isoproterenol in C6 
cells is directly proportional to the culture density. The 
opposite appears to be true for lipid methylation. Possibly 
the reduced isoproterenol stimulation of lipid methylation in 
high density cultures is due to a reduction in 8-adrenergic 
receptor number in such populations. 
lho 
More difficult to explain is the higher basal rate 
of methylation in low density cultures compared to high density 
cultures. Perhaps this is due to a higher rate of metabolism in 
cells growing at a rapid rate. Clea.rly, the increase in the rate 
\:)"1 "',\, . 1 :"'0(\).;.)·","0.,\ of~~j\~Q.-\ j ')~C'-\\ ~ on exposure of C6 cells to isoproterenol is 
a 8-adrenergic receptor-mediated event (Table 16) and it occurs 
under conditions in which cAMP accumulation is stimulated. 
However, ESR studies indicate that lipid methylation is not 
responsible for fluidity changes in the membranes of cells 
stimulated by isoproterenol. 
This observation argues against the theory of Hirata 
and Axelrod (1980) that PNME or any other product of N-methylation 
of PE promote a-adrenergic coupling by fluidising the membrane. 
My conclusion is backed by the results presented in Table 13 
which show that cell membranes enriched in PNME, PDME or PE do 
not differ in physical properties from control cells. 
The re suI ts pre sen ted in Tab1 e 1 7 indicate tha t ~"'3'M~-\\~\ 
<J '{ I;:)->'? ' "" '-C < "a\~l' ~ C>\i\ is stimulated by cAMP analogues. This 
is in agreement with the findings of Castano et al. (1980), and 
suggests that lipid methylation is not a primary event in the 
B-adrenergic response. However Pritchard et a1. (1981) have shown 
that cAMP analogues have either little effect, or lead to a 
decrease in the rate of lipid methylation in hepatocytes. 
The observa t ion (Tabl e 18) tha t the ac id condi t ion s 
used to stop the methylation reaction can increase that apparent 
rate of ~~~Q.'\\.j' yv~f \"'~(f~X"t\~~~ ;\'1 ;~k(t C.Q\\~ when compared to 
terminating the reaction with PBS is consistent with the findings 
of Moore et al. (1982) . This does not undermine the conclusions 
of these experiments, since the distribution of incorporated [3 H] 
was not altered. 
4 . 2 . 1 Methyltransferases and Lipid Methylation 
Before speculation about the relative capacities and 
kinetics of the steps of the phospholipid methylation pathway are 
made, the question of how many phospholipid methyltransferases 
are present must be addressed. 
Audubert and Vance (1983) argue that only one phospho-
lipid methyltransferase, with a pH optimum of 10.0, is present in 
hepatocytes. In the systems examined by Hirata and Axelrod (1980) 
two enzymes were suggested with pH optima of 7.0 and 10.0. Simi-
larly, Crews et al. (1980a)have provided evidence to suggest that 
in rat brain synaptosomes two enzymes are present with pH optima 
of 7.5 and 10.5. 
In C6 cells an examination of the phospholipid methyl 
transferase activity by the method employed by Audubert and Vance 
(1983) indicates that there are two pH optima for phospholipid 
methyltransferase activity; 7.0 and 10.5 (Gillespie, McKenzie, 
and Brophy~ unpublished results). Thus, for an explanation of the 
relative activity of each stage of the phospholipid methylation 
reaction in C6 cells it would seem appropriate to interpret the 
results of Tables 18 and 19 in terms of being catalysed by two 
phospholipid methyltransferases. 
Vance and de Kruijiff (1980) have stressed that the 
amount of PC synthesised by N-methylation is extremely small in 
hepatocytes. Presumably the capacity of the pathway in C6 cells 
is limited. Two pieces of evidence support this conclusion. 
Table 5 shows that although cells could be enriched in substrate 
for the phospholipid methylation pathway (PE and PNME) , no trace 
of the immediately subsequent phospholipids in the methylation 
pathway were found in these cells. On the other hand Table 19 
shows that enrichment of the cell membranes with intermediates 
of the methylation pathway did stimulate phospholipid methylation. 
The distribution of radioactivity associated with the 
incorporated methyl groups in Table 18 suggests that the iso-
proterenol-stimulation of the rate of methylation is due to a 
general increase in E~'f'M'~\<jVIJ\>~ \V\~<. ~'>'t;{.\<J~'\ within C6 cells, 
and is not specific for the phospholipids. 
Careful scrutiny of the data published by Hirata et al. 
(19 79 a)shows that the same pattern was recorded. This argues 
against a specific role of any particular phospholipid class 
(such as PC) in the effects produced by the lipid methylation 
reaction. 
3 The considerable amount of [ H] methyl groups found 
in the neutral lipid fraction (Table 18) is in accord with the 
findings of Zatz et al. (1981) who showed that a large percentage 
of lipid methylation in rat lung was due to incorporation of 
[methyl-3 H] groups into neutral lipids. Kloog et al. (1982) have 
also demonstrated that 30% of the total radioactivity incorporated 
into rat parotid, retinal and basophilic cells was found associated 
with ubiquinone. 
Table 18 shows that a considerable amount of [3 H] label 
was found at the origin. This could be due to methionine that had 
not been incorporated into lipid. 
4.3 Phospholipid Polar Headgroup Modification and its Effects 
on Lipid Methylation (Sections 3.7-3.7.4) 
Enriching C6 cells membranes with PE, PNME or PDME 
increases the basal rates of lipid methylation in intact cells. 
A similar pattern of stimulation was found for DME- and NME-treated 
MOp31C cells (Maeda et al., 1980~ However these workers did not 
observe a stimulation of the basal rate of lipid methylation in 
ethanolamine-treated cells. 
C6 cells exposed to NME and DME incorporated a greater 
3 percentage of [methyl- H) groups into the phospholipid fraction, 
apparently at the expense of the neutral lipid fraction, and the 
polar material at the origin. The decrease in the radioactivity 
at the origin, might be due to a greater consumption of [methyl-
3 H]methionine by these cells. The decrease in the methylation 
of the neutral lipid fraction could be due to greater competition 
for newly synthesised s-adenos~[methyl-3H1methionine (SAM) in 
these cells. Although methylation of the neutral lipid fraction 
appears to be catalysed by distinct methyltransferases from those 
involved in phospholipid methylatio~~atz et a1~ 1981), both 
classes of enzymes would presumably, compete for the same pool of 
SAM. Perhaps the phospholipid methyltransferases have a greater 
affinity for SAM than do the fatty acidmethyltransferases. 
Cells enriched in PDME or PNME showed a large increase 
in incorporation of [3 H1 label into those phospholipids that 
were next in the methylation pathway (Table 19). This is as 
one might expect since the enriched phospholipid will be rapidly 
methylated. Presumably the greater stimulation of the rate of 
basal methylation in cells enriched with PNME reflects two methyl 
groups being incorporated for each PNME molecule methylated as 
opposed to one per PDME molecule. 
However one might expect PE molecules to incorporate 
3 
three [methyl- H) groups. That the cells exposed to ethanolamine 
do not show a greater increase in basal methylation rate when 
compared to NME-treated cells, suggests some other fate for the 
19, 
3 [methyl- HJ groups incorporated into the ethanolamine-treated 
cells. 
It could be that the cells enriched in PE have an 
active base-exchange pathway which causes a decrease in the 
availability of PE substrate for the methylation reaction. An 
alternative explanation is that the first step of the phospholipid 
methylation reaction is of limited capacity, and cannot incorporate 
3 
all the [methyl- H] groups available. A decreased uptake of 
methionine in ethanolamine-treated cells would appear to be ruled 
out by Fig.16. A limited capacity of PMT I might explain why no 
change is seen in the percentage of label incorporated into the 
neutral lipid fraction in PE-rich cells. This would also explain 
why the radioactivity at the origin (possibly due to free 
methionine) does not decrease in the same fashion as in the DME-
and NME-treated cells. 
Methionine uptake in the cells enriched in PNME, PDME 
or PE is not stimulated in proportion to the increase in rate of 
basal lipid methylation. This indicates that the stimulation in 
the basal rate of lipid methylation by PDME, PNME or PE enrich-
ment is probably due to an increase in the availability of phos-
pholipid substrate for the PMT s, rather than increased avail-
ability of methionine for SAM biosynthesis. By contrast experi-
ments with yeast cells which had an increased PE:PC ratio 
(Trivedi et al., 1982) showed that increasing the PE:PC ratio 
decreased methionine and other amino acid uptake . 
4.3.1 Demethylation in Cells Enriched in PDME and PNME 
in response to Isoproterenol 
The demethylation observed in Table 20 could be due 
to two possible causes. The first is that, since it seems that 
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the lipid methylation pathway is of limited capacity, it could 
be that in the DME- and NME-treated cells the pathway is already 
saturated and simply cannot be increased by a-adrenergic stimula-
tion. This could be due to the fact that any constraints on the 
activity of the enzymes that are normally eaused by the reception 
are relieved by the alteration of the membrane phospholipid 
composition. In addition to this point, Mato et al. (1980) have 
shown that the receptor-mediated stimulation of phospholipid 
methylation in hepatocytes is at a maximum at. l5min, and 
declines to basal levels after GOmin of exposure of the cells to 
glucagon. 
Hashizume et al. (1983) claim that the a-receptor 
constrains the activity of PMT II, the enrichment of the cell 
membranes with PDME or PNME would stimulate PMT II, and possibly 
this overcomes the limitations on PMT II activity normally 
imposed by the a-receptor. 
This however does not fully explain the decrease in 
lipid methylation rate that is observed. I suggest that the 
altered membrane phospholipid environment, or products from the 
methylation reaction activate a phospholipase C which is specific 
for the unsaturated fatty acid-rich phospholipids of the methyla-
tion pathway. Nemecz and Farkas (1980) have demonstrated that 
exposure to isoproterenol stimulates the activity of a phospholi-
pase C in rat liver plasma membranes, and that this effect of 
isoproterenol is not mediated by the a-adrenergic receptor. 
Removal of the phospholipid polar headgroup by the activity of 
a phospholipase would explain the loss in radioactivity from 
the cells. If a phospholipase A2 was activated by isoproterenol 
191;t 
as suggested by Mallorga et al. (1980), one would expect to 
see an accumulation of radioactivity in LPC relative to control 
cells, this was not observed in cells enriched in PDME which were 
stimulated with isoproterenol (data not shown). Breakdown of 
methylated PC to LPC would not be expected to decrease the 
amount of [3 H] recovered from the lipid fraction. 
Similarly a loss of S-receptors in the cells exposed 
to DME, NME or ethanolamine as suggested in section 4.1 would 
not explain loss of [3 H] label from the cells on exposure to 
isoproterenol. 
Why then does demethylation not accompany isoproterenol-
stimulation of the control cells? Possibly, activation of phos-
pholipase C is regulated by the altered phospholipid composition 
of the treated cells, but Castano et al. (1980) followed the 
time course of stimulation of lipid methylation by glucagon in 
hepatocytes. They found that the stimulation of lipid methyla-
tion reached a maximum after l5min exposure to a non-saturating 
dose of glucagon. The rate of lipid methylation decreased 
thereafter, reaching basal levels after 60min. This suggests 
that a decrease in the isoproterenol-stimulated increase in the 
rate of lipid methylation could eventually occur, possibly due to 
receptor desensitisation, or due to the activation of phospholi-
pase C. 
Perhaps the incorporation of large amounts of PDME or 
PNME alters the lipid domains of the membrane around phospholipase 
C molecules. This is unlikely, since PC synthesised by the 
methylation pathway is supposed to be translocated to the outer 
leaflet of the bilayer, presumably this is where the phospholipase 
C would be located. 
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Hous1ay has shown that5-doxylstearic acid spin 
label localises in the outer leaflet of the bilayer, and would 
be sensitive to any such domain changes suggested above. The 
absence of any change in the order parameter of DME- and NME-
treated cells (Table 13) argues against modification of lipid 
domains by PDME or PNME enrichment. 
4.4 B-Adrenergic Responsiveness and Lipid Methylation 
in High Passage C6 cells (Sections 3.8-3.8.5) 
Continuous passage of C6 cells is probably a good 
analogy to the ageing process. On the other hand, continuous 
passage may produce alteration of the cell character by cumula-
tive effects of exposure to the trypsin used in the procedure. 
The morphological changes, and the increase in cell 
size caused by continuous passage that was observed in C6 cells 
(Plate 21, Section 3.8.2) are similar to the relative differences 
observed in C6 cells of passage number 22 and 88 by Parker et al. 
(1980) . The reduction in stimulation of cAMP content on exposure 
to isoproterenol (Table 22) is similar, but not as drastic as 
the reductions observed by Mallorga et al. (1981). 
Particularly interesting is the observation (Table 23) 
that the high passage (HP) cells display an increase in the basal 
rate of lipid methylation, and a demethylation similar to DME-
and NME-treated cells, on exposure to isoproterenol. Mallorga 
et al. (1981) showed that HP cells display an enhanced activity 
of the high Km form of phosphodiesterase, and a decrease in 6-
receptor number. 
In the C6 cells enriched with PE, PNME or PDME it 
seems that phosphodiesterase activity is enhanced (Table 14), 
in this sense these cells are similar in character to the HP 
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cells produced by Mallorga et ale (198 1 ) It is possible then, 
as hypothesised in Section 4.1, that the cells exposed to bases 
also have a decreased 8-adrenergic receptor complement. It 
seems then that the HP cells and the cells grown in the presence 
of bases exhibit similar characteristics. It might be instructive 
to look for common causes of these effects. 
Changes in the lipid composition of the RP cells could 
be responsible for the effects described; however lipid composi-
tion was not examined by Mallorga et al. (19Bl), or by myself, 
so it is impossible to comment on this possibility. 
I have already mentioned that the enhanced basal 
methylation rate in cells exposed to bases could be due to relief 
of restraints on PMT activity by the S-receptor upon altering the 
phospholipid composition. perhaps, since S-adrenergic receptor 
number in HP cells is decreased, the constraints on PMT activity 
are also alleviated in HP cells. If this was the case, it might 
explain the enhanced basal methylation in the HP cells. If that 
werethe case it would seem that the demethylation in response to 
isoproterenol in cells exposed to bases is not a result of the 
elevated basal intracellular cAMP levels, since in HP cells basal 
cAMP content was lower than in low passage cells (Mallorga et al., 
1981) . This would point to the altered phospholipid composition 
of DME- and NME-treated cells being the cause of demethylation. 
The decreased 8-adrenergic responsiveness of HP cells 
was shown to be most likely due to a defect in the coupling of the 
receptor to the G/C unit, since NaF- and Gpp(NH-)p-stimulated 
adenylate cyclase activity was normal. Perhaps, a similar 
situation prevails in the cells exposed to DME, NME and ethanol-
amine. 
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Crews et al. (1981) have demonstrated age-dependent 
changes in the lipid methylation pathway in rat brain synaptosomes. 
They found a progressive increase in the activity of phospholipid 
methyl transferase I in synaptosomes prepared from rat brains of 
age 1-21 months. PMT II activity was not affected. The distri-
bution of incorporated [methyl-3 H) groups in the HP cells was not 
examined, but if a similar situation prevails as in the rat synapt~ 
somes, this might explain why the basal rate of lipid methylation 
was elevated in the HP cells. 
CONCLUSIONS 
"0 Wad some Pow1r the giftie gie us 
To see oursels as others see us! 
It wad frae many a blunder free us 
And foolish notion" 
R. Burns. 
1!f8 
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5.0 CONCLUSIONS 
5.1 Phospholipid Polar Headgroups and the 8-Adrenergic Response 
It seems that the activity of the 8-adrenergic system 
is modulated by the chemical properties of the phospholipid polar 
headgroups as well as by the physical properties of the lipid 
matrix. The most susceptible functions to polar headgroup 
influence appear to be the activity of the catalytic unit of 
adenylate cyclase and the coupling between it and the hormone 
receptor. Phosphodiesterase activity in C6 and other cell mem-
branes is also modulated by changes in the phospholipid polar 
headgroup composition. It seems likely that both the rate of 
cAMP synthesis and its rate of breakdown can be regulated by 
the membrane phospholipids. Whether or not a similar regulation 
occurs in vivo is not clear, but clearly, the possibility exists 
for a sensitive control of the 8-adrenergic response of the cell. 
Cellular phospholipid composition in a given cell line is 
maintained constant by a combination of catabolic and anabolic 
reactions. This does not exclude the possibility that rapid 
transient changes in phospholipid composition, such as rapid 
temporary changes initiated by receptor stimulation/could regulate 
8-adrenergic responsiveness by activation-deactivation of the 
production of secondary messengers. If the assumption is correct 
that boundary lipid regulates membrane protein function, then 
only small, but selective alterations in phospholipid composition 
would be necessary to effect changes in the activity of the 
membrane proteins. Phospholipid methylation could be a mechanism 
by which control of signal transduction is effected. 
Control of membrane protein function by phospholipids 
may not be so simple a mechanism as suggested above. The fine 
tuning necessary for rapid response of and feedback control 
over the system might involve other regulatory agents such as 
protein kinases, calmodulin and phospholipases. 
2Gu 
The modification of phospholipid polar headgroup 
composition in vivo by growing cells in media containing headgroups 
is a usp.ful technique with which to study phospholipid:protein 
interactions, since there appears to be a minimum of undesirable 
perturbations to the system, and of particular importance no 
change in the physical properties of the lipid matrix. These 
are the first recorded studies in which this technique has been 
applied to the study of the 8-adrenergic system. 
The conclusion that the change in the activity of 
adenylate cyclase in the C6 cells treated with DME, NME, or 
ethanolamine are due to the altered phospholipid composition is 
supported by the observation of Engelhard et al. (1976) that the 
increased basal adenylate cyclase activity in membranes prepared 
from cells enriched in PE could be reduced to similar values to 
the control cells by detergent solubilisation of the membranes 
which removed most of the membrane lipid from the enzyme. 
Alternatively, the incorporated PDME, PNME or PE 
could displace endogenous boundary lipid from the enzyme and 
result in activation of the enzyme by changes in the composition 
of lipids intimately associated with the enzyme. 
The reduction in the stimulation of cAMP accumulation 
by isoproterenol in these cells appeared to be principally due to 
an enhanced phosphodiesterase activity in these cells (Table 14). 
However the fact that theophylline cannot restore the degree of 
stimulation by isoproterenol to control levels indicates that the 
PDME-, PN~E-,and PE-enriched cells also have a less effective 
courling between the G/C unit and the B-adrenergic receptor, 
or 3 reduced B-adrenergic receptor number. 
Defects 1n coupling between the 6-receptor and the 
adenylate cyclase 1n virus infected C6 cells has been shown to 
decrease the cAMP response of these cells to isoproterenol 
stimulation (Munzel and Kosche1, 1982; Higashida et a1., 1982). 
A reduction in the number of 8-receptors was observed by 
Higashida et al. (1982), but not by Munzel and Koschel (1982). 
5.2 Lipid Methylation; a Role in S-adrenergic Desensitisation? 
The results discussed in Section 4.2 allow some 
conclusions to be drawn about the nature of lipid methylation ~n 
C6 cells. 
Lipid methylation results in the methylation of neutral 
lipids and of PEe The pathway is of very limited capacity and 
does not cause ~anges in the composition of the bulk phospho-
lipid, nor is it likely to be a significant source of PC bio-
synthesis. It seems likely that two methyltransferases are 
responsible for catalysing the reaction, and that the first 
methylation of PE to PNME appears to be the rate limiting step 
(4.3). The rate of lipid methylation can be stimulated by 
B-adrenergic stimulation, and the result is a general increase 
in the rate of methylation of all the lipid components of the 
cells which is not confined to anyone particular class of 
lipids (4.2.1). Any enhanced coupling of the S -receptor to the 
catalytic unit by an increased rate of lipid methylation does not 
come about by changes in bulk lipid order. 
Calculation of the number of methylated phospholipids 
per B-adrenergic receptor (see appendix VIII) indicates that 
isoproterenol stimulation of lipid methylation in C6 cells 
produces 10-30 methylatedphospholipid molecules per B-adrenergic 
receptor. This is the same order of magnitude as the number of 
lipid molecules in the boundary layer (Jost et al., 1973). 
Therefore one cannot exclude the possibility that stimulation of 
lipid methylation modulates the function of B-adrenergic receptors 
by modifying the composition of boundary lipid. 
The stimulation in the rate of lipid methylation is 
always accompanied by an elevation of the intracellular cAMP 
content whether the elevated cAMP content is a result of 
increased basal adenylate cyclase activity or caused by S-
adrenergic stimulation. However it is impossible to conclude 
whether lipid methylation expedites this increase in intra-
cellular cAMP content or vice versa. Dibutyrl cAMP can partly 
mimic the 8-adrenergic stimulation of the rate of lipid methyla-
tion, which implies that cAMP stimulates the lipid methyl trans-
ferases. 
On the basis of these findings, and with reference to 
studies by other workers, I shall examine the likely role of 
lipid methylation in the 8-adrenergic response. 
The possible roles of lipid methylation in the 
activation of the 8-adrenergic response have already been 
discussed. I propose that lipid methylation is unlikely to be 
involved in facilitating the 8-adrenergic response, and that a 
more likely function of lipid methylation is to initiate events 
which terminate the S-adrenergic signal and when cells become 
desensitised. 
Good evidence that B-adrenergic receptor desensitization 
in C8 cells is mediated by phospholipids comes from work by Mallorga 
et al. (1980). They found that Phospholipase A2 activation was 
responsible for 8-receptor loss after prolonged exposure of the 
cells to isoproterenol. Phospholipase inhibitors could prevent 
the loss of stimulation of cAMP content on challenge with iso-
proterenol. Similarly later work by this group showed that HP 
cells possessed an elevated phospholipase A2 activity (Fishman 
et al., 1981). 
It was also found that on exposure to isoproterenol there was an 
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enhanced breakdown of methyl- H PC (Mallorga et al., 1980) which correlated 
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with an increased rate of release of 14 [1- C]arachldonic acid, 
which had been previously incorporated into the cells. This 
breakdown of [methyl-3 H]PC and loss of [methyl-3H] groups on 
exposure to isoproterenol supports my theory that in the cells 
treated with bases a phospholipase C activity is responsible for 
demethylation upon isoproterenol stimulation. 
Nemecz et ale (1980) have shown that phospholipase C 
treatment of rat liver plasma membranes leads to a loss of i50-
proterenol-stimulated increase in intracellular cAMP content, 
and an elevation of basal adenylate cyclase activity. Further 
evidence to implicate a phospholipase C in the demethylation 
reaction is the observation by Leprohan et ale (1983) that the 
stimulation of the rate of lipid methylation by dopamine in rat 
3 brain neurons is followed by a release of [ H] choline amounting 
to 30% of the 3 [methyl- H) incorporated, within 30min. 
As to the agents and mechanism behind the desensitisation 
provoked by phospholipase activity, one can only speculate. LPC 
and products of phospholipase A2 or phospholipase C action would 
appear to be the most likely candidates. LPC itself would appear 
to be an unlikely agent since although Shier et ale (1976) have 
shown that LPC can inhibit adenyl ate cyclase, it seems that the 
primary event in C6 desensitation is an uncoupling of the 
receptor from the catalytic/regulatory subunits of adenylate 
cyclase (Fishman et al., 1981). Furthermore, if LPC was the 
agent involved there would be no need for a pool of unsaturated 
PC, since saturated acyl chain species of LPC would be as effective 
if the polar headgroup of the LPC molecule was the active component 
initiating receptor loss. 
Phospholipase C activation might cause receptor loss 
by breaking down phospholipids in the immediate vicinity of the 
8-receptor. Alternatively phosphatidic acid synthesis from 1,2-
diacylglycerol could act as a calcium ionophore, but this seems 
unlikely also since Brostrom et al. 2+ (1982) have shown that Ca 
does not appear to have any direct effect on a-receptor number in 
C6 cells. 
These objections favour a product of phospholipase A2 
activity as being the cause of desensitisation and uncoupling of 
the 8-receptor. Some indirect evidence supports this conclusion. 
Shitara et al. (1982) have shown that in C6 cells an increase in 
3 the rate of uptake of [ HJdeoxyglucose parallels ~he time 
course of desensitisation. It is known that uptake of hexose 
sugars into cells is promoted by calcium ionophores (Bass et al., 
1982) and is accompanied by mobilisation of intracellular Ca 2 + 
pools. Bass et al. (1982) 3 demonstrated that [ HJ-deoxyglucose 
uptake into human polymorphonuclear lymphocytes can be stimulated 
by products of the lipoxygenase pathway of arachidonic acid 
metabolism. The most potent activators of 3 [ H]-deoxyglucose 
uptake were found to be 5-HETE and 5,12-0iHETE. These hydroxy 
eicosatetraenoic acids are produced from arachidonic acid by the 
action of 5-lipoxygenase (see Wolfe, 1982 for a review of these 
pathways of arachidonic acid metabolism) . Volp e et al. (1980) 
2+ have demonstrated that these compounds are extremely potent Ca 
ionophores. 
As to the actual mechanism of desensitisation, two 
possibilities are likely. Since uncoupling of the 8-adrenergic 
receptor is the first event in C6 desensitisation (Fiederich et 
al., 1983; Fishman et al., 1981), it is most likely that 
effects of these compounds are on the receptor molecule or its 
immediate lipid matrix. It has been demonstrated by Stenson and 
Parker (1980) that these HETE compounds are incorporated into 
both phospholipids and membrane triacylglycerols after their 
release, in human neutrophils. It could be that they destabilise 
the binding capacity of the 8-adrenergic receptor, and lead to 
receptor loss when they are incorporated into the plasma membrane. 
The second possibility is that since these compounds 
are calcium ionophores, they cause a redistribution of intra-
~+ 
cellular Ca~ pools. A large proportion of the phosphodiesterase 
and adenylate cyclase activity in C6 cells is calcium dependent 
(Brostrom et al., 1976; Wolf and Brostrom, 1976), the effects 
of the cation being mediated by calmodulin. Increasing intra-
2+ 
cellular Ca levels to 100~M inhibits C6 adenylate cyclase, but 
stimulates phosphodiesterase activity. 
Thus lipoxygenase metabolites could terminate the 
cAMP response after 8-agonist stimulation. The lipoxygenase 
metabolites would be produced from arachidonic acid released 
from PC by phospholipase A2 action. A small pool of PC enriched 
in arachidonic acid would be provided by the phospholipid 
methylation pathway. Thus, changes in calcium mobilisation by 
lipoxygenase products might be another explanation of the 
apparently increased phosphodiesterase activity in C6 cells 
exposed to bases. An accumulation of the desensitising agents 
could occur as a result of the elevated basal lipid methylation 
in these cells. 
SUGGESTIONS FOR FURTHER WORK 
"There are spaces still to be filled 
before the map is complete though 
these days, its only in the explored 
territories that men write, sadly 
here live monsters". 
Norman MacCaig 
6.0 SUGGESTIONS FOR FURTHER WORK 
1. To verify the conclusions drawn from the data in Table 14 
that phosphodiesterase activity in cells exposed to DME, 
NME or ethanolamine is elevated, it would be advisable to assay 
the phosphodiesterase activity in the modified cells. 
2 • To establish whether the cells exposed to the phos-
pholipid polar headgroup analogues are indeed desensitised, it 
would be important to measure the B-adrenergic receptor number. 
Measurements of the dissociation constant (Kd) of the B-receptors 
in these cells would indicate whether the phospholipid polar 
headgroup modifications did destabilise the active conformation 
of the receptor units. A normal receptor complement does not 
necessarily imply that all the receptors present are functional. 
A valuable confirmatory experiment would be to determine the 
coupling factor in the modified cells. To do this it would be 
necessary to measure the Kd of a B-adrenergic ligand, e.g. 
dihydroalprenolol, and divide this value by the concentration 
of isoproterenol required to elicit an increase in cAMP content 
which is 50% of the maximum attainable value (Higashida et al., 
1982). This would allow an index to be derived which would give 
an indication of how closely coupled the B-adrenergic receptors 
and the adenylate cyclase units are in these cells. From the 
data derived from such experiments one would be able to decide 
whether or not it was likely that enrichment of C6 cell mem-
branes with PDME, PNME or PE produced B-adrenergic receptor-
adenylate cyclase decoupling. 
3 • To examine the theory that the isoproterenol-induced 
demethylation in cells with modified phospholipid polar headgroup 
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composition is due to phospholipase C activity, it would be 
necessary to examine the phospholipase C activity in these cells, 
On the other hand, if products of the phospholipid 
methylation reaction are responsible for the demethylation and 
apparent a-adrenergic desensitisation in these cells, it would 
be necessary to examine the phospholipase A2 activity in these 
cells. If products of enhanced phospholipase A2 activity are 
responsible for the desensitisation, the likely metabolites of 
arachidonic acid metabolism could be determined by TLC of 
extracts from cells exposed to bases after incorporation of 
14 h'd' 'd [ c]-arac 1 on1C aC1 . 
4 . It seems most likely that the lesion in a-adrenergic 
responsiveness in the base-treated cells could be due to a defect 
in the a-adrenergic receptor coupling to the G/C unit. However, 
it would be useful to check that the adeny1ate cyclase activity 
mediated by the G-protein and directly by the catalytic unit is 
not compromised in these cells. This could be checked by 
measuring adeny1ate cyclase activity in response to NaF, which 
has its effect mediated via the G-protein, and by measuring 
cAMP accumulation in response to forsko1in, which is believed 
to stimulate the catalytic unit directly. 
\ 
Measurement of the adeny1ate cyclase activity in 
membrane preparations would shed light on the results shown in 
Table 14 If the enhanced basal adeny1ate cyclase activity 
is indeed due to activation of the catalytic unit by the modified 
phospholipid composition, one would expect that detergent-
solubilisation of the membranes would lower the adenylate cyclase 
activity to values similar to the untreated cells. 
20~ 
5 • Finally, to determine whether the B-adrenergically-
stimulated increase in cAMP content in C6 cells is dependent 
on phospholipid methylation, it would be interesting to measure 
the response to isoproterenol when lipid methylation is blocked 
by an inhibitor, such as cycloleucine. 
21u 
APPENDICES 
21). 
APPENDIX I: HAEMATOXYLIN-EOSIN STAIN 
(Ref. Drury and Wallington, 1980) 
(a) Prepara tion of Reagen ts 
(i) Haematoxylin Stain 
The following reagents were dissolved in 1 litre 
of distilled water overnight: haematoxylin (lg); sodium 
iodate (0.2g); and potassium alum (50g). To this mixture 
citric acid (lg) and chloral hydrate (50g) were added and the 
solution boiled for 5min. 
(ii) Acid Alcohol 
13M HCl (1 ml) was added to methanol (lOOml) and 
mixed. 
(i i1) Scott's Tap Water 
Sodium bicarbonate (3.5g) and magnesium sulphate 
(20g) and a few crystals of thymol were dissolved in 1 litre 
of distilled water. 
(iv) Eosin Stain 
Eosin 1% (w/v) was dissolved in distilled water. 
Cells were grown on sterile glass cover slips and 
fixed in 2.5% (v/v) glutaraldehyde as described in Section 2.1. 
(b) Procedure 
The coverslips with the fixed cells attached were 
immersed in baths containing the following reagents in turn for 
the times indicated. 
1- Xylene - 5 min. 
2 . Ethanol - 2 min. 
3 . Methylated Spirits - lt min. 
4 . Water - 1 min. 
5. Haematoxylin Stain - 12 min. 
6. The coverslips were washed in tap water, and dipped 
four times in acid alcohol. 
7. Scott's tap water - 1 min. 
8. The coverslips were washed with tap water. 
9. Eosin stain - 5 min. 
10. Methylated spirits - 30 sec. 
11. Ethanol - 2 min. 
12. Ethanol - 1; min. 
13. Xylene - 5 min. 
Before the xylene dried out the coverslips were mounted on 
glass coverslips with "DPX" (British Drug Houses Ltd.) and 
examined by microscope. The cell nuclei are stained blue, 
and the cytoplasm is stained red. 
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APPENDIX II: PREPARATION AND USE OF CHEMICAL TESTS TO 
IDENTIFY LIPIDS RESOLVED ON T.L.C. SYSTEMS 
AFTER DEVELOPMENT 
1. Ninhydrin Stain (Ref. Christie, 1973) 
(a) Preparation 
Ninhydrin (lg) was dissolved in acetone (100 m1) . 
(b) Use of the Stain 
21.) 
The stain was sprayed evenly over the t.l.c. plate 
which was then warmed for 5 min in an oven at 100°C. Lipids 
containing free amino groups (PE and PS) show up as bright 
crimson spots. 
2. Zinzadze Reagent (Ref. Christie, 1973) 
(a) preparation 
Two solutions were prepared. Solution I was 
prepared by boiling 40.1g of M00 3 in 1 litre of 12M H2S0 4 
till dissolved. Solution II was prepared by adding powdered 
molybdenum (1.78g) to Solution I and boiling the solution for 
15min. Solution II was allowed to cool, any residue was 
removed by filtration, and discarded. Equal volumes of I and 
II were mixed and diluted with two volumes of water, to produce 
the working reagent. 
(b) Use of the Stain 
The working reagent was sprayed evenly over the 
t.l.c. plate, and the stain allowed to develop at room tempera-
ture. After Smin, all phospholipids appeared as blue spots. 
3. periodate-Schiffs Reagent (Ref. Christie, 1973) 
(a) Prepara tion 0 f the S ta in 
Three reagents were required. 2% Sodium periodate 
and 2% sodium bisulphite solutions were made up. Schiffs 
reagent was used fresh from the bottle. 
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(b) Use of the Stain 
The t.l.c. plate was sprayed with sodium 
periodate solution and dried at 55°C. The dried plate was then 
sprayed with sodium bisulphite solution and dried at 55°C. This 
was repeated till the iodine stain had disappeared. The cooled 
plate was then sprayed evenly with Schiffs reagent and allowed 
to develop at room temperature. Phospholipids containing 
vicinal diol groups (PI,PG) rapidly appear as purple spots. 
4. Ferric Chloride Stain (Ref. Christie, 1973) 
(a) Preparation of the Sta in 
FeC1 3 .6H 20 (50mg) was dissolved in water (90ml) 
with acetic acid (5ml) and conc. sulphuric acid (5ml). 
(b) Use of the Stain 
The t.l.c. plate was sprayed evenly with reagent 
and heated for 3min at 100°C. The appearance of red-violet 
spots indicate the presence of cholesterol or cholesterol 
esters. 
5. Dragendorff Reagent (Ref. Christie, 1973) 
This test is specific for phospholipids containing 
choline groups (PC, Sphingomyelin and LPC) . 
Two solutions were made: 
I: potassium iodide (40g) was dissolved in 100ml of water. 
II: Bismuth subnitrate (1.7g) was dissolved in acetic acid 
(20% v/v). 
Immediately before use, Sml of I were mixed with 
20ml of II and diluted with distilled water (75ml). 
Use of the Stain 
The t.l.c. plate was sprayed with the mixture, choline-
containing lipids (PC, LPC and Sphingomyelin) appeared within a 
few minutes as orange spots when the plate was gently warmed. 
APPENDIX III: SDS POLYACRYLAMIDE GEL ELECTROPHORESIS 
(Ref. Laemmli, 1970) 
(a) Preparation of Solutions 
(i) Stock solutions: 
acrylamide 30% (w/v) Bio-Rad Laboratories 
bis-acrylamide 0.8% (w/v)Bio-Rad Laboratories 
(ii) Separating Gel Buffer (dilute four-fold before use) 
1.SM Tris He1 Buffer, containing sodium dodecy1 
sulphate (0.4%, w/v). 
pH to 8.7 with concentrated He1. 
(iii) Stacking Gel Buffer (dilute four-fold before use) 
O.SM Tris HCl buffer containing sodium dodecy1 
sulphate (0.4%, w/v) 
pH to 6.8 with concentrated Hel. 
(iv) Sample Buffer (dilute two-fold before use) 
0.13M Tris HCl buffer containing: 
20% (v/v) glycerol 
2% (v Iv) mercaptoethanol 
4% (w/v) sodium dodecyl sulphate 
0.1% (w Iv) bromophenol blue 
pH to 6.8 with concentrated Hel. 
(v) Reservoir Buffer (dilute five-fold before use) 
0.12SM Tris Hel containing: 
0.96M Tris glycine and 0.5% (w/v) sodium dodecyl 
sulphate. 
After dilution prior to use, adjust pH to 8.3 with 
concentrated Hel. 
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(b) Gel Solutions 
(i) Separating Gel 
To make a 12% acrylamide gel (30ml/slab) the stock 
solutions were mixed in the proportions below in the following 
order: 
Separating gel buffer 
Distilled water 
Acrylamide solution 
TEMED 
7.5ml 
10.5 ml 
12 ml 
20Ul 
10% (w/v) ammonium persulphate lOOUl 
The mixture was degassed prior to addition of TEMED 
and ammonium persulphate, after addition of the latter compo-
nents the mixture was poured into the casting apparatus and 
allowed to set. 
(ii) Stacking Gel 
The stacking gel, IOmls/slab (4% acrylamide), was 
made by mixing the stock solutions in the proportions: 
Stacking gel buffer 2.5ml 
Distilled water 
Acrylamide solution 
TEMED 
10% ammonium persulphate 
6.1ml 
1.34ml 
lOUl 
SOUl 
The mixture was degassed as above, and the gel cast on top 
of the solidified separating gel. 
Rurming Conditions 
Electrophoresis was carried out using a voltage of 130V and a current 
of 30mA overnight. The power pack was used in the constant voltage node. 
Staining Conditions 
The staining solution consisted of the following: 
0.05% (v/v) Coanassie Blue 
25% (v/v)isoprop~loJ., 
10% (v/v) acetic acid 
'!be dye was dissolved in 1,320 ml of distilled water, and then the sol vents 
were added. The stain solution was filtered, and stored till required.The 
sr:s polyacrylamide gels were stained in this solution for 3Omin. 
restaining 
'!he stained gels were left to destain overnight in 10% (v/v) acetic acid 
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APPENDIX IV: COCKTAILS FOR LIQUID SCINTILLATION SPECTROMETRY 
Two cocktail solutions were used in this project for deter-
mining radioactivity in aqueous samples or for measuring the 
radioactivity in lipid samples after evaporation of organic 
solvent. 
1. Scintillation Cocktail used with Lipid Extracts 
2,5-Diphenyoxalazole (lOg) and 1,4-di-2-(4-methyl-5-
phenyl oxazolyl) benzene (0.6g) were dissolved in 2 litres of 
analar grade toluene. 10ml of this cocktail was added to lipid 
residue in scintillation vials. Counting efficiency was found 
to be 55% for tritium. 
2. Scintillation Cocktail for Aqueous Samples 
This cocktail was used for determining the radio-
activity in silica gel samples from t.l.c. plates and for the 
aqueous supernatant from cyclic AMP assays. 
Cocktail 1 was mixed with triton X-laO and water 
in the proportions: 
Toluene cocktail/Triton X-lOa/water 10:5:1 (v/v) 
counting efficiency for tritium was found to be about 25\. 
15ml of cocktail were added to the sample in scintillation vials. 
APPENDIX V: 
Fig.17: 
FATTY ACID METHYL ESTER PROFILES FROM C6 CELLS 
ANALYSED BY GAS LIQUID CHROMATOGRAPHY 
Fatty acid methyl ester profile obtained after 
analysis of C6 cell preparations on a g.l.c. 
column packed with 15% EGSSX as the stationary 
phase. 
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Fig.18(overleaf): Fatty acid methyl ester profile obtained 
after analysis of C6 cell preparations on a 
g.l.c. column packed with lS% EGSSY as the 
stationary phase. 
EGSS-X: A copolymer of polymeric ethylene-glycol 
succinate with methylsilicone 
ESS-Y As above, but with a higher proportion of methyl-
silicone (Christie, 1973). 
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APPENDIX VI: 
Fig.l9: 
Fig.20: 
Fig.21: 
DPH FLUORESCENCE SPECTRA 
Excitation spectrum of DPH incorporated 
into C6 cell membranes 
Emission spectrum of DPB incorporated into 
C6 cell membranes 
Absorption spectrum of DPB in tetrahydrofuran 
FLUORESCENCE 
INTENSITY 
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Fig.19: 
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APPENDIX VII: COMPOSITION OF REAGENT B (PROTEIN ASSAY) 
reagent B was made immiedietly before use by mixing the following solutions: 
2% Na K tartrate (0.5ml.) 
1% copper sulphate(O.5m1) 
2% sodium carbonate ( 5Cknl.) 
220 
APPENDIX VIII: CALCULATION OF INCREASE IN 
NUMBER OF N-METHYLATED PHOSPHOLIPIDS PER 
S-ADRENERGIC RECEPTOR AFTER ISOPROTERENOL 
STIMULATION. 
Incubation mixture contains 1 m1 of O.lmM non radioactive 
methionine = 100nmol to which is added 70~Ci of [3H] methionine 
specific activity of methionine 
= 70~Ci/100nmol 
= 0.7n Ci/pmol 
Now since 1 nCi = 2220 d.p.m. 
specific activity = 1554 dpm/pmol 
From Table 18: PNME = 2% of total [3H] recovered 
(Columns 1 and 2) PDME ... 6 " " " " 
PC = 11 " " " " 
. N-Methylated phospholipid= 19 " 
" " " 
Since % does not changeon isoproterenol stimulation, number of CH 3 
groups incorporated = ~ 19% of 12382 - ~ 19% of 8907 = 660 dpm ... 
0.424 pmol 
Now 0.424 pmo1 
= 0.424 x 10- 12 x 6 x 10 23 molecules 
= 2.54 x 101lmolecules methylated 
from Table 9, number of ce1ls/mg protein = 10 7 , 
sin c e Li n br 0 t ray con t a ins o. 4 mg pro t e in = 'V 2 x 10 6 cell s 
(a) Assuming 4,000B receptors/cell = 8 x 109 receptors/0.4mg protein 
(b) Assuming 10,000 B receptors/cell = 2 x 10 10 receptors/0.4mg protein 
( a) Ratio = 
(b) Ratio = 
2.54 x 10 11mo1ecules 
2 x 1010 receptors 
2.54 x 1011 molecules 
9 8 x 10 receptors 
= 
= 31 
12.8 N-methylated 
phospholipids per 
B-adrenergic receptor 
N-methylated phospho-
lipids per 8-adrenergic 
receptor 
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